Document:

Exhibit
10.2

 

REGISTRATION
RIGHTS AGREEMENT

 

This
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 7, 2022, is by and
between White Lion Capital, LLC, a Nevada limited liability company (the “Investor”), and Aesther
Healthcare Acquisition Corp., a Delaware corporation (the “Company”).

 

RECITALS

 

A.
The Company and the Investor have entered into that certain Common Stock Purchase Agreement, dated as of the date hereof (the “Purchase
Agreement”), which Purchase Agreement provides that the Company shall issue to the Investor the Commitment Shares (as defined
in the Purchase Agreement), and the Company may issue, from time to time, to the Investor up to $75,000,000 in aggregate gross purchase
price of newly issued shares of the Company’s Class A common stock, par value $0.0001 per share, or, following the Merger,
newly issued shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), subject
to the Exchange Cap and other limitations set forth therein.

 

B.
Pursuant to the terms of, and in consideration for the Investor entering into, the Purchase Agreement, and to induce the Investor to
execute and deliver the Purchase Agreement, the Company has agreed to provide the Investor with certain registration rights with respect
to the Registrable Securities (as defined herein) as set forth herein.

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the representations, warranties, covenants and agreements contained herein and in the Purchase
Agreement, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, intending to be
legally bound hereby, the Company and the Investor hereby agree as follows:

 

	1.	Definitions.

 

Capitalized
terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement. As used in
this Agreement, the following terms shall have the following meanings:

 

(a)
“Adverse Disclosure” shall mean any public disclosure of material non-public information, which disclosure,
in the good faith judgment of the Chief Executive Officer of the Company or the Board of Directors of the Company, after consultation
with counsel to the Company, (i) would be required to be made in any Registration Statement or Prospectus in order for the applicable
Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements contained therein (in the case of any Prospectus, in the light of the circumstances under which they were made)
not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being filed, declared effective
or used, as the case may be, and (iii) the Company has a bona fide business purpose for not making such information public.

 

(b)
“Agreement” shall have the meaning assigned to such term in the preamble of this Agreement

 

(c)
“Allowable Grace Period” shall have the meaning assigned to such term in Section 3(p).

 

(d)
“Blue Sky Filing” shall have the meaning assigned to such term in Section 6(a).

 

(e)
“Business Day” means any day other than Saturday, Sunday or any other day on which commercial banks in New
York, New York are authorized or required by law to remain closed.

 

(f)
“Claims” shall have the meaning assigned to such term in Section 6(a).

 

(g)
“Commission” means the U.S. Securities and Exchange Commission or any successor entity.

 

    	 

    	 

    

 

(h)
“Common Stock” shall have the meaning assigned to such term in the recitals to this Agreement.

 

(i)
“Company” shall have the meaning assigned to such term in the preamble of this Agreement.

 

(j)
“Effective Date” means the date that the applicable Registration Statement has been declared effective by the
Commission.

 

(k)
“Indemnified Damages” shall have the meaning assigned to such term in Section 6(a).

 

(l)
“Initial Registration Statement” shall have the meaning assigned to such term in Section 2(a).

 

(m)
“Investor” shall have the meaning assigned to such term in the preamble of this Agreement.

 

(n)
“Investor Party” and “Investor Parties” shall have the meaning assigned to such terms in Section 6(a).

 

(o)
“Legal Counsel” shall have the meaning assigned to such term in Section 2(b).

 

(p)
“New Registration Statement” shall have the meaning assigned to such term in Section 2(c).

 

(q)
“Person” means any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership,
limited liability company, trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.

 

(r)
“Prospectus” means the prospectus in the form included in the Registration Statement at the applicable Effective
Date of the Registration Statement, as supplemented from time to time by any Prospectus Supplement, including the documents incorporated
by reference therein.

 

(s)
“Prospectus Supplement” means any prospectus supplement to the Prospectus filed with the Commission from time
to time pursuant to Rule 424(b) under the Securities Act, including the documents incorporated by reference therein.

 

(t)
“Purchase Agreement” shall have the meaning assigned to such term in the recitals to this Agreement.

 

(u)
“register,” “registered,” and “registration” refer to a
registration effected by preparing and filing one or more Registration Statements in compliance with the Securities Act and pursuant
to Rule 415 and the declaration of effectiveness of such Registration Statement(s) by the Commission.

 

(v)
“Registrable Securities” means all of (i) the Shares, (ii) the Commitment Shares and (iii) any capital
stock of the Company issued or issuable with respect to such Shares or Commitment Shares, including, without limitation, (1) as
a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise and (2) shares of capital
stock of the Company into which the shares of Common Stock are converted or exchanged and shares of capital stock of a successor entity
into which the shares of Common Stock are converted or exchanged, in each case until such time as such securities cease to be Registrable
Securities pursuant to Section 2(f).

 

(w)
“Registration Statement” means a registration statement or registration statements of the Company filed under
the Securities Act covering the resale by the Investor of Registrable Securities, as such registration statement or registration statements
may be amended and supplemented from time to time, including all documents filed as part thereof or incorporated by reference therein.

 

(x)
“Registration Period” shall have the meaning assigned to such term in Section 3(a).

 

(y)
“Rule 144” means Rule 144 promulgated by the Commission under the Securities Act, as such rule may be amended
from time to time, or any other similar or successor rule or regulation of the Commission that may at any time permit the Investor to
sell securities of the Company to the public without registration.

 

    	2

    	 

    

 

(z)
“Rule 415” means Rule 415 promulgated by the Commission under the Securities Act, as such rule may be amended
from time to time, or any other similar or successor rule or regulation of the Commission providing for offering securities on a delayed
or continuous basis.

 

(aa)
“Staff” shall have the meaning assigned to such term in Section 2(e).

 

(bb)
“Violations” shall have the meaning assigned to such term in Section 6(a).

 

	2.	Registration.

 

(a)
Mandatory Registration. The Company shall prepare and, as soon as practicable after the date of this Agreement, file with the
Commission an initial Registration Statement on Form S-1 (or any successor form) covering the resale by the Investor of (i)
all of the Commitment Shares and (ii) the maximum number of Registrable Securities as shall be permitted to be included thereon in accordance
with applicable Commission rules, regulations and interpretations so as to permit the resale of such Registrable Securities by the Investor
under Rule 415 under the Securities Act at then prevailing market prices (and not fixed prices) (the “Initial Registration
Statement”). The Initial Registration Statement shall contain the “Selling Stockholder” and “Plan of
Distribution” sections in substantially the form attached hereto as Exhibit B. The Company shall use its commercially
reasonable efforts to have the Initial Registration Statement declared effective by the Commission as soon as reasonably practicable
following the filing thereof with the Commission.

 

(b)
Legal Counsel. Subject to Section 5 hereof, the Investor shall have the right to select one legal counsel to review, solely
on its behalf, any registration pursuant to this Section 2 (“Legal Counsel”), which shall be Greenberg
Traurig, P.A., or such other counsel as thereafter designated by the Investor. Investor shall pay, and the Company shall have no obligation
to reimburse the Investor for, any and all legal fees and expenses of the Legal Counsel incurred on Investor’s behalf in connection
with the transactions contemplated hereby.

 

(c)
Sufficient Number of Shares Registered. If at any time all Registrable Securities are not covered by the Initial Registration
Statement filed pursuant to Section 2(a) as a result of Section 2(e) or otherwise, the Company shall use its commercially reasonable
efforts to file with the Commission one or more additional Registration Statements so as to cover all of the Registrable Securities not
covered by such initial Registration Statement, in each case, as soon as practicable (taking into account any position of the staff of
the Commission (“Staff”) with respect to the date on which the Staff will permit such additional Registration
Statement(s) to be filed with the Commission and the rules and regulations of the Commission) (each such additional Registration Statement,
a “New Registration Statement”). The Company shall use its commercially reasonable efforts to cause each such
New Registration Statement to become effective as soon as reasonably practicable following the filing thereof with the Commission.

 

(d)
No Inclusion of Other Securities. In no event shall the Company include any securities other than Registrable Securities on any
Registration Statement pursuant to Section 2(a) or Section 2(c) without consulting the Investor and Legal Counsel prior to
filing such Registration Statement with the Commission.

 

(e)
Offering. If the Staff or the Commission seeks to characterize any offering pursuant to a Registration Statement filed pursuant
to this Agreement as constituting an offering of securities that does not permit such Registration Statement to become effective and
be used for resales by the Investor on a delayed or continuous basis under Rule 415 at then-prevailing market prices (and not fixed prices),
or if after the filing of any Registration Statement pursuant to Section 2(a) or Section 2(c), the Company is otherwise required
by the Staff or the Commission to reduce the number of Registrable Securities included in such Registration Statement, then the Company
shall reduce the number of Registrable Securities to be included in such Registration Statement (after consultation with the Investor
and Legal Counsel as to the specific Registrable Securities to be removed therefrom) until such time as the Staff and the Commission
shall so permit such Registration Statement to become effective and be used as aforesaid. Notwithstanding anything in this Agreement
to the contrary, if after giving effect to the actions referred to in the immediately preceding sentence, the Staff or the Commission
does not permit such Registration Statement to become effective and be used for resales by the Investor on a delayed or continuous basis
under Rule 415 at then-prevailing market prices (and not fixed prices), the Company shall not request acceleration of the Effective Date
of such Registration Statement, the Company shall promptly (but in no event later than 48 hours) request the withdrawal of such Registration
Statement pursuant to Rule 477 under the Securities Act. In the event of any reduction in Registrable Securities pursuant to this paragraph,
the Company shall use its commercially reasonable efforts to file one or more New Registration Statements with the Commission in accordance
with Section 2(c) until such time as all Registrable Securities have been included in Registration Statements that have been declared
effective and the Prospectuses contained therein are available for use by the Investor.

 

    	3

    	 

    

 

(f)
Any Registrable Security shall cease to be a “Registrable Security” at the earliest of the following: (i) when a Registration
Statement covering such Registrable Security becomes or has been declared effective by the Commission and such Registrable Security has
been sold or disposed of pursuant to such effective Registration Statement; (ii) when such Registrable Security is held by the Company
or one of its Subsidiaries or otherwise ceases to be outstanding; (iii) when such Registrable Security has otherwise been transferred,
without bearing a legend restricting further transfer, and subsequent public distribution of them shall not require registration under
the Securities Act (iv) the first (1st) anniversary of the date of the last sale of any Registrable Securities to the
Investor pursuant to the Purchase Agreement; and (v) when the Registrable Securities are eligible for resale pursuant to Rule 144
without volume or any other limitations contained therein.

 

	3.	Related
    Obligations.

 

The
Company shall use its commercially reasonable efforts to effect the registration of the Registrable Securities in accordance with the
intended method of disposition thereof, and, pursuant thereto, during the term of this Agreement, the Company shall have the following
obligations:

 

(a)
The Company shall promptly prepare and file with the Commission the Initial Registration Statement pursuant to Section 2(a) hereof and
one or more New Registration Statements pursuant to Section 2(c) hereof with respect to the Registrable Securities, and the Company
use its commercially reasonable efforts to cause each such Registration Statement to become effective as soon as practicable after such
filing. Subject to Allowable Grace Periods, the Company shall keep each Registration Statement effective (and the Prospectus contained
therein available for use) pursuant to Rule 415 for resales by the Investor on a continuous basis at then-prevailing market prices (and
not fixed prices) at all times until the earlier of (i) the date on which the Investor shall have sold all of the Registrable Securities
covered by such Registration Statement and (ii) the date of termination of the Purchase Agreement if as of such termination date
the Investor holds no Registrable Securities (or, if applicable, the date on which such securities cease to be Registrable Securities
after the date of termination of the Purchase Agreement) (the “Registration Period”). Notwithstanding anything
to the contrary contained in this Agreement (but subject to the provisions of Section 3(p) hereof), the Company shall ensure that,
when filed and at all times while effective, each Registration Statement (including, without limitation, all amendments and supplements
thereto) and the Prospectus (including, without limitation, all amendments and supplements thereto) used in connection with such Registration
Statement shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or
necessary to make the statements therein (in the case of Prospectuses, in the light of the circumstances in which they were made) not
misleading, in each case, except for any such statements or omissions are made in conformity with information furnished or required to
be furnished in writing to the Company by Investor expressly for use in connection with the preparation of such Registration Statement
or Prospectus or any such amendment thereof or supplement thereto (it being hereby acknowledged and agreed that the written information
set forth in the first, fourth, sixth and eleventh paragraphs of Exhibit B attached hereto, and on Exhibit C attached
hereto, is the only written information furnished to the Company by or on behalf of the Investor expressly for use in any Registration
Statement or Prospectus). The Company shall submit to the Commission, as soon as reasonably practicable after the date that the Company
learns that no review of a particular Registration Statement will be made by the Staff or that the Staff has no further comments on a
particular Registration Statement (as the case may be), a request for acceleration of effectiveness of such Registration Statement to
a time and date as soon as reasonably practicable in accordance with Rule 461 under the Securities Act.

 

    	4

    	 

    

 

(b)
Subject to Section 3(p) of this Agreement, the Company shall use its commercially reasonable efforts to prepare and file with the
Commission such amendments (including, without limitation, post-effective amendments) and supplements to each Registration Statement
and the Prospectus used in connection with each such Registration Statement, which Prospectus is to be filed pursuant to Rule 424 promulgated
under the Securities Act, as may be necessary to keep each such Registration Statement effective (and the Prospectus contained therein
current and available for use) at all times during the Registration Period for such Registration Statement, and, during such period,
comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company required
to be covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance
with the intended methods of disposition by the Investor. Without limiting the generality of the foregoing, the Company covenants and
agrees that (i) at or before 8:30 a.m. (New York City time) on the second (2nd) Trading Day immediately following the
Effective Date of the Initial Registration Statement and any New Registration Statement (or any post-effective amendment thereto), the
Company shall file with the Commission in accordance with Rule 424(b) under the Securities Act the final Prospectus to be used in connection
with sales pursuant to such Registration Statement (or post-effective amendment thereto), and (ii) if the transactions contemplated
by any Purchase are material to the Company (individually or collectively with all other prior Purchases, the consummation of which have
not previously been reported in any Prospectus Supplement filed with the Commission under Rule 424(b) under the Securities Act or in
any report, statement or other document filed by the Company with the Commission under the Exchange Act), or if otherwise required under
the Securities Act (or the interpretations of the Commission thereof), in each case as reasonably determined by the Company, then, at
or before 8:30 a.m., New York City time, on the first (1st) Trading Day immediately following the Purchase Settlement Date,
if a Purchase Notice was properly delivered to the Investor hereunder in connection with such Purchase, the Company shall file with the
Commission a Prospectus Supplement pursuant to Rule 424(b) under the Securities Act with respect to the Purchase(s), the
total Purchase Amount for the Shares subject to such Purchase(s) (as applicable), the applicable Purchase Amount(s) for such Shares and
the net proceeds that are to be (and, if applicable, have been) received by the Company from the sale of such Shares. To the extent not
previously disclosed in the Prospectus or a Prospectus Supplement, the Company shall disclose in its Quarterly Reports on Form 10-Q and
in its Annual Reports on Form 10-K the information described in the immediately preceding sentence relating to all Purchase(s)
consummated during the relevant fiscal quarter and shall file such Quarterly Reports and Annual Reports with the Commission within the
applicable time period prescribed for such report under the Exchange Act. In the case of amendments and supplements to any Registration
Statement on Form S-1 or Prospectus related thereto which are required to be filed pursuant to this Agreement (including, without
limitation, pursuant to this Section 3(b)) by reason of the Company filing a report on Form 8-K, Form 10-Q or
Form 10-K or any analogous report under the Exchange Act, the Company shall have incorporated such report by reference into
such Registration Statement and Prospectus, if applicable, or shall file such amendments or supplements to the Registration Statement
or Prospectus with the Commission on the same day on which the Exchange Act report is filed which created the requirement for the Company
to amend or supplement such Registration Statement or Prospectus, for the purpose of including or incorporating such report into such
Registration Statement and Prospectus. The Company consents to the use of the Prospectus (including, without limitation, any supplement
thereto) included in each Registration Statement in accordance with the provisions of the Securities Act and with the securities or “Blue
Sky” laws of the jurisdictions in which the Registrable Securities may be sold by the Investor, in connection with the resale of
the Registrable Securities and for such period of time thereafter as such Prospectus (including, without limitation, any supplement thereto)
(or in lieu thereof, the notice referred to in Rule 173(a) under the Securities Act) is required by the Securities Act to be delivered
in connection with resales of Registrable Securities.

 

(c)
The Company shall (A) permit Legal Counsel an opportunity to review and comment upon (i) each Registration Statement at least
two (2) Business Days prior to its filing with the Commission and (ii) all amendments and supplements to each Registration
Statement (including, without limitation, the Prospectus contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports
on Form 10-Q, Current Reports on Form 8-K, and any similar or successor reports or Prospectus Supplements the contents
of which is limited to that set forth in such reports) within a reasonable number of days prior to their filing with the Commission,
and (B) shall reasonably consider any comments of the Investor and Legal Counsel on any such Registration Statement or amendment
or supplement thereto or to any Prospectus contained therein. The Company shall promptly furnish to Legal Counsel, without charge, (i) electronic
copies of any correspondence from the Commission or the Staff to the Company or its representatives relating to each Registration Statement
(which correspondence shall be redacted to exclude any material, non-public information regarding the Company or any of its
Subsidiaries), (ii) after the same is prepared and filed with the Commission, one (1) electronic copy of each Registration
Statement and any amendment(s) and supplement(s) thereto, including, without limitation, financial statements and schedules, all documents
incorporated therein by reference, if requested by the Investor, and all exhibits and (iii) upon the effectiveness of each Registration
Statement, one (1) electronic copy of the Prospectus included in such Registration Statement and all amendments and supplements
thereto; provided, however, the Company shall not be required to furnish any document (other than the Prospectus, which may be provided
in .PDF format) to Legal Counsel to the extent such document is available on EDGAR).

 

    	5

    	 

    

 

(d)
Without limiting any obligation of the Company under the Purchase Agreement, the Company shall promptly furnish to the Investor, without
charge, (i) after the same is prepared and filed with the Commission, at least one (1) electronic copy of each Registration
Statement and any amendment(s) and supplement(s) thereto, including, without limitation, financial statements and schedules, all documents
incorporated therein by reference, if requested by the Investor, all exhibits thereto, (ii) upon the effectiveness of each Registration
Statement, one (1) electronic copy of the Prospectus included in such Registration Statement and all amendments and supplements
thereto (or such other number of copies as the Investor may reasonably request from time to time) and (iii) such other documents,
including, without limitation, copies of any final Prospectus and any Prospectus Supplement thereto, as the Investor may reasonably request
from time to time in order to facilitate the disposition of the Registrable Securities owned by the Investor; provided, however, the
Company shall not be required to furnish any document (other than the Prospectus, which may be provided in .PDF format) to the Investor
to the extent such document is available on EDGAR).

 

(e)
The Company shall take such action as is reasonably necessary to (i) register and qualify, unless an exemption from registration
and qualification applies, the resale by the Investor of the Registrable Securities covered by a Registration Statement under such other
securities or “Blue Sky” laws of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions,
such amendments (including, without limitation, post-effective amendments) and supplements to such registrations and qualifications as
may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions as may be reasonably
necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv) take
all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided,
however, the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business
in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(e), (y) subject itself to general
taxation in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. The Company shall
promptly notify Legal Counsel and the Investor of the receipt by the Company of any notification with respect to the suspension of the
registration or qualification of any of the Registrable Securities for sale under the securities or “Blue Sky” laws of any
jurisdiction in the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.

 

(f)
The Company shall notify Legal Counsel and the Investor in writing of the happening of any event, as promptly as reasonably practicable
after becoming aware of such event, as a result of which the Prospectus included in a Registration Statement, as then in effect, includes
an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain
any material, non-public information regarding the Company or any of its Subsidiaries), and, subject to Section 3(p),
promptly prepare a supplement or amendment to such Registration Statement and such Prospectus contained therein to correct such untrue
statement or omission and deliver one (1) electronic copy of such supplement or amendment to Legal Counsel and the Investor (or
such other number of copies as Legal Counsel or the Investor may reasonably request). The Company shall also promptly notify Legal Counsel
and the Investor in writing (i) when a Prospectus or any Prospectus Supplement or post-effective amendment has been filed, when
a Registration Statement or any post-effective amendment has become effective (notification of such effectiveness shall be delivered
to Legal Counsel and the Investor by facsimile or e-mail on the same day of such effectiveness), and when the Company receives
written notice from the Commission that a Registration Statement or any post-effective amendment will be reviewed by the Commission;
provided, however, the Company shall not be required to notify Legal Counsel or the Investor of any such filing or effectiveness that
is available on EDGAR, (ii) of any request by the Commission for amendments or supplements to a Registration Statement or related
Prospectus or related information, (iii) of the Company’s reasonable determination that a post-effective amendment to a Registration
Statement would be appropriate and (iv) of the receipt of any request by the Commission or any other federal or state governmental
authority for any additional information relating to the Registration Statement or any amendment or supplement thereto or any related
Prospectus. The Company shall respond as promptly as reasonably practicable to any comments received from the Commission with respect
to a Registration Statement or any amendment thereto. Nothing in this Section 3(f) shall limit any obligation of the Company under
the Purchase Agreement.

 

(g)
The Company shall (i) use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness
of a Registration Statement or the use of any Prospectus contained therein, or the suspension of the qualification, or the loss of an
exemption from qualification, of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is
issued, to obtain the withdrawal of such order or suspension at the earliest possible time and (ii) notify Legal Counsel and the
Investor of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any
proceeding.

 

    	6

    	 

    

 

(h)
The Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless
(i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such
information is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be
disclosed in such Registration Statement pursuant to the Securities Act, (iii) the release of such information is ordered pursuant
to a subpoena or other final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such
information has been made generally available to the public other than by disclosure in violation of this Agreement or any other Transaction
Document. The Company agrees that it shall, upon learning that disclosure of such information concerning the Investor is sought in or
by a court or governmental body of competent jurisdiction or through other means, give prompt written notice to the Investor and allow
the Investor, at the Investor’s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order
for, such information.

 

(i)
Without limiting any obligation of the Company under the Purchase Agreement, the Company shall use its commercially reasonable efforts
either to (i) cause all of the Registrable Securities covered by each Registration Statement to be listed on the Trading Market,
or (ii) secure designation and quotation of all of the Registrable Securities covered by each Registration Statement on another
Eligible Market. The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section 3(i).

 

(j)
The Company shall cooperate with the Investor and, to the extent applicable, facilitate the timely preparation and delivery of Registrable
Securities, as DWAC Shares, to be offered pursuant to a Registration Statement and enable such DWAC Shares to be in such denominations
or amounts (as the case may be) as the Investor may reasonably request from time to time. Investor hereby agrees that it shall cooperate
with the Company, its counsel and Transfer Agent in connection with any issuances of DWAC Shares, and hereby represents, warrants and
covenants to the Company that that it will resell such DWAC Shares only pursuant to the Registration Statement in which such DWAC Shares
are included, in a manner described under the caption “Plan of Distribution” in such Registration Statement, and in a manner
in compliance with all applicable U.S. federal and state securities laws, rules and regulations, including, without limitation, any applicable
prospectus delivery requirements of the Securities Act. At the time such DWAC shares are offered and sold pursuant to the Registration
Statement, such DWAC Shares shall be free from all restrictive legends may be transmitted by the Transfer Agent to the Investor by crediting
an account at DTC as directed in writing by the Investor.

 

(k)
Upon the written request of the Investor, the Company shall as soon as reasonably practicable after receipt of notice from the Investor
and subject to Section 3(p) hereof, (i) incorporate in a Prospectus Supplement or post-effective amendment such information
as the Investor reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including,
without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price being
paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required
filings of such Prospectus Supplement or post-effective amendment after being notified of the matters to be incorporated in such Prospectus
Supplement or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement or Prospectus contained
therein if reasonably requested by the Investor.

 

(l)
Reserved.

 

(m)
The Company shall make generally available to its security holders (which may be satisfied by making such information available on EDGAR)
as soon as practical, but not later than ninety (90) days after the close of the period covered thereby, an earnings statement (in
form complying with, and in the manner provided by, the provisions of Rule 158 under the Securities Act) covering a twelve-month period
beginning not later than the first day of the Company’s fiscal quarter next following the applicable Effective Date of each Registration
Statement.

 

(n)
The Company shall otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the Commission
in connection with any registration hereunder.

 

    	7

    	 

    

 

(o)
To the extent required by the Transfer Agent, within one (1) Business Day after each Registration Statement which covers Registrable
Securities is declared effective by the Commission, the Company shall deliver, and shall cause legal counsel for the Company to deliver,
to the Transfer Agent for such Registrable Securities (with copies to the Investor) confirmation that such Registration Statement has
been declared effective by the Commission substantially in the form attached hereto as Exhibit A.

 

(p)
Notwithstanding anything to the contrary contained herein (but subject to the last sentence of this Section 3(p)), at any time after
the Effective Date of a particular Registration Statement when the Investor is not in possession of any Registrable Securities, the Company
may, upon written notice to Investor, suspend Investor’s use of any prospectus that is a part of any Registration Statement (in
which event the Investor shall immediately discontinue sales of the Registrable Securities pursuant to such Registration Statement contemplated
by this Agreement, but shall settle any previously made sales of Registrable Securities), if the Investor’s continued use of such
Prospectus in connection with any sale, transfer or other disposition of Registrable Securities by the Investor pursuant to such Registration
Statement would (i) require the Company to make any Adverse Disclosure, (ii) require the inclusion in such Registration Statement and
Prospectus of financial statements that are unavailable to the Company for reasons beyond the Company’s control, or (iii) in the
good faith judgment of the majority of the Board of Directors of the Company (after consultation with counsel to the Company), be materially
detrimental to the Company, and the majority of the Board of Directors of the Company concludes as a result that it is prudent to suspend
the Investor’s continued use of such Prospectus in connection with any sale, transfer or other disposition of Registrable Securities
by the Investor pursuant to such Registration Statement, and to defer an amendment or supplement to such Registration Statement (or such
Prospectus) contemplated by this Agreement on a post effective basis, as applicable, at such time (each, an “Allowable Grace
Period”); provided, however, that in no event shall the Investor be suspended from selling Registrable Securities
pursuant to any Registration Statement for a period that exceeds 45 consecutive Trading Days or an aggregate of 90 days in any 365-day period;
and provided, further, the Company shall not effect any such suspension during the Valuation Period following the Purchase
Date for each Purchase. Upon disclosure of such information or the termination of the condition described above, the Company shall provide
prompt notice, but in any event within one Business Day of such disclosure or termination, to the Investor and shall promptly terminate
any suspension of sales it has put into effect and shall take such other reasonable actions to permit registered sales of Registrable
Securities as contemplated in this Agreement (including as set forth in the first sentence of Section 3(f) with respect to the information
giving rise thereto unless such material, non-public information is no longer applicable). Notwithstanding anything to the
contrary contained in this Section 3(p), the Company shall cause the Transfer Agent to deliver DWAC Shares to a transferee of the
Investor in accordance with the terms of the Purchase Agreement in connection with any sale of Registrable Securities with respect to
which (i) the Company has made a sale to Investor and (ii) the Investor has entered into a contract for sale, and delivered
a copy of the Prospectus included as part of the particular Registration Statement to the extent applicable, in each case prior to the
Investor’s receipt of the notice of an Allowable Grace Period and for which the Investor has not yet settled.

 

	4.	Obligations
    of the Investor.

 

(a)
At least five (5) Business Days prior to the first anticipated filing date of each Registration Statement (or such shorter period
to which the parties agree), the Company shall notify the Investor in writing of the information the Company requires from the Investor
with respect to such Registration Statement. For purposes of this Agreement and the Purchase Agreement, it shall be a condition precedent
to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the Registrable Securities
of the Investor that the Investor shall furnish to the Company such information regarding itself, the Registrable Securities held by
it and the intended method of disposition of the Registrable Securities held by it, as shall be reasonably required to effect and maintain
the effectiveness of the registration of such Registrable Securities and shall execute such documents in connection with such registration
as the Company may reasonably request.

 

(b)
The Investor, by its acceptance of the Commitment Shares and Registrable Securities, agrees to cooperate with the Company as reasonably
requested by the Company in connection with the preparation and filing of each Registration Statement hereunder, including by providing
all information requested by the Company that its counsel has advised in writing (and communicated to Investor) as being required under
the Securities Act to be disclosed with respect to Investor and the offering by it of Registrable Securities, unless the Investor has
notified the Company in writing of the Investor’s election to exclude all of the Investor’s Registrable Securities from such
Registration Statement.

 

    	8

    	 

    

 

(c)
The Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3(p)
or the first sentence of 3(f), the Investor shall immediately discontinue disposition of Registrable Securities pursuant to any Registration
Statement(s) covering such Registrable Securities until the Investor’s receipt of the copies of the supplemented or amended Prospectus
contemplated by Section 3(p) or the first sentence of Section 3(f) or receipt of notice that no supplement or amendment is required.
Notwithstanding anything to the contrary in this Section 4(c), the Company shall cause the Transfer Agent to deliver DWAC Shares to a
transferee of the Investor in accordance with the terms of the Purchase Agreement in connection with any sale of Registrable Securities
with respect to which the Investor has entered into a contract for sale prior to the Investor’s receipt of a notice from the Company
of the happening of any event of the kind described in Section 3(p) or the first sentence of Section 3(f) and for which the
Investor has not yet settled.

 

(d)
The Investor covenants and agrees that it shall comply with the prospectus delivery and other requirements of the Securities Act as applicable
to it in connection with sales of Registrable Securities pursuant to a Registration Statement.

 

(e)
The Investor shall notify the Company in writing as promptly as reasonably practicable after becoming aware of any untrue statement of
a material fact in any Prospectus or the omission to state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading.

 

	5.	Expenses
    of Registration.

 

All
reasonable expenses of the Company, other than sales or brokerage commissions and fees and disbursements of counsel for, and other expenses
of, the Investor, incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3, including, without
limitation, all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of counsel for
the Company, shall be paid by the Company.

 

	6.	Indemnification.

 

(a)
In the event any Registrable Securities are included in any Registration Statement under this Agreement, to the fullest extent permitted
by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each of its directors, officers, shareholders,
members, partners, employees, agents, representatives (and any other Persons with a functionally equivalent role of a Person holding
such titles notwithstanding the lack of such title or any other title) and each Person, if any, who controls the Investor within the
meaning of the Securities Act or the Exchange Act and each of the directors, officers, shareholders, members, partners, employees, agents,
representatives (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding the lack of
such title or any other title) of such controlling Persons (each, an “Investor Party” and collectively, the
“Investor Parties”), against any losses, obligations, claims, damages, liabilities, contingencies, judgments,
fines, penalties, charges, costs (including, without limitation, court costs, reasonable attorneys’ fees, costs of defense and
investigation), amounts paid in settlement or expenses, joint or several, (collectively, “Claims”) reasonably
incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the
foregoing by or before any court or governmental, administrative or other regulatory agency, body or the Commission, whether pending
or threatened, whether or not an Investor Party is or may be a party thereto (“Indemnified Damages”), to which
any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof)
arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in a Registration Statement
or any post-effective amendment thereto or in any filing made in connection with the qualification of the offering under the securities
or other “Blue Sky” laws of any jurisdiction in which Registrable Securities are offered (“Blue Sky Filing”),
or the omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein
not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in any Prospectus (as amended
or supplemented) or in any Prospectus Supplement or the omission or alleged omission to state therein any material fact necessary to
make the statements made therein, in light of the circumstances under which the statements therein were made, not misleading (the matters
in the foregoing clauses (i) and (ii) being, collectively, “Violations”). Subject to Sections 6(c)
and 6(e), the Company shall reimburse the Investor Parties, promptly as such expenses are incurred and are due and payable, for any reasonable
legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim. Notwithstanding
anything to the contrary contained herein, the indemnification agreement contained in this Section 6(a): (i) shall not apply to
a Claim by an Investor Party arising out of or based upon a Violation which occurs in reliance upon and in conformity with information
furnished in writing to the Company by such Investor Party for such Investor Party expressly for use in connection with the preparation
of such Registration Statement, Prospectus or Prospectus Supplement or any such amendment thereof or supplement thereto (it being hereby
acknowledged and agreed that the written information set forth in the first, fourth, sixth and eleventh paragraphs of Exhibit B
attached hereto, and on Exhibit C attached hereto, is the only written information furnished to the Company by or on
behalf of the Investor expressly for use in any Registration Statement, Prospectus or Prospectus Supplement); (ii) shall not be available
to the Investor to the extent such Claim is based on a failure of the Investor to deliver or to cause to be delivered the Prospectus
(as amended or supplemented) made available by the Company (to the extent applicable), including, without limitation, a corrected Prospectus,
if such Prospectus (as amended or supplemented) or corrected Prospectus was timely made available by the Company pursuant to Section 3(d)
and then only if, and to the extent that, following the receipt of the corrected Prospectus no grounds for such Claim would have existed;
and (iii) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent
of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of the Investor Party and shall survive the transfer of any of the Registrable Securities by
the Investor pursuant to Section 9.

 

    	9

    	 

    

 

(b)
In connection with any Registration Statement in which the Investor is participating, the Investor agrees to severally and not jointly
indemnify, hold harmless and defend, to the same extent and in the same manner as is set forth in Section 6(a), the Company, each
of its directors, each of its officers who signs the Registration Statement, each selling shareholder, and each Person, if any, who controls
the Company within the meaning of the Securities Act or the Exchange Act (each, a “Company Party”), against
any Claim or Indemnified Damages to which any of them may become subject, under the Securities Act, the Exchange Act or otherwise, insofar
as such Claim or Indemnified Damages arise out of or are based upon any Violation, in each case, to the extent, and only to the extent,
that such Violation occurs in reliance upon and in conformity with written information relating to the Investor furnished to the Company
by the Investor expressly for use in connection with such Registration Statement, the Prospectus included therein or any Prospectus Supplement
thereto (it being hereby acknowledged and agreed that the written information set forth in the first, fourth, sixth and eleventh paragraphs
of Exhibit B attached hereto, and on Exhibit C attached hereto, is the only written information furnished to the Company
by or on behalf of the Investor expressly for use in any Registration Statement, Prospectus or Prospectus Supplement); and, subject to
Section 6(c) and the below provisos in this Section 6(b), the Investor shall reimburse a Company Party any legal or other expenses
reasonably incurred by such Company Party in connection with investigating or defending any such Claim; provided, however,
the indemnity agreement contained in this Section 6(b) and the agreement with respect to contribution contained in Section 7
shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Investor,
which consent shall not be unreasonably withheld or delayed; and provided, further that the Investor shall
be liable under this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the aggregate net proceeds
to the Investor as a result of all sales by the Investor of Common Stock that was issued to the Investor pursuant to the Purchase Agreement.
Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Company Party and shall
survive the transfer of any of the Registrable Securities by the Investor pursuant to Section 9.

 

(c)
Promptly after receipt by an Investor Party or Company Party (as the case may be) under this Section 6 of notice of the commencement
of any action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Investor Party
or Company Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section 6,
deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right to participate
in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control
of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Investor Party or the Company Party (as the
case may be); provided, however, an Investor Party or Company Party (as the case may be) shall have the right to retain
its own counsel with the reasonable fees and expenses of such counsel to be paid by the indemnifying party if: (i) the indemnifying
party has agreed in writing to pay such fees and expenses; (ii) the indemnifying party shall have failed promptly to assume the
defense of such Claim and to employ counsel reasonably satisfactory to such Investor Party or Company Party (as the case may be) in any
such Claim; or (iii) the named parties to any such Claim (including, without limitation, any impleaded parties) include both such
Investor Party or Company Party (as the case may be) and the indemnifying party, and such Investor Party or such Company Party (as the
case may be) shall have been advised by counsel that a conflict of interest is likely to exist if the same counsel were to represent
such Investor Party or such Company Party and the indemnifying party (in which case, if such Investor Party or such Company Party (as
the case may be) notifies the indemnifying party in writing that it elects to employ separate counsel at the expense of the indemnifying
party, then the indemnifying party shall not have the right to assume the defense thereof on behalf of the indemnified party and such
counsel shall be at the expense of the indemnifying party, provided further that in the case of clause (iii) above
the indemnifying party shall not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel
for all Investor Parties or Company Parties (as the case may be). The Company Party or Investor Party (as the case may be) shall reasonably
cooperate with the indemnifying party in connection with any negotiation or defense of any such action or Claim by the indemnifying party
and shall furnish to the indemnifying party all information reasonably available to the Company Party or Investor Party (as the case
may be) which relates to such action or Claim. The indemnifying party shall keep the Company Party or Investor Party (as the case may
be) reasonably apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying
party shall be liable for any settlement of any action, claim or proceeding effected without its prior written consent; provided,
however, the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall,
without the prior written consent of the Company Party or Investor Party (as the case may be), consent to entry of any judgment or enter
into any settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff
to such Company Party or Investor Party (as the case may be) of a release from all liability in respect to such Claim or litigation,
and such settlement shall not include any admission as to fault on the part of the Company Party. For the avoidance of doubt, the immediately
preceding sentence shall apply to Sections 6(a) and 6(b) hereof. Following indemnification as provided for hereunder, the indemnifying
party shall be subrogated to all rights of the Company Party or Investor Party (as the case may be) with respect to all third parties,
firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying
party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the
Investor Party or Company Party (as the case may be) under this Section 6, except to the extent that the indemnifying party is materially
and adversely prejudiced in its ability to defend such action.

 

    	10

    	 

    

 

(d)
No Person involved in the sale of Registrable Securities who is guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) in connection with such sale shall be entitled to indemnification from any Person involved in such sale of Registrable
Securities who is not guilty of fraudulent misrepresentation.

 

(e)
The indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as and when bills are received or Indemnified Damages are incurred; provided that any Person
receiving any payment pursuant to this Section 6 shall promptly reimburse the Person making such payment for the amount of such
payment to the extent a court of competent jurisdiction determines that such Person receiving such payment was not entitled to such payment.

 

(f)
The indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the
Company Party or Investor Party against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be
subject to pursuant to the law.

 

	7.	Contribution.

 

To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted
by law; provided, however: (i) no contribution shall be made under circumstances where the maker would not
have been liable for indemnification under the fault standards set forth in Section 6 of this Agreement, (ii) no Person involved
in the sale of Registrable Securities which Person is guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) in connection with such sale shall be entitled to contribution from any Person involved in such sale of Registrable
Securities who was not guilty of fraudulent misrepresentation; and (iii) contribution by any seller of Registrable Securities shall
be limited in amount to the aggregate net proceeds to the Investor as a result of all sales by the Investor of Common Stock that was
issued to the Investor pursuant to the Purchase Agreement. Notwithstanding the provisions of this Section 7, the Investor shall
not be required to contribute, in the aggregate, any amount in excess of the amount by which the amount described in the immediately
preceding sentence exceeds the amount of any damages that the Investor has otherwise been required to pay, or would otherwise be required
to pay under Section 6(b), by reason of such untrue or alleged untrue statement or omission or alleged omission.

 

    	11

    	 

    

 

	8.	Reports
    Under the Exchange Act.

 

With
a view to making available to the Investor the benefits of Rule 144, the Company agrees to, so long as the Investor owns Registrable
Securities (or shares of Common Stock that would constitute Registrable Securities but for clause (v) of Section 2(f)):

 

(a)
use its commercially reasonable efforts to make and keep public information available, as those terms are understood and defined in Rule
144;

 

(b)
use its commercially reasonable efforts to file with the Commission in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act so long as the Company remains subject to such requirements (it being understood
that nothing herein shall limit any of the Company’s obligations under the Purchase Agreement) and the filing of such reports and
other documents is required for the applicable provisions of Rule 144;

 

(c)
furnish to the Investor, promptly upon request, (i) a written statement by the Company, if true, that it has complied with the reporting,
submission and posting requirements of Rule 144 and the Exchange Act, (ii) a copy of the most recent annual or quarterly report
of the Company and such other reports and documents so filed by the Company with the Commission if such reports are not publicly available
via EDGAR, and (iii) such other information as may be reasonably requested to permit the Investor to sell such securities pursuant
to Rule 144 without registration; and

 

(d)
take such additional action as is reasonably requested by the Investor to enable the Investor to sell the Registrable Securities pursuant
to Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions
to the Transfer Agent as may be reasonably requested from time to time by the Investor and otherwise fully cooperate with Investor and
Investor’s broker to effect such sale of securities pursuant to Rule 144.

 

	9.	Assignment
    of Registration Rights.

 

Neither
the Company nor the Investor shall assign this Agreement or any of their respective rights or obligations hereunder, other than by operation
of law, including any merger or consolidation, or in connection with any reorganization or restructuring.

 

	10.	Amendment
    or Waiver.

 

No
provision of this Agreement may be amended or waived by the parties from and after the date that is one (1) Trading Day immediately
preceding the date of filing of the Initial Registration Statement with the Commission. Subject to the immediately preceding sentence,
no provision of this Agreement may be (i) amended other than by a written instrument signed by both parties hereto or (ii) waived
other than in a written instrument signed by the party against whom enforcement of such waiver is sought. Failure of any party to exercise
any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a
waiver thereof.

 

	11.	Miscellaneous.

 

(a)
Solely for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed
to own of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more
Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received
from such record owner of such Registrable Securities.

 

    	12

    	 

    

 

(b)
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement shall be given
in accordance with Section 10.4 of the Purchase Agreement.

 

(c)
Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right
or remedy, shall not operate as a waiver thereof. The Company and the Investor acknowledge and agree that irreparable damage would occur
in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that either party shall be entitled to an injunction or injunctions to prevent or cure breaches of
the provisions of this Agreement by the other party and to enforce specifically the terms and provisions hereof (without the necessity
of showing economic loss and without any bond or other security being required), this being in addition to any other remedy to which
either party may be entitled by law or equity.

 

(d)
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal
laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State
of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New
York. Each party hereby irrevocably submits to the exclusive jurisdiction of the federal courts sitting in The City of New York, Borough
of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or
discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not
personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or
that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents
to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices
to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. If any provision of this
Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect the validity or
enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of any provision of this Agreement
in any other jurisdiction. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR
THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED
HEREBY.

 

(e)
The Transaction Documents set forth the entire agreement and understanding of the parties solely with respect to the subject matter thereof
and supersedes all prior and contemporaneous agreements, negotiations and understandings between the parties, both oral and written,
solely with respect to such matters. There are no promises, undertakings, representations or warranties by either party relative to subject
matter hereof not expressly set forth in the Transaction Documents. Except as contemplated by Section 4(a), nothing contained in this
Agreement shall limit, modify or affect in any manner whatsoever (i) the conditions precedent to a Purchase contained in Article
VII of the Purchase Agreement or (ii) any of the Company’s obligations under the Purchase Agreement.

 

(f)
This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors. This Agreement is
not for the benefit of, nor may any provision hereof be enforced by, any Person, other than the parties hereto, their respective successors
and the Persons referred to in Sections 6 and 7 hereof.

 

(g)
The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless
the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and
plural forms thereof. The terms “including,” “includes,” “include” and words of like import shall
be construed broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,”
“hereof” and words of like import refer to this entire Agreement instead of just the provision in which they are found.

 

(h)
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
or signature delivered by e-mail in a “.pdf” format data file, including any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and shall
be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.

 

(i)
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

(j)
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party.

 

[Signature
Pages Follow]

 

    	13

    	 

    

 

IN
WITNESS WHEREOF, Investor and the Company have caused their respective signature page to this Registration Rights Agreement to be
duly executed as of the date first written above.

 

	 	COMPANY:
	 	 
	 	AESTHER
    HEALTHCARE ACQUISITION CORP.
	 	 	 

	 	By:	/s/
    
	 	Name:	Suren
    Ajjarapu
	 	Title:	Chief
    Executive Officer

 

	 	INVESTOR:
	 	 
	 	WHITE
    LION CAPITAL, LLC
	 	 	 

	 	By:	/s/
    
	 	Name:	Yash
    Thukral
	 	Title:	Managing
    Partner

 

    	14

    	 

    

 

EXHIBIT
A

 

FORM
OF NOTICE OF EFFECTIVENESS 

OF
REGISTRATION STATEMENT

 

[●]

[●]

[●]

 

Re:
Aesther Healthcare Acquisition Corp.

 

Ladies
and Gentlemen:

 

We
are counsel to Aesther Healthcare Acquisition Corp., a Delaware corporation (the “Company”), and have represented
the Company in connection with that certain Common Stock Purchase Agreement, dated as of July 6, 2022 (the “Purchase Agreement”),
entered into by and among the Company and the Investor named therein (the “Holder”) pursuant to which the Company
will issue to the Holder from time to time shares of the Company’s Class A common stock, par value $0.0001 per share (the
“Common Stock”). Pursuant to the Purchase Agreement, the Company also has entered into a Registration Rights
Agreement, dated as of July 6, 2022, with the Holder (the “Registration Rights Agreement”), pursuant to which
the Company agreed, among other things, to register the offer and sale by the Holder of the Registrable Securities (as defined in the
Registration Rights Agreement) under the Securities Act of 1933, as amended (the “Securities Act”). In connection
with the Company’s obligations under the Registration Rights Agreement, on [●], 2022, the Company filed a Registration Statement
on Form S-1 (File No. 333-[●]) (the “Registration Statement”) with the Securities and
Exchange Commission (the “Commission”) relating to the Registrable Securities which names the Holder as an
underwriter and a selling stockholder thereunder.

 

In
connection with the foregoing, based solely on our review of the Commission’s EDGAR website, we advise you that the Registration
Statement became effective under the Securities Act on [●], 2022. In addition, based solely on our review of the information made
available by the Commission at http://www.sec.gov/litigation/stoporders.shtml, we confirm that the Commission has not issued any stop
order suspending the effectiveness of the Registration Statement. To our knowledge, based solely on our participation in the conferences
mentioned above regarding the Registration Statement and our review of the information made available by the Commission at http://www.sec.gov/litigation/stoporders.shtml,
no proceedings for that purpose are pending or have been instituted or threatened by the Commission.

 

We
assume no obligation to update or supplement this letter to reflect any facts or circumstances which may hereafter come to our attention
with respect to the matters herein and statements expressed above, including any changes in applicable law that may hereafter occur.

 

This
letter is being delivered solely for the benefit of the person to whom it is addressed; accordingly, it may not be quoted, filed with
any governmental authority or other regulatory agency or otherwise circulated or utilized for any purposes without our prior written
consent.

 

	 	Very
    truly yours,
	 	 
	 	[ISSUER’S
    COUNSEL]
	 	 	              
	 	By:	 

 

cc:
White Lion Capital, LLC

 

    	15

    	 

    

 

EXHIBIT
B

 

SELLING
STOCKHOLDER

 

This
prospectus relates to the possible resale from time to time by White Lion Capital of any or all of the shares of common stock that may
be issued by us to White Lion Capital under the Purchase Agreement. For additional information regarding the issuance of common stock
covered by this prospectus, see the section titled “White Lion Capital Committed Equity Financing” above. We are registering
the shares of common stock pursuant to the provisions of the Registration Rights Agreement we entered into with White Lion Capital on
{} in order to permit the selling stockholder to offer the shares for resale from time to time. Except for the transactions contemplated
by the Purchase Agreement and the Registration Rights Agreement or as otherwise disclosed in this prospectus, White Lion Capital has
not had any material relationship with us within the past three years. As used in this prospectus, the term “selling stockholder”
means White Lion Capital, LLC.

 

The
table below presents information regarding the selling stockholder and the shares of common stock that it may offer from time to time
under this prospectus. This table is prepared based on information supplied to us by the selling stockholder, and reflects holdings as
of [●], 2022. The number of shares in the column “Maximum Number of Shares of Common Stock to be Offered Pursuant to this
Prospectus” represents all of the shares of common stock that the selling stockholder may offer under this prospectus. The selling
stockholder may sell some, all or none of its shares in this offering. We do not know how long the selling stockholder will hold the
shares before selling them, and we currently have no agreements, arrangements or understandings with the selling stockholder regarding
the sale of any of the shares.

 

Beneficial
ownership is determined in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes shares of common
stock with respect to which the selling stockholder has voting and investment power. The percentage of shares of common stock beneficially
owned by the selling stockholder prior to the offering shown in the table below is based on an aggregate of [●] shares of our common
stock outstanding on [●], 2022. Because the purchase price of the shares of common stock issuable under the Purchase Agreement
is determined on the Purchase Settlement Date with respect to each Purchase, the number of shares that may actually be sold by the Company
under the Purchase Agreement may be fewer than the number of shares being offered by this prospectus.

 

	Name of Selling Stockholder	 	Number of
    Shares of
 Common Stock
 Owned Prior to
 Offering	 	 	Maximum Number
    of
 Shares of Common Stock
 to be Offered Pursuant to
 this Prospectus	 	 	Number of
    Shares of
 Common Stock
 Owned After Offering	 
	 	 	Number(1)	 	 	Percent	 	 	 	 	 	Number(2)	 	 	Percent(2)	 
	White Lion Capital,
    LLC(3)	 	 	[●]		 	 	*		 	 	[●]		 	 	0	 	 	 	—	 

 

 

 

	*	Represents
    beneficial ownership of less than 1% of the outstanding shares of our common stock.

 

	(1)	In
    accordance with Rule 13d-3(d) under the Exchange Act, we have excluded from the number of shares beneficially owned prior
    to the offering all of the shares that White Lion Capital may be required to purchase under the Purchase Agreement, because the issuance
    of such shares is solely at our discretion and is subject to conditions contained in the Purchase Agreement, the satisfaction of
    which are entirely outside of White Lion Capital’s control, including the registration statement that includes this prospectus
    becoming and remaining effective. Furthermore, the Purchase of common stock are subject to certain agreed upon maximum amount limitations
    set forth in the Purchase Agreement. Also, the Purchase Agreement prohibits us from issuing and selling any shares of our common
    stock to White Lion Capital to the extent such shares, when aggregated with all other shares of our common stock then beneficially
    owned by White Lion Capital, would cause White Lion Capital’s beneficial ownership of our common stock to exceed the 4.99%
    Beneficial Ownership Cap. The Purchase Agreement also prohibits us from issuing or selling shares of our common stock under the Purchase
    Agreement in excess of the Exchange Cap or unless the Exchange Cap limitation would not apply under applicable Nasdaq rules, unless
    we obtain stockholder approval to do so. Neither the Beneficial Ownership Limitation nor the Exchange Cap (to the extent applicable
    under Nasdaq rules) may be amended or waived under the Purchase Agreement.

 

    	16

    	 

    

 

	(2)	Assumes
    the sale of all shares being offered pursuant to this prospectus.

 

	(3)	The
    business address of White Lion Capital, LLC (“WLC”) is 17631 Ventura Blvd., Suite 1008, Encino, CA 91316. WLC’s
    principal business is that of a private investor. Dmitriy Slobodskiy Jr., Yash Thukral, SamYaffa, and Nathan Yee are the managing
    principals of WLC. Therefore, each of Slobodskiy Jr., Thukral, Yaffa, and Yee may be deemed to have sole voting control and investment
    discretion over securities beneficially owned directly by WLC and, indirectly, by WLC. We have been advised that WLC is not a member
    of the Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer. The foregoing should not be construed
    in and of itself as an admission by Slobodskiy Jr., Thukral, Yaffa, and Yee as to beneficial ownership of the securities beneficially
    owned directly by WLC and, indirectly, by WLC.

 

PLAN
OF DISTRIBUTION

 

The
shares of common stock offered by this prospectus are being offered by the selling stockholder, White Lion Capital, LLC. The shares may
be sold or distributed from time to time by the selling stockholder directly to one or more purchasers or through brokers, dealers, or
underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market
prices, at negotiated prices, or at fixed prices, which may be changed. The sale of the shares of our common stock offered by this prospectus
could be effected in one or more of the following methods:

 

	 	●	ordinary
    brokers’ transactions;
	 	 	 
	 	●	transactions
    involving cross or block trades;
	 	 	 
	 	●	through
    brokers, dealers, or underwriters who may act solely as agents;
	 	 	 
	 	●	“at
    the market” into an existing market for our common stock;
	 	 	 
	 	●	in
    other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected through
    agents;
	 	 	 
	 	●	in
    privately negotiated transactions; or
	 	 	 
	 	●	any
    combination of the foregoing.

 

In
order to comply with the securities laws of certain states, if applicable, the shares may be sold only through registered or licensed
brokers or dealers. In addition, in certain states, the shares may not be sold unless they have been registered or qualified for sale
in the state or an exemption from the state’s registration or qualification requirement is available and complied with.

 

White
Lion Capital is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act.

 

White
Lion Capital has informed us that it intends to use one or more registered broker-dealers (one of which is an affiliate of White Lion
Capital) to effectuate all sales, if any, of our common stock that it may acquire from us pursuant to the Purchase Agreement. Such sales
will be made at prices and at terms then prevailing or at prices related to the then current market price. Each such registered broker-dealer
will be an underwriter within the meaning of Section 2(a)(11) of the Securities Act. White Lion Capital has informed us that each
such broker-dealer may receive commissions from White Lion Capital and, if so, such commissions will not exceed customary brokerage commissions.

 

Brokers,
dealers, underwriters or agents participating in the distribution of the shares of our common stock offered by this prospectus may receive
compensation in the form of commissions, discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent,
of the shares sold by the selling stockholder through this prospectus. The compensation paid to any such particular broker-dealer by
any such purchasers of shares of our common stock sold by the selling stockholder may be less than or in excess of customary commissions.
Neither we nor the selling stockholder can presently estimate the amount of compensation that any agent will receive from any purchasers
of shares of our common stock sold by the selling stockholder.

 

    	17

    	 

    

 

We
know of no existing arrangements between the selling stockholder or any other stockholder, broker, dealer, underwriter or agent relating
to the sale or distribution of the shares of our common stock offered by this prospectus.

 

We
may from time to time file with the SEC one or more supplements to this prospectus or amendments to the registration statement of which
this prospectus forms a part to amend, supplement or update information contained in this prospectus, including, if and when required
under the Securities Act, to disclose certain information relating to a particular sale of shares offered by this prospectus by the selling
stockholder, including the names of any brokers, dealers, underwriters or agents participating in the distribution of such shares by
the selling stockholder, any compensation paid by the selling stockholder to any such brokers, dealers, underwriters or agents, and any
other required information.

 

As
consideration for its irrevocable commitment to purchase our Common Stock under the Purchase Agreement, on [●], 2022, we issued
to White Lion Capital [●] Shares as Commitment Shares.

 

We
also have agreed to indemnify White Lion Capital and certain other persons against certain liabilities in connection with the offering
of shares of our common stock offered hereby, including liabilities arising under the Securities Act or, if such indemnity is unavailable,
to contribute amounts required to be paid in respect of such liabilities. White Lion Capital has agreed to indemnify us against liabilities
under the Securities Act that may arise from certain written information furnished to us by White Lion Capital specifically for use in
this prospectus or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons,
we have been advised that in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act
and is therefore, unenforceable.

 

We
estimate that the total expenses for the offering will be approximately $[●].

 

White
Lion Capital has represented to us that at no time prior to the date of the Purchase Agreement has White Lion Capital, any of its affiliates
or any entity managed or controlled by White Lion Capital engaged in or effected, directly or indirectly, for its own principal account,
any short sale (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of our common stock that establishes a net
short position with respect to our common stock. White Lion Capital has agreed that during the term of the Purchase Agreement, none of
White Lion Capital, any of its affiliates nor any entity managed or controlled by White Lion Capital will enter into or effect, directly
or indirectly, any of the foregoing transactions for its own principal account or for the principal account of any other such entity.

 

We
have advised the selling stockholder that it is required to comply with Regulation M promulgated under the Exchange Act. With certain
exceptions, Regulation M precludes the selling stockholder, any affiliated purchasers, and any broker-dealer or other person who participates
in the distribution from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the
subject of the distribution until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order
to stabilize the price of a security in connection with the distribution of that security. All of the foregoing may affect the marketability
of the securities offered by this prospectus.

 

This
offering will terminate on the date that all shares of our common stock offered by this prospectus have been sold by the selling stockholder.

 

Our
common stock is currently listed on The Nasdaq Capital Market under the symbol “AEHA”.

 

    	18

    	 

    

 

EXHIBIT
C

 

The
business address of White Lion Capital, LLC (“WLC”) is 17631 Ventura Blvd #1008, Encino, CA 91316. WLC’s principal
business is that of a private investor. Dmitriy Slobodskiy Jr., Yash Thukral, SamYaffa, and Nathan Yee are the managing principals
of WLC. Therefore, each of Slobodskiy Jr., Thukral, Yaffa, and Yee may be deemed to have sole voting control and investment discretion
over securities beneficially owned directly by WLC and, indirectly, by WLC. We have been advised that WLC is not a member of the Financial
Industry Regulatory Authority, or FINRA, or an independent broker-dealer. The foregoing should not be construed in and of itself as an
admission by Slobodskiy Jr., Thukral, Yaffa, and Yee as to beneficial ownership of the securities beneficially owned directly by WLC
and, indirectly, by WLC.

 

White
Lion Capital has represented to us that at no time prior to the date of the Purchase Agreement has White Lion Capital or, any of its
agents, representatives or affiliates or any entity managed or controlled by White Lion Capital engaged in or effected, in any manner
whatsoever, directly or indirectly, for its own principal account, any short sale (as such term is defined in Rule 200 of Regulation
SHO of the Exchange Act) of our common stock, which that establishes a net short position with respect to our common stock. White Lion
Capital has agreed that during the term of the Purchase Agreement, neither of White Lion Capital, nor any of its agents, representatives
or affiliates nor any entity managed or controlled by White Lion Capital will enter into or effect, directly or indirectly, any of the
foregoing transactions for its own principal account or for the principal account of any other such entity.

 

    	19Exhibit
10.14

 

Privileged
and Confidential 

 

SECOND
RESTATED AND AMENDED SHAREHOLDERS’ AGREEMENT 

 

This
Second Restated and Amended Shareholders’ Agreement (“Agreement”) is entered into as of April 19, 2022 (“Execution
Date”) but shall only become effective upon the completion of the Proposed Distribution (as defined below) (the “Effective
Date”).

 

By
and Among:

 

		1.	CMDB
                                            II, a company incorporated in the Republic of Mauritius, and having its registered office
                                            at IFS Court, Twenty Eight, Cybercity, Ebene, Republic of Mauritius (“CMDB”
                                            which expression shall, unless the context requires otherwise, mean and include its successors
                                            and permitted assigns);

 

		2.	Sequoia
                                            Capital India III Ltd., a company incorporated in the Republic of Mauritius, and having its
                                            registered office at 5th Floor, Ebene Esplanade, 24 Cyber City, Ebene - Mauritius (“Sequoia”,
                                            which expression shall, unless the context requires otherwise, mean and include its successors
                                            and permitted assigns);

 

		3.	GB-V
                                            Growth Fund Investment Limited Partnership, a partnership incorporated under the Laws of
                                            Japan and having its registered office at 10-11 Sakuragaoka-cho, Shibuya-Ku, Tokyo, 150-0031,
                                            Japan (“Global Brains” which expression shall, unless the context requires
                                            otherwise, mean and include its successors and permitted assigns);

 

		4.	Telstra
                                            Ventures Fund II, L.P , represented by T Ventures Fund II GP, L.P. (acting through its sole
                                            general partner, T Ventures Fund II GP, Ltd.), a partnership incorporated under the laws
                                            of Guernsey and having its registered office at North Suite 2, Town Mills, Rue Du Pre, St
                                            Peter Port, Guernsey, GY1 1LT (“TV” which expression shall, unless the
                                            context requires otherwise, mean and include its successors and permitted assigns);

 

		5.	Cisco
                                            Systems International BV, a company incorporated under the laws of The Netherlands and having
                                            its registered office at State Street Corporation, Lafayette Corporate Center, 2 Avenue de
                                            Lafayette – LCC 2, Boston, Massachusetts 02111-2900 (“Cisco” which
                                            expression shall, unless the context requires otherwise, mean and include its successors
                                            and permitted assigns);

 

		6.	GPC
                                            NIV Ltd., a company incorporated under the laws of Cayman Islands and having its registered
                                            office at Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104,
                                            Cayman Islands (“GPC” which expression shall, unless the context requires
                                            otherwise, mean and include its successors and permitted assigns);

 

		7.	OurCrowd
                                            International Investment III L.P., a partnership incorporated under the laws of British Virgin
                                            Islands, and having its registered office at Craigmuir Chambers, P.O. Box 71, Road Town,
                                            Tortola, British Virgin Islands (“OurCrowd” which expression shall, unless
                                            the context requires otherwise, mean and include its successors and permitted assigns);

 

		8.	UM
                                            Legacy LLC, a limited liability company organized under the laws of Delaware, United States
                                            of America, and having its registered office at 130 West Union Street, Pasadena, CA, 91103,
                                            United States of America (“Series U Investor”, which expression shall,
                                            unless the context requires otherwise, mean and include its successors and permitted assigns);

 

    1

     

    

 

		9.	Near
                                            Pte. Ltd. (previously, Adnear Pte. Ltd.) (Company Registration No. 201205693G), a private
                                            company incorporated in Singapore, having its registered address at 160 Robinson Road, #20-03,
                                            SBF Centre, Singapore 068914 Singapore 049246 (“Near Sing” which
                                            expression shall, unless the context requires otherwise, mean and include its successors
                                            and permitted assigns);

 

		10.	Near
                                            Intelligence Holdings Inc., a Delaware corporation (the “Company”, which
                                            expression shall, unless the context requires otherwise, mean and include its successors
                                            and permitted assigns); and

 

		11.	The
                                            persons identified as Founders and whose name and particulars are listed in Schedule 2 (together
                                            “Founders” and individually “Founder” which expression
                                            shall, unless the context requires otherwise, mean and include their successors and permitted
                                            assigns).

 

CMDB,
Sequoia, Global Brains, TV, Cisco, GPC and OurCrowd are referred to as “Existing Investors”. The Series U Investor
together with the Existing Investors are referred to as the “Investors”. The Investors, Near Sing, the Company and
the Founders, are individually referred to as “Party” and collectively referred to as “Parties”.

 

WHEREAS

 

		1.	Near
                                            Sing is a private limited company, which along with its Subsidiaries (defined hereinafter)
                                            has been engaged in the Business (as defined hereinafter) until the Contribution
                                            (as defined hereinafter).

 

		2.	The
                                            issued and paid up capital of Near Sing on the Execution Date is USD 90,259,717.01 (United
                                            States Dollars ninety million two hundred fifty-nine thousand seven hundred seventeen and
                                            cents one) divided into 71,963,894 (forty-three million one hundred ninety thousand) ordinary
                                            shares, 95,418,000 (ninety-five million four hundred eighteen thousand) Series A preference
                                            shares, 49,635,000 (forty-nine million six hundred thirty five thousand) Series B preference
                                            shares, 4,909,756 (four million nine hundred nine thousand seven hundred fifty six) Series
                                            C preference shares, and 91,194,915 (ninety-one million one hundred ninety-four thousand
                                            nine hundred fifteen) Series D preference shares and 66,140,480 Series U preference shares.
                                            (Note: solely for purposes of this Agreement, the non-capitalized terms “ordinary shares”
                                            and “preference shares” shall refer to the existing shares in the capital of
                                            Near Sing and, as set forth in Section 1 hereof, the capitalized terms “Ordinary Shares”
                                            and “Preference Shares” are defined as the Company Common Stock and Company Preferred
                                            Stock, respectively).

 

		3.	Pursuant
                                            to a business transfer agreement dated as of 1 January 2022 (“BTA”), Near
                                            Sing has undertaken an internal reorganisation, and transferred with effect from 1 January
                                            2022 substantially all of its assets (with the exception of (i) the assets necessary or required
                                            for the liquidation of Near Sing, and (ii) the following dormant subsidiaries of Near Sing
                                            ((a) Near Australia Pty. Ltd., (b) Near Americas, Inc. and (c) Near India Pvt. Ltd. (collectively,
                                            the “Dormant Subsidiaries”)) to two wholly-owned operating subsidiaries,
                                            Near Intelligence Pte. Ltd. (a Singapore company) and Near North America Inc. (a United States
                                            company). Pursuant to this internal reorganisation, Near Sing currently functions solely
                                            as a holding company to the two operating subsidiaries and has retained legal ownership of
                                            the intellectual property of Near group with certain economic rights relating to the intellectual
                                            property rights (rest of world outside of the United States) being transferred to Near Intelligence
                                            Pte. Ltd.

 

    2

     

    

 

		4.	Prior
                                            to the Proposed Distribution (defined below), Near Sing and the Company will have completed
                                            the Contribution in accordance with the terms of the Contribution Agreement. On the closing
                                            date of Contribution, the Company will issue or will have issued 379,262.045 shares of its
                                            Common Stock, $0.0001 par value (the “Company Common Stock”), to Near
                                            Sing.

 

		5.	Prior
                                            to the Proposed Distribution, the Company will amend its Certificate of Incorporation so
                                            that the rights attaching to Company Common Stock and Company Preferred Stock (as defined
                                            below) following the Proposed Distribution will be substantially identical to the existing
                                            issued share capital of Near Sing and, thereafter, the Company will recapitalize its outstanding
                                            shares of Company Common Stock into 71,963.894 shares of Company Common Stock and 307,298.151
                                            shares of Company Preferred Stock (defined below), comprising the following (the “Company
                                            Recapitalization”):
	 	 	 

		●	95,418.000
                                            shares of the Company’s Series A Preferred Stock, $0.0001 par value (the “Company’s
                                            Series A Preferred Stock”);
	 	 	 

		●	49,635.000
                                            shares of Company’s Series B Preferred Stock, $0.0001 par value (the “Company’s
                                            Series B Preferred Stock”);
	 	 	 

		●	4,909.756
                                            shares of Company’s Series C Preferred Stock, $0.0001 par value (the “Company’s
                                            Series C Preferred Stock”);
	 	 	 

		●	91,194.915
                                            shares of Company’s Series D Preferred Stock, $0.0001 par value (the “Company’s
                                            Series D Preferred Stock”); and
	 	 	 

		●	66,140.480
                                            shares of Company’s Series U Preferred Stock, $0.0001 par value (the “Company’s
                                            Series U Preferred Stock” and together with the Company’s Series A Preferred
                                            Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock. and
                                            Series U Preferred Stock, “Company Preferred Stock”).

 

		6.	Near
                                            Sing intends to undertake a proposed capital reduction exercise pursuant to Section 78A read
                                            with Section 78B of the Companies Act 1967 of Singapore (“Companies Act”)
                                            (in relation to the Ordinary Shares) and a proposed redemption exercise pursuant to Section
                                            70 of the Companies Act (in relation to the Preference Shares), and in accordance with the
                                            Existing Shareholders’ Agreement (defined below), and the Near Sing Constitution (as
                                            amended) to distribute in specie the 71,963.894 shares of the Company Common Stock and 307,298.151
                                            shares of the Company Preferred Stock set forth above to Near Sing’s shareholders pro
                                            rata to their respective shareholdings in Near Sing on a 1000:1 basis (e.g. holders of Shareholder
                                            Preference Shares will receive 1 share of Company Preferred Stock for each 1,000 Shareholder
                                            Preference Shares) and fractional shares of Company Common Stock and Company Preferred Stock
                                            shall be issued as appropriate (e.g., 1.425 shares of Company Preferred Stock would be issued
                                            in exchange for 1,425 Shareholder Preference Shares) (the “Proposed Distribution”);

 

		7.	In
                                            aggregate, the Proposed Distribution will result in the following:
	 	 	 

		●	The
                                            current holders of Near Sing’s ordinary Shares and Near Sing’s preference shares
                                            will no longer hold any shares of capital stock of Near Sing;
	 	 	 

		●	The
                                            holders of Near Sing’s 71,963,894 ordinary shares will hold 71,963.894 shares of Company
                                            Common Stock;

 

    3

     

    

 

		●	The
                                            holders of Near Sing’s 95,418,000 Series A preference shares will hold 95,418.000 shares
                                            of the Company’s Series A Preferred Stock;
	 	 	 

		●	The
                                            holders of Near Sing’s 49,635,000 Series B preference shares will hold 49,635.000 shares
                                            of the Company’s Series B Preferred Stock;
	 	 	 

		●	The
                                            holders of Near Sing’s 4,909,756 Series C preference shares will hold 4,909.756 shares
                                            of Near Sing’s Series C Preferred Stock;
	 	 	 

		●	The
                                            holders of the Company’s 91,194,915 Series D preference shares will hold 91,194.915
                                            shares of Near Sing’s Series D Preferred Stock;
	 	 	 

		●	The
                                            holders of Near Sing’s 66,140,480 Series U preference shares will hold 66,140.480 shares
                                            of the Company’s Series U Preferred Stock;

 

		8.	Immediately
                                            following the Proposed Distribution, the authorized and issued capitalization of the Company
                                            shall be as follows: (i) 192,701.000 shares of Company Common Stock, of which 71,963.894
                                            shares will be issued and outstanding; and (ii) an aggregate of 307,299.000 shares of Company
                                            Preferred Stock in five series, consisting of 95,418.000 shares of Company Series A Preferred
                                            Stock, of which 95,418.000 shares will be issued and outstanding, 49,635.000 shares of Company
                                            Series B Preferred Stock, of which 49,635.000 shares will be issued and outstanding, 4,910.000
                                            shares of Company Series C Preferred Stock, of which 4,909.756 shares will be issued and
                                            outstanding, 91,195.000 of Company Series D Preferred Stock, of which 91,194.915 shares will
                                            be issued and outstanding, and 66,141.000 shares of Company Series U Preferred Stock, of
                                            which 66,140.480 shares will be issued and outstanding.

 

		9.	The
                                            Second Amended and Restated Certificate of Incorporation of the Company (the “A&R
                                            COI”), when filed with the Secretary of State of Delaware, will contain the
                                            rights, preferences and privileges of each class of stock of the Company, which rights, preferences
                                            and privileges will be substantially the same as the rights, preferences and privileges as
                                            the corresponding shares of Near Sing (e.g., the rights of the Near Sing ordinary shares
                                            will be substantially the same as the rights of the Company Common Stock, the rights, preferences
                                            and privileges of the Near Sing Series A preference shares of Near Sing will be substantially
                                            the same as the rights, preferences and privileges of the Company Series A Preferred Stock,
                                            etc.).

 

		10.	The
                                            Existing Investors, the Founders and Near Sing entered into a shareholders agreement dated
                                            May 9, 2019 in order to define their mutual rights and obligations, and set out the terms
                                            and conditions governing their relationships as shareholdings of Near Sing (“Original
                                            Shareholders’ Agreement”) and amended and restated such agreement on March
                                            31, 2021 (the “Existing Shareholders’ Agreement”).

 

		11.	Simultaneously
                                            with the execution of the Original Shareholders Agreement, the Founders, Near Sing and GPC
                                            entered into a share subscription agreement (“Series D Subscription Agreement”).

 

		12.	Near
                                            Sing entered into an Agreement and Plan of Merger, dated February 12, 2021 (the “Merger
                                            Agreement”), among Near Sing, Project Aura Sub, Inc., a Delaware corporation and
                                            wholly-owned Subsidiary of Near Sing (“Merger Sub”), UberMedia, Inc.,
                                            a Delaware corporation (“UberMedia”), and Shareholder Representative Services
                                            LLC (solely in its capacity as the representative of the Series U Investor), pursuant to
                                            which: (i) the Company has agreed to acquire UberMedia through the merger of Merger Sub with
                                            and into UberMedia with UberMedia surviving such merger (the “Merger”)
                                            as a wholly owned Subsidiary of the Company; and (ii) the Series U Investor agreed to exchange
                                            all outstanding preferred equity securities of UberMedia for the Series U Preference Shares
                                            issued by the Company in accordance with the Merger Agreement upon consummation of the Merger.

 

    4

     

    

 

		13.	The
                                            Parties desire to have their rights and obligations as shareholders of the Company substantially
                                            mirror their rights and obligations as shareholders of Near Sing under the Existing Shareholders’
                                            Agreement

 

		14.	Accordingly,
                                            the Parties are desirous of executing this Agreement to record and restate their inter
                                            se rights and obligations in relation to the Company and the Subsidiaries (defined
                                            hereinafter) following the Share Exchange (defined hereinafter), in accordance
                                            with the terms and conditions set out herein. It is the intent of the Parties concerned to
                                            replace and supersede the Existing Shareholders Agreement including any amendments thereof,
                                            with this Agreement.

 

		15.	The
                                            Parties acknowledge and agree that the Contribution, the Proposed Distribution and the Share
                                            Exchange are part of an integrated reorganization within the meaning of Section 368(a)(1)(F)
                                            of the Internal Revenue Code of 1986, as amended.

 

NOW
THEREFORE, IN CONSIDERATION OF MUTUAL COVENANTS, PROMISES AND TERMS AND CONDITIONS CONTAINED HEREIN THE SUFFICIENCY OF WHICH IS HEREBY
ACKNOWLEDGED BY THE PARTIES, IT IS AGREED BY AND BETWEEN THE PARTIES HERETO AS FOLLOWS:

 

		1	DEFINITIONS
                                            AND INTERPRETATION

 

		1.1	Definitions:
                                            In this Agreement the following capitalised words and expressions shall have the following
                                            meanings:

 

		1.1.1	“Act”
                                            means the Delaware General Corporation Code.

 

		1.1.2	“Additional
                                            Adjustment Shares” shall have the meaning ascribed to such term in the Merger Agreement.

 

		1.1.3	“Additional
                                            Capital” shall have the meaning as ascribed to it in Clause 4.1.

 

		1.1.4	“Additional
                                            Series U Preference Shares” shall mean any Additional Adjustment Shares (if any),
                                            issued by the Company in accordance with the terms of the Merger Agreement.

 

		1.1.5	“Adjustment
                                            Holdback Release Date” shall have the meaning ascribed to such term in the Merger
                                            Agreement.

 

		1.1.6	“Affiliate”
                                            means, (i) in respect of any specified Person, any other Person directly or indirectly Controlling
                                            or Controlled by or under direct or indirect common Control with such specified Person, (ii)
                                            in respect of the Investor, (A) without prejudice to the foregoing, the limited partners
                                            of any fund, collective investment scheme, trust, partnership (including any co-investment
                                            partnership) or investment company / special purpose vehicle / investment fund owned, managed,
                                            advised, Controlled or promoted by (a) the Investor or by its Affiliates, or (b) the investment
                                            manager or investment advisor of the Investor and/ or its Affiliates but (B) excluding any
                                            Person that the Investor or any of its Affiliates Controls by virtue of rights arising from
                                            a financial investment made by the Investor or any of its Affiliates in such Person, and
                                            (iii) in respect of any natural Person, the Relatives of such natural Person.

 

    5

     

    

 

		1.1.7	[deleted]

 

		1.1.8	“Annual
                                            Budget” shall mean the budget for a Financial Year in relation to revenue, operating
                                            expenditure, cash flow, capital expenditure and working capital and key financial ratios.

 

		1.1.9	“Applicable
                                            Law” includes all applicable statutes, enactments, acts of legislature or parliament,
                                            laws, ordinances, rules, by-laws, regulations, notifications, guidelines, policies, rules
                                            of common law, permits, licenses, approvals, consents, Authorisations, directions, directives,
                                            rulings and orders of any Government Agency, statutory authority, tribunal, arbitration body,
                                            board, court or any recognised stock exchange(s) on which the Shares may be listed, or any
                                            interpretation, policy or administration, having the force of law, by any Governmental Agency
                                            having jurisdiction over the matter in question, including but not limited to the laws of
                                            Singapore, Australia, and India.

 

		1.1.10	“As
                                            If Converted Basis” means on the basis that all the Dilution Instruments issued
                                            or granted by the Company which are convertible into Ordinary Shares or Ordinary share capital
                                            of the Company at the time of determination, have been exercised or converted into Ordinary
                                            Shares on a fully diluted basis.

 

		1.1.11	“Assets”
                                            shall mean assets or properties of every kind, nature, character and description (whether
                                            immovable, movable, tangible, intangible, absolute, accrued, fixed or otherwise) as operated,
                                            hired, rented, owned or leased by a Person from time to time, including cash, cash equivalents,
                                            receivables, securities, accounts and note receivables, real estate, plant and machinery,
                                            equipment, trademarks, brands, other intellectual property, raw materials, inventory, furniture,
                                            fixtures and insurance.

 

		1.1.12	“Authorisation(s)”
                                            shall mean any consent, approval, agreement, ratification, waiver, notice or other authorisation
                                            of or from or to any Person whether given by expressly in writing or implied by conduct or
                                            deemed given due to a failure to act within any specified time period including all corporate,
                                            creditors’, shareholders’ and Third Party approvals or consents (other than a
                                            Governmental Approval) that may be required for any purpose including but not limited to
                                            (i) the execution of the Transaction Documents, (ii) the consummation of the transactions
                                            contemplated by the Transaction Documents and (iii) carrying on the Business in a lawful
                                            manner.

 

		1.1.13	“Automatic
                                            Series A Conversion Date” shall have the meaning ascribed to it in Paragraph 3.3.1
                                            of Schedule 7.

 

		1.1.14	“Automatic
                                            Series B Conversion Date” shall have the meaning ascribed to it in Paragraph 3.3.1
                                            of Schedule 8.

 

    6

     

    

 

		1.1.15	“Automatic
                                            Series C Conversion Date” shall have the meaning ascribed to it in Paragraph 3.3.1
                                            of Schedule 9.

 

		1.1.16	“Automatic
                                            Series D Conversion Date” shall have the meaning ascribed to it in Paragraph 3.3.1
                                            of Schedule 10.

 

		1.1.17	“Automatic
                                            Series U Conversion Date” shall have the meaning ascribed to it in Paragraph 3.3.1
                                            of Schedule 11.

 

		1.1.18	“Big
                                            Four Firm” means KPMG, PricewaterhouseCoopers, Ernst & Young and Deloitte Touche
                                            Tohmatsu or such firm of chartered accountants associated with any of them and their respective
                                            successors.

 

		1.1.19	“Board”
                                            or “Board of Directors” means the directors acting as a board of directors
                                            of the Company or Subsidiaries, as the case may be, appointed in accordance with this Agreement
                                            and the Constitution.

 

		1.1.20	“Business”
                                            means the business of designing and developing of software for providing location and audience
                                            based data driven analytical services, including owning and operating a location intelligence
                                            and human mobility data platform or otherwise dealing in or with all software, hardware and
                                            programs of any and all kinds and description ancillary or related to the above.

 

		1.1.21	“Business
                                            Day” means any day on which banks in Singapore, India, Japan, Australia, UK, US,
                                            Cayman Islands, Netherlands and Mauritius are open for general banking operations.

 

		1.1.22	“Business
                                            Plan” means a business plan of the Company and/or the Subsidiaries, as the case
                                            may be, prepared by the Founders and the Company, approved in accordance with the terms of
                                            this Agreement and as may be updated from time to time in the manner prescribed in this Agreement.

 

		1.1.23	“Buy-Back
                                            Notice” shall have the meaning as ascribed to it in Clause 12.3.3(a).

 

		1.1.24	“Buy-Back
                                            Option” means the GPC Buy-Back Option or the Other Shareholders’ Buy-Back
                                            Option, as the case may be.

 

		1.1.25	“Buy-Back
                                            Shares” shall have the meaning as ascribed to it in Clause 12.3.3(a).

 

		1.1.26	“CMDB
                                            Director” shall have the meaning as ascribed to it in Clause 3.1.2(b).

 

		1.1.27	“Capital
                                            Restructuring” means any form of restructuring of the Company’s share capital
                                            including not limited to the matters set out in Paragraph 3 of Part A of Schedule 5.

 

		1.1.28	“Chairman”
                                            shall have the meaning as ascribed to it in Clause 3.1.5.

 

		1.1.29	“Charter
                                            Documents” shall mean collectively the Constitution, the certificate of incorporation
                                            or similar organisational or incorporation documents.

 

		1.1.30	“CFC”
                                            means a controlled foreign corporation.

 

    7

     

    

 

		1.1.31	“Cisco
                                            Requirements” shall have the meaning as ascribed to it in Clause 12.4.5(g).

 

		1.1.32	Closing
                                            Date” shall have the meaning ascribed to such term in the Merger Agreement

 

		1.1.33	“CoC
                                            Acceptance Notice” shall have the meaning as ascribed to it in Clause 15.5.4.

 

		1.1.34	“CoC
                                            Acceptance Period” shall have the meaning as ascribed to it in Clause 15.5.4.

 

		1.1.35	“CoC
                                            Purchaser” shall have the meaning as ascribed to it in Clause 15.5.1.

 

		1.1.36	“CoC
                                            Sale Notice” shall have the meaning as ascribed to it in 15.5.2.

 

		1.1.37	“CoC
                                            Selling Shareholder” shall have the meaning as ascribed to it in Clause 15.5.1.

 

		1.1.38	“CoC
                                            Shares” shall have the meaning as ascribed to it in Clause 15.5.1.

 

		1.1.39	“CoC
                                            Tag Right” shall have the meaning as ascribed to it in Clause 15.5.1.

 

		1.1.40	“Code”
                                            means the Internal Revenue Code of 1986.

 

		1.1.41	“Company”
                                            shall have the meaning as ascribed to it in the recitals to this Agreement.

 

		1.1.42	“Company
                                            Shares” shall have the meaning as ascribed to in Clause 30.1 Agreement.

 

		1.1.43	“Conforming
                                            of Rights” shall have the meaning as ascribed to it in Clause 14.1.1.

 

		1.1.44	“Contribution”
                                            has the meaning set forth in the Contribution Agreement.

 

		1.1.45	“Contribution
                                            Agreement” means that certain Contribution Agreement dated ______, 2022 between
                                            Near Sing and the Company..

 

		1.1.46	“Control”
                                            (including, with its correlative meanings, the terms “Controlled by” or “under
                                            common Control with”) means (a) the possession, directly or indirectly, of the power
                                            to direct, or cause the direction of, management and policies of a Person whether through
                                            the ownership of voting securities, by agreement or otherwise, or the power to elect more
                                            than half of the directors, partners or other individuals exercising similar authority with
                                            respect to a Person; (b) the possession, directly or indirectly, of a voting interest in
                                            excess of 50% (fifty percent) in a Person; or (c) the power to direct, directly or indirectly,
                                            voting power in excess of 50% (fifty percent) in a Person.

 

		1.1.47	“Consents”
                                            means any consent, approval, agreement, ratification, waiver, notice or other authorisation
                                            of or from or to any Person whether given by expressly in writing or implied by conduct or
                                            deemed given due to a failure to act within any specified time period including all corporate,
                                            creditors’, shareholders’, scheduled banks and financial institutions and Third
                                            Party approvals or consents (other than a Governmental Approval) that may be required for
                                            any purpose including but not limited to (i) the execution of the Transaction Documents,
                                            (ii) the consummation of the transactions contemplated by the Transaction Documents, and
                                            (iii) carrying on the Business in a lawful manner.

 

    8

     

    

 

		1.1.48	“Constitution”
                                            means the Certificate of Incorporation of the Company or the Subsidiaries, as the case may
                                            be, as amended from time to time in accordance with Applicable Law and this Agreement.

 

		1.1.49	“Core
                                            Business” means business of designing and developing of software for providing
                                            location based advertising services or otherwise dealing in or with all software, hardware
                                            and programs related to the above.

 

		1.1.50	“Deed
                                            of Adherence” shall mean the deed of adherence in the form annexed hereto as Schedule
                                            6.

 

		1.1.51	“Default
                                            Notice” shall have the meaning as ascribed to it in Clause 24.1.

 

		1.1.52	“Dilution
                                            Instruments” means Ordinary Shares, or any Shares, securities, rights, options,
                                            warrants, appreciation rights or instruments (including debt instruments except with respect
                                            to loans for which convertibility has not been triggered), arrangements (whether oral or
                                            in writing) which are convertible into or entitle the holder to acquire or receive any Ordinary
                                            Shares of the Company or any rights or options to purchase or subscribe Ordinary Shares,
                                            or Shares with voting rights or economic rights.

 

		1.1.53	“Director”
                                            shall mean a director on the Board.

 

		1.1.54	“Disputing
                                            Parties” shall have the meaning as ascribed to it in Clause 29.4.

 

		1.1.55	“Drag
                                            Along Notice” shall have the meaning as ascribed to it in Clause 12.4.5(a).

 

		1.1.56	“Dragged
                                            Shares” means the GPC Drag Shares or the Other Shareholders’ Drag Shares,
                                            as the case may be.

 

		1.1.57	“Dragged
                                            Shareholders” means the GPC Dragged Shareholders or the Other Shareholders’
                                            Drag Shareholders, as the case may be.

 

		1.1.58	“Drag
                                            Along Right” means the GPC Drag Along Right or the Other Shareholders’ Drag
                                            Along Right, as the case may be.

 

		1.1.59	“Electing
                                            Shareholders” shall have the meaning as ascribed to it in Clause 13.6.

 

		1.1.60	“Employee
                                            RSUs” means employee restricted stock units from the Employee RSU Pool convertible
                                            into Ordinary Shares, in accordance with the terms of an Employee RSU Plan.

 

		1.1.61	“Employee
                                            RSU Pool” means a pool of Employee Restricted Stock Units (RSUs) comprising at
                                            the date of this Agreement, in aggregate, 101,458.000 (One Hundred One Thousand Four Hundred
                                            Fifty Eight) RSUs, and any combination of Employee RSU as are approved via increases to the
                                            Employee RSU Pool where such increases to the Employee RSU Pool are approved in accordance
                                            with this Agreement from time to time.

 

    9

     

    

 

		1.1.62	“Employee
                                            RSU Plan” means an employee restricted stock plan adopted by the Board and the
                                            Shareholders of the Company, for the benefit of the employees of the Company and the Subsidiaries,
                                            and for the benefit of such Persons to administer the grant, vesting and exercise of the
                                            Employee restricted stock units.

 

		1.1.63	“Encumbrance”
                                            means (i) any mortgage, charge (whether fixed or floating), pledge, lien, hypothecation,
                                            non-disposal undertaking, assignment, deed of trust, security interest, escrow, power of
                                            attorney (by whatever name called), Financial Indebtedness or other encumbrance of any kind
                                            securing or conferring any priority of payment in respect of any obligation of any Person,
                                            including without limitation, any right granted by a transaction which, in legal terms, is
                                            not the granting of security but which has an economic or financial effect similar to the
                                            granting of security under Applicable Law; (ii) any voting agreement, interest, option, right
                                            of first offer, right of first refusal or any transfer restriction imposed under Applicable
                                            Law or contract in favour of any Person; and (iii) any adverse claim as to title, possession
                                            or use and the term “Encumber” shall be construed accordingly.

 

		1.1.64	“ESG”
                                            shall mean environmental, social and governance matters.

 

		1.1.65	“ESG
                                            Management System” shall mean the part of the overall management system of the
                                            Company that includes the materially relevant policies, organizational structure, planning
                                            activities, responsibilities, practices, procedures and resources for developing, implementing,
                                            achieving, reviewing and maintaining compliance with the ESG Requirements, dedicated to the
                                            systematic and structured improvement of environmental, health and safety, social and governance
                                            performance, targeted to identify and manage ESG risks and opportunities in both the Company’s
                                            activities and in the loan and investment appraisal and management processes, integrated
                                            in the Company’s organisational structure, planning activities, responsibilities, practices,
                                            procedures, processes and resources.

 

		1.1.66	“ESG
                                            Requirements” shall mean environmental laws, social laws, any environment and/or
                                            social permit, license, consent, approval or other Authorization required by the Company
                                            to conduct the Business, and any other requirement notified to the Company by GPC.

 

		1.1.67	“ESG
                                            Reporting Requirements” shall mean the annual reporting requirement of the Company
                                            (and its Subsidiaries) to demonstrate material compliance with ESG Requirements in a form
                                            and manner acceptable to GPC.

 

		1.1.68	“Existing
                                            Near Sing Shares” shall have the meaning as ascribed to in Clause 301.

 

		1.1.69	“Existing
                                            Shareholders Agreement” shall have the meaning as ascribed to in Recital 3 of this
                                            Agreement.

 

		1.1.70	“Exit
                                            Default Rights” shall have the meaning assigned to it in Clause 12.1.

 

		1.1.71	“Exit
                                            Default Triggering Investor” shall have the meaning assigned to it in Clause 12.1.

 

    10

     

    

 

		1.1.72	“Exit
                                            Drag Price” means the minimum price per Share as determined by an independent merchant
                                            banker who will be appointed by the Board, for the purpose of identifying a Potential Buyer
                                            and undertaking an independent price discovery for exercising the GPC Drag Along Right.

 

		1.1.73	“Exit”
                                            shall have the meaning assigned to it in Clause 9.1.

 

		1.1.74	“Exit
                                            Period” shall have the meaning assigned to it in Clause 9.1.

 

		1.1.75	“Exit
                                            Price” means:

 

in
relation to Series A Preference Shares, Series B Preference Shares, Series C Preference Shares and Series D Preference Shares, a USD
equivalent of:

 

		(a)	1.5x
                                            of the respective Investment Amount, plus any declared but unpaid dividends on the relevant
                                            Preference Share, where the relevant Exit date or Liquidation Event date (as the case may
                                            be) falls on or prior to 31 August 2022, and

 

		(b)	2x
                                            of the respective Investment Amount, plus any declared but unpaid dividends on the relevant
                                            Preference Share, where the relevant Exit date or Liquidation Event date (as the case may
                                            be) falls after 31 August 2022, and

 

in
relation to Series U Preference Shares only, a USD equivalent of:

 

		(c)	1x
                                            of the respective Investment Amount, plus any declared but unpaid dividends on the Series
                                            U Preference Share, where the relevant Exit date or Liquidation Event date (as the case may
                                            be) falls on or prior to 31 August 2022, and

 

		(d)	1.5x
                                            of the respective Investment Amount, plus any declared but unpaid dividends on the Series
                                            U Preference Share, where the relevant Exit date or Liquidation Event date (as the case may
                                            be) falls after 31 August 2022.

 

		1.1.76	“Extended
                                            Exit Period” shall have the same meaning as ascribed to it in Clause 11.7.

 

		1.1.77	“FCPA”
                                            means the Foreign Corrupt Practices Act, 1977.

 

		1.1.78	“Financial
                                            Indebtedness” means any indebtedness for or in respect of:

 

		(a)	monies
                                            borrowed;
	 	 	 

		(b)	any
                                            amount raised by acceptance under any acceptance credit, bill acceptance or bill endorsement
                                            facility or dematerialised equivalent;
	 	 	 

		(c)	any
                                            amount raised pursuant to any note purchase facility or the issue of bonds, notes, debentures,
                                            loan stock or any similar instrument;
	 	 	 

		(d)	the
                                            amount of any liability in respect of any lease or hire purchase contract which would, in
                                            accordance with applicable accounting standards, be treated as a finance or capital lease;

 

    11

     

    

 

		(e)	receivables
                                            sold or discounted (other than any receivables to the extent they are sold on a non-recourse
                                            basis);

 

		(f)	any
                                            amount raised under any other transaction (including any forward sale or purchase agreement)
                                            having the commercial effect of a borrowing including either Founder’s or the Company’s
                                            or a Subsidiaries’ obligation to pay in relation to any call or put option relating
                                            to any interest owned by a party in the Company or the Subsidiaries, as the case may be;
	 	 	 
		(g)	any
                                            derivative transaction entered into in connection with protection against or benefit from
                                            fluctuation in any rate or price including any credit support arrangement in respect thereof
                                            (and, when calculating the value of any derivative transaction, only the marked to market
                                            value shall be taken into account);
	 	 	 

		(h)	shares
                                            which are expressed to be redeemable;
	 	 	 

		(i)	any
                                            counter-indemnity obligation in respect of a guarantee, indemnity, bond, standby or documentary
                                            letter of credit or any other instrument issued by a bank or financial institution; and
	 	 	 

		(j)	the
                                            amount of any liability in respect of any guarantee or indemnity, or under any other arrangement
                                            for any of the items referred to in paragraphs (a) to (i) above.

 

		1.1.79	“Financial
                                            Year” means a period, not exceeding a year, in respect of which an audited profit
                                            and loss account of the Company or the Subsidiaries, as the case may be has been or is to
                                            be prepared for the purpose of laying before the Company or the Subsidiaries, as the case
                                            may be at its annual General Meeting, whether that period is a year or not, or such other
                                            period as the Board may decide.

 

		1.1.80	“First
                                            Completion Date” shall have the meaning as ascribed to it in the Series D Subscription
                                            Agreement.

 

		1.1.81	“Founder
                                            Director” shall have the same meaning as ascribed to it in Clause 3.1.2(a).

 

		1.1.82	“Free
                                            Sale Period” shall have the meaning as ascribed to it in Clause 15.3.6.

 

		1.1.83	“Fully
                                            Diluted Basis” means a calculation assuming that all Dilution Instruments, including
                                            any options issued or reserved for issuance under any stock option plan or scheme by whatever
                                            name called of the Company or the Subsidiaries, as the case may be, existing at the time
                                            of determination have been exercised or converted into Ordinary Shares, including but not
                                            limited to any options or warrants issued or reserved for issuance under any stock option
                                            plan, the Employees Stock Option and Warrants Pool, or scheme.

 

		1.1.84	“Further
                                            Offered Terms” shall have the meaning as ascribed to it in Clause 4.4.

 

		1.1.85	“Further
                                            Offered Terms Notice” shall have the meaning as ascribed to it in Clause 4.4.

 

		1.1.86	“General
                                            Meeting” means a general meeting of the Shareholders of the Company or the Subsidiaries,
                                            as the case may be, convened and held in accordance with the Constitution, Applicable Law
                                            and the Transaction Documents.

 

    12

     

    

 

		1.1.87	“Governmental
                                            Approvals” means any permission, approval, consent, license, permit, order, decree,
                                            authorisation, registration, filing, notification, notarisation, certificate, authority,
                                            exemption or ruling to or from or with any Governmental Agency.

 

		1.1.88	“Government
                                            Agency” means any relevant governmental or quasi-governmental authority, statutory
                                            authority or quasi-statutory or regulatory authority, administrative, monetary, fiscal or
                                            judicial body, department, commission, authority, tribunal, agency or stock exchange or taxing
                                            authority or any body entitled to exercise executive power or power of any nature or body
                                            or other organisation to the extent that the rules, regulations, standards, requirements,
                                            procedures or orders of such authority, body or other organisation have the force of Applicable
                                            Law.

 

		1.1.89	“Group”
                                            shall mean the Company and all its Subsidiaries from time to time.

 

		1.1.90	“GPC
                                            Buy-Back Option” shall have the meaning as ascribed to it in Clause 12.3.1.

 

		1.1.91	“GPC
                                            CoC Shares” shall have the meaning as ascribed to it in Clause 15.5.3.

 

		1.1.92	“GPC
                                            Directors” shall have the meaning as ascribed to it in Clause 3.1.2(e).

 

		1.1.93	“GPC
                                            Drag Along Right” shall have the meaning as ascribed to it in Clause 12.4.3(a).

 

		1.1.94	“GPC
                                            Drag Shares” shall have the meaning as ascribed to it in Clause 12.4.3(a).

 

		1.1.95	“GPC
                                            Dragged Shareholders” shall have the meaning as ascribed to it in Clause 12.4.3(a).

 

		1.1.96	“GPC
                                            Outstanding Shares” shall have the meaning as ascribed to it in Clause 12.3.1(a).

 

		1.1.97	“GPC
                                            Potential Buyer” shall have the meaning as ascribed to it in Clause 12.4.1.

 

		1.1.98	“GPC
                                            Trade Sale Right” shall have the meaning as ascribed to it in Clause 12.4.1.

 

		1.1.99	“Holdback
                                            Event” means the occurrence of any act, omission or event for which the Company
                                            is entitled to indemnification under the Merger Agreement or has any right to adjust the
                                            purchase price under the Merger Agreement, including each indemnity claim and purchase price
                                            adjustment provided for under the Merger Agreement.

 

		1.1.100	“Holdback
                                            Shares” mean the number of Series U Preference Shares (or Ordinary Shares issued
                                            upon conversion of any Series U Preference Shares) that the Company may repurchase or redeem
                                            pursuant to the Merger Agreement in satisfaction of any indemnity claim or purchase price
                                            adjustment under the Merger Agreement, in each case as calculated in accordance with the
                                            terms of the Merger Agreement.

 

    13

     

    

 

		1.1.101	“IFC
                                            Performance Standards” shall mean the International Finance Corporation (IFC) 2012
                                            Performance Standards on Social and Environmental Sustainability (including the technical
                                            reference documents known as World Bank Group Environmental, Health, and Safety (EHS) Guidelines).

 

		1.1.102	“ILO
                                            Conventions” shall mean all and any conventions of the International Labour Organization,
                                            the United Nations.

 

		1.1.103	“Information”
                                            shall have the meaning as ascribed to it in Clause 27.1.

 

		1.1.104	“IPO”
                                            shall mean the initial public offering of Shares or other securities of the Company (including
                                            depository receipts), on a Recognised Stock Exchange.

 

		1.1.105	“Imere”
                                            shall mean Near India Private Limited.

 

		1.1.106	“Indemnity
                                            Holdback Release Date” shall have the meaning ascribed to such term in the Merger
                                            Agreement.

 

		1.1.107	“Intending
                                            Purchaser” shall have the meaning as ascribed to it in Clause 15.3.1.

 

		1.1.108	“Investment
                                            Amount” means, in relation to each Investor, (i) their respective subscription
                                            amount as set out under Series A Subscription Agreement, Series B Subscription Agreement,
                                            Series C Subscription Agreement, Series D Subscription Agreement, as the case may be, and
                                            (in relation to the Series U Investor only) as consideration for exchanging all outstanding
                                            preferred equity securities of UberMedia for the Series U Preference Shares pursuant to the
                                            terms of the Merger Agreement, plus (ii) all amounts invested towards the subscription of
                                            Shares by the original subscriber of such Shares which have subsequently been acquired by
                                            the relevant Investor, which as of the Closing Date will total USD 138,615,671 (United States
                                            Dollars One Hundred Thirty Eight Million Six Hundred Fifteen Thousand and Seventy One), comprising
                                            USD 5,993,598.02 (United States Dollars Five Million Nine Hundred Ninety Three Thousand Five
                                            Hundred Ninety Eight and Two cents), USD 18,750,000 (United States Dollars Eighteen Million
                                            Seven Hundred Thousand), USD 5,000,000 (United States Dollars Five Million), USD 60,500,000
                                            (United States Sixty Million Five Hundred Thousand), and USD 48,372,072.98 (United States
                                            Dollars Forty Eight Million Three Hundred Seventy Two Thousand and Seventy Two and Ninety
                                            Eight cents) for Series A Preference Shares, Series B Preference Shares, Series C Preference
                                            Shares, Series D Preference Shares and Series U Preference Shares respectively.

 

		1.1.109	“Key
                                            Employee(s)” means the following employees of the Company:

 

		(a)	Anil
                                            Mathews, having passport number Z2932529, being a citizen of India;
	 	 	 

		(b)	Justin
                                            Joseph, having passport number Z3295338, being a citizen of India;
	 	 	 

		(c)	Shobhit
                                            Shukla, having passport number Z3804429, being a citizen of India;
	 	 	 

		(d)	Rahul
                                            Agarwal, having passport number Z3255915, being a citizen of India.

 

		1.1.110	“Liquidation
                                            Clarification Notice” shall have the meaning ascribed to it in Clause 13.6.

 

    14

     

    

 

		1.1.111	“Liquidation
                                            Clarification Request” shall have the meaning ascribed to it in Clause 13.6.

 

		1.1.112	“Liquidation
                                            Event” means,

 

		(a)	commencement
                                            of any proceedings for the voluntary winding up or corporate insolvency resolution process
                                            of by the Company and/or its Material Subsidiaries, in accordance with the Applicable Law,
                                            including any compromise or arrangement with the creditors/debtors of the Company and/or
                                            the Material Subsidiaries or failure to pay debts, under which the Company or the Material
                                            Subsidiaries may be wound up under Applicable Law pursuant to a petition which has been admitted
                                            and concluded by the relevant authority;

 

		(b)	Appointment
                                            of a provisional or official liquidator or administrator or a resolution professional or
                                            similar official in any other proceeding seeking the winding up of the Company or seeking
                                            insolvency or any relief under the Applicable Law of the Company or the Subsidiaries by an
                                            appropriate court under any Applicable Law which appointment is not revoked within 90 (ninety)
                                            Business Days;

 

		(c)	Voluntary
                                            or involuntary liquidation, dissolution or winding up, a transfer of or creation of Encumbrance
                                            on 50% (fifty per cent) or more of the Group’s assets at the time of such transfer
                                            or Encumbrance;

 

		(d)	A
                                            merger, acquisition, change in control, consolidation, reorganisation, a trade sale, or other
                                            transaction or series of transactions in which the Company’s or the Material Subsidiaries’
                                            shareholders (immediately prior to such transaction or transactions) will not retain a majority
                                            of the voting power of the surviving entity immediately following such transaction after
                                            giving effect to any conversion, exercise or exchange of any Shares convertible into or exercisable
                                            or exchangeable for, such Ordinary Shares including, without limitation, any such transaction
                                            that arises from a Strategic Sale or the Exit Rights of the Investors; or

 

		(e)	A
                                            sale, lease, license or other transfer of 50% (fifty percent) or more of the Group’s
                                            Assets.

 

		1.1.113	“Liquidation
                                            Notice” shall have the meaning as ascribed to it in Clause 13.6

 

		1.1.114	“Liquidation
                                            Proceeds” shall have the meaning ascribed to it in Clause 13.1.

 

		1.1.115	“List
                                            A Matters” means the list of matters set out in the Part-A of Schedule 4.

 

		1.1.116	“List
                                            B Matters” means the list of matters set out in the Part-B of Schedule 4.

 

		1.1.117	“Listing
                                            Date” shall have the meaning as ascribed to it in Clause 14.1.2.

 

		1.1.118	“Losses”
                                            means any and all losses, liabilities, obligations, claims, demands, actions, suits, judgments,
                                            awards, fines, penalties, taxes, fees, settlements and proceedings, expenses, royalties,
                                            deficiencies, damages (whether or not resulting from Third Party claims), charges, costs
                                            (including costs of investigation, remediation or other response actions), interests, penalties,
                                            diminution in the value of Shares of the Company, losses to the Company and/or the Subsidiaries
                                            (to the extent of the Investors’ shareholding, respectively, in the Company on a Fully
                                            Diluted Basis), out-of-pocket expenses, attorneys’ and accountants’ fees and
                                            disbursements. The term “Losses” shall not include indirect, consequential, special
                                            or remote losses, loss of profits or opportunity cost, incurred or suffered by a Person.

 

    15

     

    

 

		1.1.119	“Material
                                            Adverse Effect” means a material adverse change to any of the following:

 

		(a)	The
                                            validity or enforceability of any of the Transactional Documents, the validity or enforceability
                                            of any of the transactions contemplated thereunder, or of the rights or remedies of the Investors;
	 	 	 

		(b)	The
                                            Assets, business, property, liabilities, financial condition of the Company or the Subsidiaries;
                                            and
	 	 	 

		(c)	The
                                            ability of the Company and/or the Subsidiaries and/or the Founders to perform their respective
                                            obligations under any of the Transaction Documents due to any voluntary acts of any of the
                                            aforesaid Persons.

 

		1.1.120	“Material
                                            Subsidiary” means such Subsidiary which constitutes at least 10% (ten percent)
                                            of the aggregate enterprise value or equity value of the Group.

 

		1.1.121	“Merger
                                            Agreement” shall have the meaning ascribed to it in Recital 6 of this Agreement.

 

		1.1.122	“NCP-A”
                                            shall have the meaning ascribed to it in Paragraph 1.1 of Part A of Schedule 5.

 

		1.1.123	“NCP-B”
                                            shall have the meaning ascribed to it in Paragraph 1.1 of Part B of Schedule 5.

 

		1.1.124	“NCP-C”
                                            shall have the meaning ascribed to it in Paragraph 1.1 of Part C of Schedule 5.

 

		1.1.125	“NCP-D”
                                            shall have the meaning ascribed to it in Paragraph 1.1 of Part D of Schedule 5.

 

		1.1.126	“NCP-U”
                                            shall have the meaning ascribed to it in Paragraph 1.1 of Part E of Schedule 5.

 

		1.1.127	“Notice
                                            of Offer” shall have the meaning as ascribed to it in Clause 4.2.

 

		1.1.128	“Notify”
                                            or “Notification” means the providing of a notice in writing, including
                                            by facsimile or electronic means.

 

		1.1.129	“Observer”
                                            shall have the meaning as ascribed to it in Clause 3.1.7.

 

		1.1.130	“Offer
                                            Acceptance Notice” shall have the meaning as ascribed to it in Clause 15.3.3.

 

		1.1.131	“Offer
                                            Notice” shall have the meaning as ascribed to it in Clause 12.4.6(a)(ii).

 

		1.1.132	“Offered
                                            Terms” shall have the meaning as ascribed to it in Clause 4.2.

 

    16

     

    

 

		1.1.133	“Offeree”
                                            shall have the meaning as ascribed to it in Clause 4.1.

 

		1.1.134	“Offer
                                            Period” shall have the meaning to Clause 12.4.6(a)(ii).

 

		1.1.135	“Ordinary
                                            Shares” shall mean shares of Company Common Stock.

 

		1.1.136	“Other
                                            CoC Exiting Investor” shall have the meaning as ascribed to it in Clause 15.5.1.

 

		1.1.137	“Other
                                            Exit Default Triggering Investor(s)” shall have the meaning as ascribed to it in
                                            Clause 12.1.

 

		1.1.138	“Other
                                            Investor CoC Shares” shall have the meaning as ascribed to in Clause 15.5.3.

 

		1.1.139	“Other
                                            Investors LP 1” shall have the meaning as ascribed to it in Clause 13.2(ii).

 

		1.1.140	“Other
                                            Investors LP 2” shall have the meaning as ascribed to it in Clause 13.3(ii).

 

		1.1.141	“Other
                                            Shareholders’ Buy-Back Option” shall have the meaning as ascribed to it in
                                            Clause 12.3.2.

 

		1.1.142	“Other
                                            Shareholders’ Drag Along Right” shall have the meaning as ascribed to it
                                            in Clause 12.4.4(a).

 

		1.1.143	“Other
                                            Shareholders’ Drag Shares” shall have the meaning as ascribed to it in Clause
                                            12.4.4(a).

 

		1.1.144	“Other
                                            Shareholders’ Dragged Shareholders” shall have the meaning as ascribed to
                                            it in Clause 12.4.4(a).

 

		1.1.145	“Other
                                            Shareholders’ Outstanding Shares” shall have the meaning as ascribed to it
                                            in Clause 12.3.2.

 

		1.1.146	“Other
                                            Shareholders’ Potential Buyer” shall have the meaning as ascribed to it in
                                            Clause 12.4.2.

 

		1.1.147	“Other
                                            Shareholders’ Trade Sale Right” shall have the meaning as ascribed to it
                                            in Clause 12.4.2.

 

		1.1.148	“Other
                                            Shareholder Redemption Notice” shall have the meaning ascribed to it in Paragraph
                                            4.3 of Schedule 7 and/or Schedule 8 and/or Schedule 9 and/or Schedule 10 and/or Paragraph
                                            4.6.1 of Schedule 11, as may be applicable.

 

		1.1.149	“Other
                                            Shareholder Redemption Notice Deadline” shall have the meaning ascribed to it in
                                            Paragraph 4.3 of Schedule 7 and/or Schedule 8 and/or Schedule 9 and/or Schedule 10 and/or
                                            Paragraph 4.6.1 of Schedule 11, as may be applicable.
	 	 	 
	 	 	“Outstanding
Exit Default Triggering Investor Shares” shall have the meaning as ascribed to it in Clause 12.3.3(b).

 

    17

     

    

 

		1.1.150	“PCA”
                                            shall mean the Prevention of Corruption Act, 1988.

 

		1.1.151	“Person”
                                            means any natural person, limited or unlimited liability company, corporation, partnership
                                            (whether limited or unlimited), proprietorship, trust, union, association, government or
                                            any agency or political subdivision thereof or any other entity that may be treated as a
                                            person under Applicable Law.

 

		1.1.152	“Permitted
                                            Transfer” shall have the meaning as ascribed to it in Clause 15.1.

 

		1.1.153	“PFIC”
                                            means a Passive Foreign Investment Company.

 

		1.1.154	“PFIC
                                            Annual Information Statement” shall have the meaning as ascribed to it in Clause
                                            21.14.4.

 

		1.1.155	“Potential
                                            Buyer” means GPC Potential Buyer or the Other Shareholders’ Potential Buyer,
                                            as the case may be.

 

		1.1.156	"Preference
                                            Amount" shall have the meaning ascribed to it in Clause 13.4.

 

		1.1.157	“Preference
                                            Shareholder” means a Series A Holder, Series B Holder, Series C Holder, Series
                                            D Holder and/or Series U Holder and “Preference Shareholders” means all
                                            of them.

 

		1.1.158	“Preference
                                            Shares” means Series A Preference Shares, Series B Preference Shares, Series C
                                            Preference Shares, Series D Preference Shares and/or Series U Preference Shares.

 

		1.1.159	“Protective
                                            Covenants” shall have the meaning as ascribed to it in Clause 8.2.

 

		1.1.160	“QEF
                                            Election” means a qualified electing fund election.

 

		1.1.161	“QIPO”
                                            means an IPO which satisfies the following conditions:

 

		(a)	a
                                            merchant banker of international repute, acceptable to the Investors, is appointed in connection
                                            with the management and underwriting of the IPO;

 

		(b)	The
                                            IPO happens at an equity valuation which is at least at the Exit Price; and

 

		(c)	The
                                            IPO results in listing or quoting of the Shares on a Recognised Stock Exchange and is completed
                                            prior to the expiry of the Exit Period or such extended period as agreed by the Investors.

 

		1.1.162	“Recognised
                                            Stock Exchange” means the Singapore Exchange Securities Trading Limited or any
                                            exchange or a quotation system.

 

		1.1.163	“Redemption
                                            Notice” refers to the Series A Redemption Notice, the Series B Redemption Notice,
                                            the Series C Redemption Notice, the Series D Redemption Notice and/or the Series U Redemption
                                            Notice.

 

    18

     

    

 

		1.1.164	“Redemption
                                            Price” refers to the Series A Redemption Price, the Series B Redemption Price,
                                            the Series C Redemption Price, the Series D Redemption Price and/or the Series U Redemption
                                            Price.

 

		1.1.165	“Related
                                            Party”, with respect to the Company, shall mean:

 

		(a)	The
                                            Affiliates of the Company;

 

		(b)	The
                                            Founders, the Affiliates of the Founders, the Directors (including the Directors appointed
                                            by the Investors if any);

 

		(c)	Any
                                            Person in, or of which, any of the Persons in paragraphs (i) or (ii) above are directors,
                                            partners, proprietors or in which any of the above have any Control;

 

		(d)	Any
                                            Shareholder, including any Affiliates of such Shareholder when the Founders have Knowledge
                                            of such relationship; or

 

		(e)	Any
                                            Relative of Persons in paragraphs (a) to (c) above and any Relative of Persons in paragraph
                                            (d) of whom the Founders have Knowledge.

 

		1.1.166	“Reserved
                                            Matters” means collectively the List A Matters and the List B Matters.

 

		1.1.167	[deleted]

 

		1.1.168	“Response
                                            Notice” shall have the meaning as ascribed to it in Clause 12.4.6.

 

		1.1.169	“Right
                                            Holders” shall have the meaning as ascribed to it in Clause 4.1.

 

		1.1.170	“Rights
                                            of First Offer” shall have the meaning as ascribed to it in Clause 12.4.6.

 

		1.1.171	“ROFO
                                            Notice” shall have the meaning as ascribed to it in Clause 12.4.6.

 

		1.1.172	“ROFO
                                            Offerees” shall have the meaning as ascribed to it in Clause. 12.4.6.

 

		1.1.173	“ROFO
                                            Shares” shall have the meaning as ascribed to it in Clause 12.4.6.

 

		1.1.174	“ROFO
                                            Terms” shall have the meaning as ascribed to it in Clause 12.4.6.

 

		1.1.175	“ROFR
                                            Acceptance Period” shall have the meaning as ascribed to it in Clause 15.3.3.

 

		1.1.176	“Sequoia
                                            Director” shall have the same meaning as ascribed to it in Clause 3.1.2.

 

		1.1.177	“Series
                                            A Investors” means Sequoia and CMDB, collectively, who shall individually be referred
                                            to as the "Series A Investor" which expression shall, unless the context
                                            requires otherwise, mean and include its successors and permitted assigns.

 

		1.1.178	“Series
                                            A Conversion Factor” shall have the meaning ascribed to it in Paragraph 3.2.2 of
                                            Schedule 7.

 

    19

     

    

 

		1.1.179	“Series
                                            A Conversion Price” shall have the meaning ascribed to it in Paragraph 1 of Part
                                            A of Schedule 5.

 

		1.1.180	“Series
                                            A Conversion Notice” shall have the meaning ascribed to it in Paragraph 3.2.1 of
                                            Schedule 7.

 

		1.1.181	“Series
                                            A Dilutive Issuance” shall have the meaning ascribed to it in Paragraph 1 of Part
                                            A of Schedule 5.

 

		1.1.182	“Series
                                            A Holder” refers to a holder of Series A Preference Shares.

 

		1.1.183	“Series
                                            A Preference Amount” means in respect of the Series A Preference Share, an amount
                                            equal to the Exit Price based on the relevant Exit event date or Liquidation Event date (as
                                            the case may be).

 

		1.1.184	“Series
                                            A Preference Share(s)” means shares of Company Series A Preferred Stock.

 

		1.1.185	“Series
                                            A Redemption Event” shall have the meaning ascribed to it in Paragraph 4.1 of Schedule
                                            7.

 

		1.1.186	“Series
                                            A Redemption Notice” shall have the meaning ascribed to it in Paragraph 4.3 of
                                            Schedule 7.

 

		1.1.187	“Series
                                            A Securities” means the Series A Preference Shares and any Dilution Instruments
                                            issued to the respective Series A Holder.

 

		1.1.188	“Series
                                            A Subscription Agreement” refers to the subscription agreement dated October 17,
                                            2012 entered into between Series A Investors, the Company, Imere and the Founders.

 

		1.1.189	“Series
                                            A Subscription Price” shall have the meaning ascribed to it in the Series A Subscription
                                            Agreement.

 

		1.1.190	“Series
                                            B Conversion Factor” shall have the meaning ascribed to it in Paragraph 3.2.2 of
                                            Schedule 8.

 

		1.1.191	“Series
                                            B Conversion Notice” shall have the meaning ascribed to it in Paragraph 3.2.1 of
                                            Schedule 8.

 

		1.1.192	“Series
                                            B Conversion Price” shall have the meaning ascribed to it in Paragraph 1 of Part
                                            B of Schedule 5.

 

		1.1.193	“Series
                                            B Dilutive Issuance” shall have the meaning ascribed to it in Paragraph 1 of Part
                                            B of Schedule 5.

 

		1.1.194	“Series
                                            B Holder” refers to a holder of Series B Preference Shares.

 

		1.1.195	“Series
                                            B Investors” shall collectively mean CMDB, Sequoia, Global Brains and TV, who shall
                                            individually be referred to as the “Series B Investor”, which expression
                                            shall, unless the context requires otherwise, mean and include its successors and permitted
                                            assigns.

 

    20

     

    

 

		1.1.196	“Series
                                            B Investor Director” shall mean, individually, the CMDB Director, the TV Director
                                            and the Sequoia Director and collectively be referred to as the “Series B Investor
                                            Directors”.

 

		1.1.197	“Series
                                            B Preference Share(s)” means shares of Company Series B Preferred Stock.

 

		1.1.198	“Series
                                            B Preference Amount” means in respect of the Series B Preference Share, an amount
                                            equal to the Exit Price based on the relevant Exit event date or Liquidation Event date (as
                                            the case may be).

 

		1.1.199	“Series
                                            B Redemption Event” shall have the meaning ascribed to it in Paragraph 4.1 of Schedule
                                            8.

 

		1.1.200	“Series
                                            B Redemption Notice” shall have the meaning ascribed to it in Paragraph 4.3 of
                                            Schedule 8.

 

		1.1.201	“Series
                                            B Securities” means the Series B Preference Shares and any Dilution Instruments
                                            issued to the respective Series B Holder.

 

		1.1.202	“Series
                                            B Subscription Agreement” refers to the subscription agreement dated October 23,
                                            2014 entered into between the Series B Investors, the Company, Imere and the Founders.

 

		1.1.203	“Series
                                            B Subscription Price” shall have the meaning ascribed to it in the Series B Subscription
                                            Agreement.

 

		1.1.204	“Series
                                            C Conversion Factor” shall have the meaning ascribed to it in Paragraph 3.2.2 of
                                            Schedule 9.

 

		1.1.205	“Series
                                            C Conversion Notice” shall have the meaning ascribed to it in Paragraph 3.2.1 of
                                            Schedule 9.

 

		1.1.206	“Series
                                            C Conversion Price” shall have the meaning ascribed to it in Paragraph 1 of Part
                                            C of Schedule 5.

 

		1.1.207	“Series
                                            C Dilutive Issuance” shall have the meaning ascribed to it in Paragraph 1 of Part
                                            C of Schedule 5.

 

		1.1.208	“Series
                                            C Holder” refers to a holder of Series C Preference Shares.

 

		1.1.209	“Series
                                            C Investors” shall collectively mean TV, Cisco and Global Brains, who shall individually
                                            be referred to as the “Series C Investor”, unless the context requires otherwise,
                                            mean and include its successors and permitted assigns.

 

		1.1.210	“Series
                                            C Preference Share(s)” means shares of Company Series C Preferred Stock.

 

    21

     

    

 

		1.1.211	“Series
                                            C Preference Amount” means in respect of the Series C Preference Share, an amount
                                            equal to the Exit Price based on the relevant Exit event date or Liquidation Event date (as
                                            the case may be).

 

		1.1.212	“Series
                                            C Redemption Event” shall have the meaning ascribed to it in Paragraph 4.1 of Schedule
                                            9.

 

		1.1.213	“Series
                                            C Redemption Notice” shall have the meaning ascribed to it in Paragraph 4.3 of
                                            Schedule 9.

 

		1.1.214	“Series
                                            C Redemption Price” shall have the meaning ascribed to it in Paragraph 4.3 of Schedule
                                            9.

 

		1.1.215	“Series
                                            C Securities” means the Series C Preference Shares and any Dilution Instruments
                                            issued to the respective Series C Holder.

 

		1.1.216	“Series
                                            C Subscription Agreement” shall mean the subscription agreement dated September
                                            9, 2016 entered into between the Series C Investors, the Company, Imere and the Founders.

 

		1.1.217	“Series
                                            C Subscription Price” shall have the meaning ascribed to it in the Series C Subscription
                                            Agreement.

 

		1.1.218	“Series
                                            D Conversion Factor” shall have the meaning ascribed to it in Paragraph 3.2.2 of
                                            Schedule 10.

 

		1.1.219	“Series
                                            D Conversion Notice” shall have the meaning ascribed to it in Paragraph 3.2.1 of
                                            Schedule 10.

 

		1.1.220	“Series
                                            D Conversion Price” shall have the meaning ascribed to it in Paragraph 1 of Part
                                            D of Schedule 5.

 

		1.1.221	“Series
                                            D Dilutive Issuance” shall have the meaning ascribed to it in Paragraph 1 of Part
                                            D of Schedule 5.

 

		1.1.222	“Series
                                            D Holder” refers to a holder of Series D Preference Shares.

 

		1.1.223	“Series
                                            D Investors” shall collectively mean GPC and OurCrowd, who shall individually be
                                            referred to as the “Series D Investor”, unless the context requires otherwise,
                                            mean and include its successors and permitted assigns.

 

		1.1.224	“Series
                                            D LP 1” shall have the meaning as ascribed to it in Clause 13.2.

 

		1.1.225	“Series
                                            D LP 2” shall have the meaning as ascribed to it in Clause 13.3.

 

		1.1.226	“Series
                                            D Preference Share(s)” means shares of Company Series D Preferred Stock.

 

		1.1.227	“Series
                                            D Preference Amount” means in respect of the Series D Preference Share, an amount
                                            equal to the Exit Price based on the relevant Exit event date or Liquidation Event date (as
                                            the case may be).

 

    22

     

    

 

		1.1.228	“Series
                                            D Redemption Event” shall have the meaning ascribed to it in Paragraph 4.1 of Schedule
                                            10.

 

		1.1.229	“Series
                                            D Redemption Notice” shall have the meaning ascribed to it in Paragraph 4.3 of
                                            Schedule 10.

 

		1.1.230	“Series
                                            D Redemption Price” shall have the meaning ascribed to it in Paragraph 4.2 of Schedule
                                            10.

 

		1.1.231	“Series
                                            D Securities” means the Series D Preference Shares and any Dilution Instruments
                                            issued to the respective Series D Holder.

 

		1.1.232	“Series
                                            D Subscription Agreement” shall have the meaning as ascribed to in Recital 4 of
                                            this Agreement.

 

		1.1.233	“Series
                                            D Subscription Price” shall have the meaning ascribed to it in the Series D Subscription
                                            Agreement, in case of GPC or the price at which the Series D Preference Shares are allotted
                                            to the OurCrowd, in the case of OurCrowd.

 

		1.1.234	“Series
                                            U Conversion Factor” shall have the meaning ascribed to it in Paragraph 3.2.2 of
                                            Schedule 11.

 

		1.1.235	“Series
                                            U Conversion Notice” shall have the meaning ascribed to it in Paragraph 3.2.1 of
                                            Schedule 11.

 

		1.1.236	“Series
                                            U Conversion Price” shall have the meaning ascribed to it in Paragraph 1 of Part
                                            E of Schedule 5.

 

		1.1.237	“Series
                                            U Dilutive Issuance” shall have the meaning ascribed to it in Paragraph 1 of Part
                                            E of Schedule 5.

 

		1.1.238	“Series
                                            U Holder” means (i) initially, the Series U Investor and its successors and permitted
                                            assigns, and (ii) each subsequent holder of Series U Preference Shares subject to the terms
                                            and conditions of this Agreement.

 

		1.1.239	“Series
                                            U Investor” has the meaning ascribed to in Recital 8.

 

		1.1.240	“Series
                                            U Preference Share(s)” means shares of Compan Series U Preferred Stock. For the
                                            avoidance of doubt, Series U Preference Shares cannot be redeemed at the discretion of the
                                            Series U Holders but the Series U Holders may participate in any redemption as set forth
                                            in accordance with the terms hereof.

 

		1.1.241	“Series
                                            U Preference Amount” means in respect of the Series U Preference Share, an amount
                                            equal to the Exit Price based on the relevant Exit event date or Liquidation Event date (as
                                            the case may be).

 

		1.1.242	“Series
                                            U Redemption Event” shall have the meaning ascribed to it in Paragraph 4.3 of Schedule
                                            11.

 

    23

     

    

 

		1.1.243	“Series
                                            U Redemption Notice” shall have the meaning ascribed to it in Paragraph 4.6.1 of
                                            Schedule 11.

 

		1.1.244	“Series
                                            U Redemption Price” shall have the meaning ascribed to it in Paragraph 4.4 of Schedule
                                            11.

 

		1.1.245	“Series
                                            U Securities” means the Series U Preference Shares and any Dilution Instruments
                                            issued to the respective Series U Holder.

 

		1.1.246	“Series
                                            U Subscription Price” means the Parent Series U Per Share Value, as defined in
                                            the Merger Agreement.

 

		1.1.247	“Share
                                            Capital” shall mean the share capital of the Company.

 

		1.1.248	“Share
                                            Exchange” shall have the meaning as ascribed to it in Clause 30.1.

 

		1.1.249	“Shareholder”
                                            at any point in time, means a person who is a holder of Shares at that time.

 

		1.1.250	“Shares”
                                            means all classes of shares in the capital of the Company issued from time to time together
                                            with all accretions, rights and interests at that time attached to such shares or accruing
                                            to the holder of them by reason of being such holder (including the right to dividends and
                                            other distributions, differential rights, obligations, title, interest and claim in such
                                            shares) and shall be deemed to include all bonus shares issued in respect of such shares
                                            and shares issued pursuant to a stock split in respect of such Shares.

 

		1.1.251	“SIAC
                                            Rules” means Arbitration Rules of the Singapore International Arbitration Centre.

 

		1.1.252	“Strategic
                                            Sale” means any, or combination of, a merger or amalgamation of the Company with
                                            or into any other entity, or any transaction involving a sale of all or substantially all
                                            of the outstanding Shares, or a sale of all or substantially all of the assets of the Company
                                            and/or its Material Subsidiaries.

 

		1.1.253	“Strategic
                                            Sale Notice” shall have the meaning as ascribed to it in Clause 11.1.

 

		1.1.254	“Subscription
                                            Agreements” shall collectively mean the Series A Subscription Agreement, the Series
                                            B Subscription Agreement, the Series C Subscription Agreement, the Series D Subscription
                                            Agreement and the Merger Agreement.

 

		1.1.255	“Subsidiaries”
                                            means any subsidiary of the Company (as having the meaning ascribed thereto by Section 5
                                            of the Act), whether presently existing or which comes into existence at a later point in
                                            time. The term “Subsidiary” shall be construed accordingly.

 

		1.1.256	“Tag
                                            Accepting Investors” shall have the meaning ascribed to it in Clause 15.4.6.

 

		1.1.257	“Tag
                                            Along Right” shall have the meaning ascribed to it in Clause 15.4.1.

 

		1.1.258	“Tag
                                            Shares” shall have the meaning ascribed to it in Clause 15.4.2.

 

    24

     

    

 

		1.1.259	“Tag
                                            Along Acceptance Notice” shall have the meaning as ascribed to it in Clause 15.4.3.

 

		1.1.260	“Threshold
                                            Shareholding” means a minimum threshold shareholding equal to 7.5% (seven point
                                            five percent) of total issued and paid up share capital of the Company on a Fully Diluted
                                            Basis, subject however to Clause 21.1.

 

		1.1.261	“Third
                                            Party” shall mean any Person other than the Parties to this Agreement.

 

		1.1.262	“Trade
                                            Sale Right” shall mean the GPC Trade Sale Right or the Other Shareholders’
                                            Trade Sale Right, as the case may be.

 

		1.1.263	“Transaction
                                            Documents” means this Agreement, the Constitution and any other documents required
                                            to be delivered pursuant hereto or thereto.

 

		1.1.264	“Transferor
                                            Shareholder” shall have the meaning as ascribed to it in Clause 15.3.1.

 

		1.1.265	“Trigger
                                            Events” means:

 

		(a)	Breach
                                            or failure to observe or comply with any representation or warranty or the following Clauses
                                            of the Transaction Documents, by the Company or the Founder or any other applicable Person,
                                            which breach or failure to observe or comply is not remedied within a period of 30 (thirty)
                                            Business Days of receipt of a default notice from the Investors (acting jointly and unanimously
                                            and not severally) in the said regard:

 

		i.	Clause
                                            3.3 of this Agreement (Reserved Matters);
	 	 	 

		ii.	Clause
                                            4 of this Agreement (Pre-emptive Rights for New Issues of Shares);
	 	 	 

		iii.	Clause
                                            12 of this Agreement (Exit Default Rights);
	 	 	 

		iv.	Clause
                                            15 of this Agreement (Transfer of Shares by the Founders and the other Shareholders);
	 	 	 

		v.	Clause
                                            18 of this Agreement (Right of Inspection); and
	 	 	 

		vi.	Clause
                                            13 of this Agreement (Liquidation Preference);

 

		(b)	Material
                                            breach of the following Clauses of the Transaction Documents, by the Company or the Founder,
                                            which material breach is not remedied within a period of 30 (thirty) Business Days of receipt
                                            of a default notice from the Investors in the said regard:

 

		(i)	Clause
                                            3 of this Agreement (Management of the Company); and
	 	 	 

		(ii)	Clause
                                            21 of this Agreement (Other Covenants);

 

		(c)	Repeated
                                            and deliberate breaches of Clause 17 of this Agreement (Information Rights);

 

		(d)	Any
                                            wilful act or omission of the Founder and/ or the Company which prevents obstructs or delays
                                            the conversion of the Preference Shares in the manner contemplated under this Agreement and
                                            the Transaction Documents;

 

    25

     

    

 

		(e)	Any
                                            material breach by a Founder under his employment agreement with the Company dated March
                                            24, 2015 (as may be amended from time to time);

 

		(f)	Either
                                            Founder being convicted for fraud or violation of any Applicable Law which may lead to Material
                                            Adverse Effect or an offence involving moral turpitude and/or initiation of disciplinary
                                            action by any Governmental Agency or the finding of any audit or investigation which reveals
                                            that the affairs of the Company and/or its Subsidiaries have been conducted in a fraudulent
                                            manner; and

 

		(g)	If
                                            the Warrantors (as such term is defined in the Series D Subscription Agreement) are in material
                                            breach of their obligation to make any payment when any sum payable is due under the Transaction
                                            Documents to the Series D Investors (as the case may be).

 

		1.1.266	“USD”
                                            means the lawful currency of the United States of America.

 

		1.1.267	“Warranties”
                                            shall have the meaning ascribed to it in the Subscription Agreements.

 

		1.1.268	“Warrant”
                                            shall mean any right issued by the Company to a business collaborator of the Company and/or
                                            its Subsidiaries authorizing said business collaborator to purchase Ordinary Shares of the
                                            Company.

 

		1.2	Interpretation:

 

In
the interpretation of the Agreement, the following rules shall apply unless otherwise indicated by the context:

 

		1.2.1	Words
                                            of any gender are deemed to include those of the other gender;

 

		1.2.2	Words
                                            using the singular or plural number also include the plural or singular number, respectively;

 

		1.2.3	Where
                                            a word or phrase is defined, its other grammatical forms have a corresponding meaning;

 

		1.2.4	The
                                            terms “hereof”, “herein”, “hereby”, “hereto”
                                            and derivative or similar words refer to this entire Agreement or specified Clauses of this
                                            Agreement, as the case may be;

 

		1.2.5	The
                                            term “Clause” and “Schedule” refers to the specified Clause and Schedule
                                            of this Agreement;

 

		1.2.6	The
                                            words “directly or indirectly” mean directly or indirectly through one or more
                                            intermediary persons or through contractual or other legal arrangements, and the terms “direct
                                            or indirect” shall have the correlative meanings;

 

		1.2.7	Clauses,
                                            headings, bold typeface, index, titles and Schedule headings are only for convenience and
                                            shall be ignored for the purposes of interpretation;

 

		1.2.8	Reference
                                            to any legislation or Applicable Law or to any provision thereof shall include references
                                            to any such law as it may, after the date hereof, from time to time, be amended, supplemented
                                            or re-enacted, and any reference to statutory provision shall include reference to any subordinate
                                            legislation made from time to time under that provision;

 

    26

     

    

 

		1.2.9	Reference
                                            to the words “include” or “including” shall be construed without
                                            limitation;

 

		1.2.10	The
                                            Schedules hereto shall constitute an integral part of this Agreement;

 

		1.2.11	Time
                                            is of the essence in the performance of the respective obligations of the Parties. If any
                                            time period specified herein is extended, such extended time shall also be of the essence;

 

		1.2.12	References
                                            to the knowledge, information, belief or awareness of any Person shall be deemed to include
                                            the knowledge, information, belief or awareness of such Person after examining all information
                                            and making all due diligence inquiries, due and careful inquires, and investigations which
                                            would be expected or required from a Person of ordinary prudence, and when used in the context
                                            of the Company means the knowledge, information, belief or awareness of the Founders;

 

		1.2.13	The
                                            Parties acknowledge that they and their respective counsels have read and understood the
                                            terms of this Agreement and have participated equally in the negotiation and drafting of
                                            this Agreement. Accordingly, no court or arbitrator construing this Agreement shall construe
                                            it more stringently against one Party than against the other;

 

		1.2.14	Any
                                            word or phrase defined in the body of this Agreement as opposed to being defined in Clause
                                            1.1 shall have the meaning assigned to it therein throughout this Agreement, unless the contrary
                                            is expressly stated or clearly appears from the context;

 

		1.2.15	If
                                            any provision in Clause 1.1 is a substantive provision conferring rights or imposing obligations
                                            on any Party, effect shall be given to it as if it were a substantive provision in the body
                                            of this Agreement;

 

		1.2.16	When
                                            any number of days is prescribed in any document, the same shall be reckoned exclusively
                                            of the first and inclusively of the last day unless the last day does not fall on a Business
                                            Day, in which case the last day shall be the next succeeding day that is a Business Day;

 

		1.2.17	Any
                                            reference to “writing” includes printing, typing, lithography, emails, facsimile
                                            and other means of reproducing words in permanent visible form:

 

		1.2.18	Any
                                            reference to conduct includes any omission and any statement or undertaking, whether or not
                                            in writing;

 

		1.2.19	All
                                            references to this Agreement or any other Transaction Document shall be deemed to include
                                            any amendments or modifications to this Agreement or the relevant Transaction Documents,
                                            as the case may be, from time to time;

 

		1.2.20	Any
                                            right of the Investors to be issued Shares under this Agreement shall include the right of
                                            such Investor to have such Shares issued to or purchased by an Affiliate or a nominee. In
                                            determining an Investors’ shareholding in the Company for any purpose whatsoever, all
                                            Shares held by the Investors or any of its Affiliate shall be considered collectively;

 

    27

     

    

 

		1.2.21	Unless
                                            stated otherwise, in computing the shareholding of any Party, for determining the rights
                                            and privileges available to such Party under this Agreement and the Subscription Agreements,
                                            the shares held by its Affiliates shall be considered as being held by such Party;

 

		1.2.22	Unless
                                            stated otherwise, any and all rights available to the Investors in the Company under this
                                            Agreement or the Subscription Agreements shall be mutatis mutandis also be available to the
                                            Investors in the Subsidiaries;

 

		1.2.23	Any
                                            references to the Investor under this Agreement will include its transferee, assignee, nominee
                                            and/or Affiliate that has executed a Deed of Adherence, in accordance with the provisions
                                            of this Agreement;

 

		1.2.24	In
                                            the event that any rights that an Investor is entitled to under this Agreement with respect
                                            to one class or kind of Shares held by such Investor, cannot be given effect due to restrictions
                                            under Applicable Law, such Investor shall, subject to Applicable Law, be entitled to exercise
                                            and receive the benefit of such rights through one or more other classes or categories of
                                            Shares held by it in the Company;

 

		1.2.25	In
                                            the event any calculation pursuant to this Agreement is a fraction, then such amount shall
                                            be rounded to the nearest 0.0001

 

		1.2.26	Any
                                            obligation, covenant, warranty, representation or undertaking hereto that is expressed to
                                            be made, undertaken or given by the Company or the Founders shall be deemed mutatis mutandis
                                            to be jointly and severally made, undertaken and given by the Company and the Founders, and
                                            each of the Company and the Founders shall be jointly and severally responsible in respect
                                            of the same.

 

		2	EFFECTIVE
                                            DATE 

 

		2.1	The
                                            Existing Shareholders Agreement was effective as of the First Completion Date. This Agreement,
                                            and the amendment and restatement of the Existing Shareholders Agreement by this Agreement,
                                            shall be effective on the Effective Date and shall remain in force until terminated in accordance
                                            with Clause 23 (Termination after Closing). Following the Effective Date, the terms and conditions
                                            of the Existing Shareholders Agreement shall have no force or effect.

 

		2.2	The
                                            capitalization of the Company on a Fully Diluted Basis as of the Effective Date shall be
                                            as set out in Part B of Schedule 1.

 

		2.3	[deleted].

 

		3	MANAGEMENT
                                            OF THE COMPANY

 

		3.1	Board
                                            of Directors

 

		3.1.1	Subject
                                            to Applicable Law and the terms of this Agreement, the Assets, Business and the affairs of
                                            the Company and the Subsidiaries shall be managed exclusively by and under the direction
                                            of their respective Boards, who shall have powers to do all such lawful acts and take all
                                            such actions as are permitted under Applicable Law, the Charter Documents, subject only to
                                            the proviso that those matters that are required to be approved by the Shareholders, whether
                                            under the Act, this Agreement or the Constitution, shall be referred to the Shareholders
                                            for their approval and shall be approved in accordance with this Agreement, the Act and the
                                            Constitution.

 

    28

     

    

 

		3.1.2	With
                                            effect from the First Completion Date, the composition of the Board shall be as follows:

 

		(a)	The
                                            Founders shall have the right to nominate 2 (two) Directors, who shall be Mr. Anil Mathews
                                            and Mr. Shobhit Shukla (each a “Founder Director”) who will be appointed
                                            to the Board by the Company;

 

		(b)	So
                                            long as CMDB holds not less than the Threshold Shareholding, CMDB shall be entitled to nominate
                                            1 (one) Director on the Board (the “CMDB Director”) who will be appointed
                                            to the Board by the Company;

 

		(c)	So
                                            long as Sequoia holds not less than the Threshold Shareholding, Sequoia shall be entitled
                                            to nominate 1 (one) Director on the Board (the “Sequoia Director”) who
                                            will be appointed to the Board by the Company;

 

		(d)	So
                                            long as TV holds not less than the Threshold Shareholding, TV shall be entitled to nominate
                                            1 (one) Director on the Board (the “TV Director”) who will be appointed
                                            to the Board by the Company; and

 

		(e)	So
                                            long as GPC holds not less than the Threshold Shareholding:

 

		(i)	GPC
                                            will be entitled to nominate 1 (one) Director on the Board who will be appointed to the Board
                                            by the Company; and
	 	 	 

		(ii)	In
                                            addition to the above, GPC shall have the right to nominate 1 (one) Director on the Board,
                                            concurrently with their Investment Amount being equal to at least USD 50,000,000 (United
                                            States Dollar Fifty Million) (each a “GPC Director”).

 

(The
CMDB Director, the Sequoia Director, the TV Director and the GPC Directors shall individually be referred to as “Investor Director”
and collectively as “Investor Directors”)

 

		3.1.3	[deleted]

 

		3.1.4	Any
                                            power to appoint a Director under this Clause 3 includes a power to remove or replace such
                                            Director appointed pursuant to this Clause 3 from time to time. All appointments, removals
                                            and replacements under this Clause 3 shall be effected by Notification to the Company and
                                            shall take effect immediately upon such Notification being received by the Company. Upon
                                            either of Sequoia, TV or CMDB ceasing to have a right to nominate a Director, such Party
                                            shall cause such Series B Investor Director nominated by it to resign from the Board.

 

		3.1.5	Unless
                                            otherwise agreed by the majority of the Board, Anil Mathews shall be the chairman of the
                                            Board (the “Chairman”). The Chairman shall not have a second or casting
                                            vote. In the absence of the Chairman at any meeting, the Board may elect one of their members
                                            present at such meeting to chair the meeting in question.

 

    29

     

    

 

		3.1.6	The
                                            Board may set up such other committees of the Board as it deems fit from time to time and
                                            Sequoia, TV, CMDB and GPC will, so long as they have a right to nominate at least 1 (one)
                                            Director each to the Board pursuant to Clause 3.1.2, be entitled to nominate such Investor
                                            Director as a member of all such committees.

 

		3.1.7	Regardless
                                            of whether Sequoia, TV, CMDB or GPC exercises its respective right to nominate an Investor
                                            Director: (a) each Investor holding more than 5% (five percent) of the Shares in the Company
                                            on a Fully Diluted Basis shall be entitled to appoint 1 (one) non-voting observer (each an
                                            “Observer”); (b) the Series U Investor shall be entitled to appoint 1 (one) Observer,
                                            for so long as the Series U Investor holds an aggregate of at least 5% (five percent) of
                                            the Series U Preference Shares issued on the Closing Date; and (c) the Founders shall be
                                            entitled to appoint 1 (one) Observer to the Board and/or committees of the Board, who shall
                                            (i) be given all relevant information as is provided to the Board members, at the same time
                                            as it is furnished to the Board members; and (ii) be entitled to attend and speak at all
                                            meetings of the Board and/or committees. Notwithstanding the preceding sentence in this Clause
                                            3.1.7, the Parties agree that Cisco shall be entitled to appoint 2 (two) Observers to the
                                            Board. It is clarified that the Observer shall not be entitled to vote on any resolution
                                            sought to be adopted at any meetings of the Board and/or committees thereof and shall not
                                            be considered for quorum. An Observer may be restricted from receiving such information or
                                            attending meetings which deal with a matter over which there is an actual conflict between
                                            the respective Shareholder interests and the Company’s interest. An Observer shall,
                                            at all times, receive, use or otherwise deal with any information received, in its capacity
                                            as an Observer, solely for the purposes of discharging its obligations as an Observer to
                                            the Board and shall be prohibited from making use of such information for any other purpose
                                            or third party, including its personal use.

 

		3.1.8	[deleted]

 

		3.1.9	The
                                            Company agrees and acknowledges that the Investor Directors shall be non-executive Directors
                                            of the Company and shall have no responsibility for the day-to-day management of the Company
                                            and/or its subsidiaries. The Founder Directors, in their capacities as officers of the Company,
                                            shall be responsible for the conduct of the Business. The Company shall enter into indemnification
                                            agreements with each member of the Board to indemnify and hold harmless from and against
                                            any Loss caused to such Director arising out of or, in relation to or otherwise in respect
                                            of such Director having served as a member on the Board.

 

		3.1.10	None
                                            of the Directors (including the Chairman) are entitled to receive remuneration for holding
                                            office as Director or exercising the functions of that office, except as may be decided in
                                            accordance with the Constitution. For the avoidance of doubt, Directors hall be entitled
                                            to remuneration from the Company or the Subsidiaries and executive Directors shall be entitled
                                            to participate in the Employee RSU Plan on such terms as are decided by the Board. Provided
                                            the provisions of this Clause 3.1.10 shall not affect the remuneration payable to the Founders
                                            in their capacities as employees of any of the Subsidiaries or the Company as the case may
                                            be.

 

    30

     

    

 

		3.1.11	The
                                            Board shall meet at least 1 (one) time in every 3 (three) months. Unless otherwise agreed
                                            in writing by the Investor Directors, the Company shall provide prior notice of at least
                                            14 (fourteen) days of the meetings of the Board or committees thereof to all the Directors
                                            and Observers. For avoidance of doubt, consent of the 2/3rd (two-third) of the
                                            Investor Directors shall be mandatory for holding any Board meetings or committee meetings
                                            at a notice shorter than 14 (fourteen) days.

 

		3.1.12	Each
                                            notice of a meeting of the Board or committee shall contain inter alia, an agenda specifying
                                            in reasonable detail the matters to be discussed at the relevant meeting together with the
                                            draft resolutions and other appropriate documentation with respect to agenda items calling
                                            for Board action, to adequately inform Directors and Observers regarding the matters to be
                                            placed before the Board. With the consent of the 2/3rd (two-thirds) of the Investor Directors,
                                            the Board or committee may also consider any matter not circulated in the agenda. Notwithstanding
                                            the foregoing, no matters outside the agenda being a Reserved Matter shall be discussed at
                                            such relevant meeting of the Board or committee thereof without the consent of all the Investor
                                            Directors.

 

		3.1.13	Travel,
                                            hotel and related expenses incurred by the Directors and Observers for attending meetings
                                            of the Board and committees shall be borne by the Company.

 

		3.1.14	Any
                                            Director may, and the company secretary, if so appointed, shall on the requisition of a Director,
                                            summon a meeting of the Board or committee, in accordance with the notice and other requirements
                                            set out in this Clause 3. Any Director wishing to place a matter on the agenda for any meeting
                                            of the Board may do so by communicating with the Chairman and the company secretary sufficiently
                                            in advance of the meeting of the Board, so as to permit timely dissemination of information
                                            with respect to the agenda items to all Directors and Observers.

 

		3.1.15	Quorum:

 

		(a)	Subject
                                            to the provisions of Applicable Law and this Clause 3, the quorum for all meetings of the
                                            Board shall be a majority of the Directors, including at all times the presence of each of
                                            the Series B Investor Directors and 1 (One) GPC Director. Provided that any decision in respect
                                            of a Reserved Matter shall at all times be in compliance with Clause 3.3 (Reserved Matters).
                                            If the quorum is not present within half an hour of the scheduled time of the meeting or
                                            cease to exist at any time during such meeting, the meeting shall stand adjourned (“Adjourned
                                            Meeting”) and be reconvened to the same day, location and time on the following
                                            week. If such day is not a Business Day, the Adjourned Meeting shall be held on the next
                                            Business Day at the same location and time. Subject to the Applicable Law, the Directors
                                            present at such Adjourned Meeting shall constitute the quorum for such meeting provided that
                                            (i) no List A Matters will be taken up for discussion or voted upon at such Adjourned Meetings
                                            unless a GPC Director is present in such meeting or such GPC Director has provided its written
                                            consent in respect of such List A Matters, in each case in accordance with Clause 3.3 (Reserved
                                            Matters); (ii) no List B Matter will be taken up for discussion or voted upon at such Adjourned
                                            Meetings unless each of the Investor Directors are present in such meeting or each of such
                                            Investor Directors have provided their written consent in respect of such List B Matters,
                                            in each case in accordance with Clause 3.3 (Reserved Matters); and (iii) no matters shall
                                            be discussed at such Adjourned Meeting which were not a part of the agenda for the original
                                            meeting of the Board. Provided however, if an Investor Director (whose consent is required
                                            pursuant to Clause 3.3 (Reserved Matters)) is not in attendance at such Adjourned
                                            Meeting and/or prior to such Adjourned Meeting, has not provided his assent, dissent or waiver
                                            in respect of the Reserved Matter(s) sought to be discussed or voted upon at such Adjourned
                                            Meeting nor has waived his right in respect of such Reserved Matter, such Director shall
                                            be deemed to have voted against such Reserved Matter, and the Directors present at such Adjourned
                                            Meeting may discuss and vote on the Reserved Matter(s) which were part of the agenda for
                                            the original Board meeting.

 

    31

     

    

 

		(b)	Without
                                            prejudice to the above, subject to Clause 3.3 (Reserved Matters), each of the Investor Directors
                                            may at any time waive its right to form part of the quorum for a particular Board meeting,
                                            in writing, and at any such Board meeting, no new matters other than those forming part of
                                            the agenda for the said Board meeting shall be discussed or taken up. It is clarified that
                                            any such waiver shall only be applicable with respect to the particular Board meeting in
                                            respect of which the waiver is provided, and shall under no circumstances be deemed to be
                                            a waiver by an Investor of its right to right to form part of the quorum, in toto,
                                            in terms of this Agreement.

 

		3.1.16	Subject
                                            to Clause 3.3(Reserved Matters), a Directors’ resolution in writing signed by all of
                                            the Directors shall be deemed to be a decision of the Board without the need for a meeting
                                            provided that the proposed resolution is notified in writing to all Directors before it is
                                            signed by the Directors. Any such resolution may consist of several documents in original,
                                            facsimile or electronic form, each signed by one or more Directors.

 

		3.1.17	Subject
                                            to Clause 3.3 (Reserved Matters) or as otherwise provided herein, decisions of the Board
                                            will be taken by a simple majority vote of participating Directors. Each Director participating
                                            in the meeting has 1 (one) vote. Meetings of the Board shall be conducted in English. The
                                            outcome of the agenda items (which items shall be set out in the notice provided under Clause
                                            3.1.12) discussed in each of the Board meetings will be circulated to each Director through
                                            e-mail within reasonable time after the consummation of the relevant Board meeting.

 

		3.2	Shareholders’
                                            Meetings

 

		3.2.1	The
                                            annual general meeting of the Company shall be held as per the requirements of the Act. Subject
                                            to the foregoing, the Board may convene an extraordinary General Meeting whenever they deem
                                            appropriate. Subject to Applicable Law, at least 14 (fourteen) Business Days prior written
                                            notice of every General Meeting of Shareholders shall be given to all Shareholders whose
                                            names appear on the register of members of the Company. A meeting of the Shareholders may
                                            be called by giving shorter notice with the written consent of the Shareholders subject to
                                            Applicable Law.

 

		3.2.2	The
                                            notice to Shareholders shall specify the place, date and time of the meeting. Every notice
                                            convening a meeting of the Shareholders shall set forth in full and sufficient detail the
                                            business to be transacted thereat, and no business shall be transacted at such meeting unless
                                            the same has been stated in the notice convening the meeting.

 

		3.2.3	The
                                            Chairman of the Board shall be the chairman for all General Meetings. The chairman of a General
                                            Meeting of the Company shall not have any second or casting vote. In the absence of the chairman
                                            at any meeting, the Shareholders shall elect one of the Shareholders to chair the meeting
                                            in question.

 

    32

     

    

 

		3.2.4	To
                                            constitute a quorum for a General Meeting of the Company, least 4 (four) Shareholders holding
                                            at least a majority of the majority of the outstanding Shares of the Company, which shall
                                            at all times include GPC, Sequoia and CMDB, shall be present in person or through an authorised
                                            representative of such Shareholder(s) at the commencement and throughout the duration of
                                            the meeting provided that any decision in respect of a Reserved Matter shall at all times
                                            be in compliance with Clause 3.3 (Reserved Matters). If the quorum is not present within
                                            half an hour of the scheduled time of the meeting, the meeting shall stand adjourned to the
                                            same day, location and time on the following week. If such day is not a Business Day, the
                                            meeting shall be held on the next Business Day. The Shareholders present at such adjourned
                                            meeting shall constitute the quorum for such meeting provided that (i) no List A Matter will
                                            be taken up for discussion or voted upon at such adjourned meeting unless GPC is present
                                            in such meeting or GPC has provided their written consent in respect of such List A Matters,
                                            in each case in accordance with Clause 3.3 (Reserved Matters); (ii) no List B Matter will
                                            be taken up for discussion or voted upon at such adjourned meetings unless each of the Investors
                                            are present in such meeting or each Investor has provided their written consent in respect
                                            of such List B Matters, in each case in accordance with Clause 3.3 (Reserved Matters); and
                                            (iii) no matters shall be discussed at such adjourned meeting which were not a part of the
                                            agenda for the original shareholders meeting. Provided however, if an Investor (whose consent
                                            is required pursuant to Clause 3.3 (Reserved Matters)) is not in attendance at such
                                            adjourned meeting and/or prior to such adjourned meeting, has not provided their assent,
                                            dissent or waiver in respect of the Reserved Matter(s) sought to be discussed at such adjourned
                                            meeting nor has waived his right in respect of such Reserved Matter, such Investor shall
                                            be deemed to have voted against such Reserved Matter, and the Shareholders present at such
                                            adjourned meeting may discuss and vote on the Reserved Matter(s) which were part of the agenda
                                            for the original shareholders’ meeting.

 

		3.2.5	Without
                                            prejudice to the above, subject to Clause 3.3 (Reserved Matters), any Investor may at any
                                            time waive its right to form part of the quorum for a particular Shareholders’ meeting,
                                            in writing, and at any such Shareholders’ Meeting, no new matters other than those
                                            forming part of the agenda shall be discussed and/or voted upon. Any such waiver shall only
                                            be applicable in respect of the meeting for which it is given and shall not be deemed to
                                            be a waiver to attend all Shareholders’ meeting in toto, in terms of this Agreement.

 

		3.2.6	Subject
                                            to Clause 3.3 (Reserved Matters), all resolutions of the Shareholders shall require the approval
                                            of the Shareholders holding at least a majority of the outstanding Shares.

 

		3.2.7	Subject
                                            to Clause 3.3 (Reserved Matters), a resolution in writing which has been circulated, together
                                            with such information and documentation that is reasonably required or necessary for the
                                            Shareholders to review in connection with such resolution, to all Shareholders at least 14
                                            (fourteen) Business Days prior to the date of such resolution is to take effect (or such
                                            shorter period of notice in respect of any particular resolution in writing as may be agreed
                                            by all of the Shareholders) and signed by Shareholders holding, (a) in the case of an ordinary
                                            resolution, the majority of the total voting rights of all the Shareholders of the Company;
                                            (b) in the case of a special resolution, at least 3/4rs (three-quarters) of the
                                            total voting rights of all the Shareholders of the Company, shall be valid and effective
                                            as if it had been passed at a General Meeting of the Company duly convened and held. Any
                                            such resolution may consist of several documents in the like form each signed by one or more
                                            of the Shareholders. The expressions “in writing” and “signed” include
                                            approval by telex, cable, wireless, telefax or electronic mail transmission. The Shareholders
                                            may, for the resolutions passed in writing, participate in the General Meetings by video
                                            conferencing or any other means of contemporaneous communication including telephone/audio
                                            participation, in the manner permitted under Applicable Laws.

 

    33

     

    

 

		3.3	Reserved
                                            Matters

 

		3.3.1	Notwithstanding
                                            anything stated in the Transaction Documents or any power conferred upon the Board by this
                                            Agreement, the Act or the Constitution, neither the Company, the Founders nor any Shareholder,
                                            Director, officer, committee, committee member, employee, agent or any of their respective
                                            delegates shall, take any decisions in any manner, including by way of:

 

		(a)	the
                                            Board, at a meeting of the Board / committees of the Board, or by circulation, as the case
                                            may be;

 

		(b)	the
                                            Shareholders, at any meeting of the Shareholders; or

 

		(c)	otherwise
                                            in any manner,

 

		(i)	in
                                            respect of any List A Matters unless the affirmative prior written consent or approval of
                                            GPC has been obtained (A) whether at a meeting of the Board or a committee thereof or through
                                            a representative of GPC at a General Meeting, or through any resolutions by circulation;
                                            (B) in writing from the authorised signatory of GPC prior to the relevant Board meeting or
                                            General Meeting, as applicable; or (C) in writing from the authorised signatory of GPC prior
                                            to any decisions or actions in respect of List A Matters is taken by or with respect to the
                                            Company.

 

		(ii)	in
                                            respect of any List B Matters unless the affirmative prior written consent or approval of
                                            Investors representing not less than 75% (seventy five percent) of their inter-se
                                            shareholding, voting on an As If Converted Basis has been obtained (A) whether at a meeting
                                            of the Board or a committee thereof or through representatives of such Investors at a General
                                            Meeting, or through any resolutions by circulation; (B) in writing from the authorised signatories
                                            of such Investors prior to the relevant Board meeting or General Meeting, as applicable;
                                            or (C) in writing from the authorised signatories of such Investors prior to any decisions
                                            or actions in respect of List B Matters is taken by or with respect to the Company.

 

Provided
however, nothing in this Clause 3.3 shall apply to the right of the Exit Default Triggering Investor to trigger the Exit Default Rights.

 

For
the avoidance of any doubt, it is clarified that if a Reserved Matter is being discussed or voted upon at an adjourned meeting (whether
of the Board or the Shareholders), and the Investor Director or the Investor, as the case may be (whose consent is required pursuant
to this Clause 3.3 (Reserved Matters)) is not in attendance at such adjourned meeting and/or prior to such adjourned meeting,
has not provided their assent, dissent or waiver in respect of the Reserved Matter(s) sought to be discussed or voted upon at such adjourned
meeting nor has waived his right in respect of such Reserved Matter, such Investor Director or Investor, as the case may be, shall be
deemed to have voted against such Reserved Matter, and the Directors or Shareholders present at such adjourned meeting, as the case may
be, may discuss and vote on the Reserved Matter(s) which were part of the agenda for the original Board meeting or shareholders’
meeting, as the case may be.

 

    34

     

    

 

For
the avoidance of any doubt, it is further clarified that any resolution passed or decision taken in any other manner whatsoever in violation
of Clause 3.3 shall not be valid. Further, it is clarified that any consent given in terms of Clause 3.3 shall only be applicable to
the particular instance in which it is given and shall not be extended and deemed to be an approval, under any circumstances, for any
item or other instance. It is further clarified the approval requirements under Clause 3.3 are in addition to and without prejudice to
any other approval requirements set out in this Agreement and/or under Applicable Laws.

 

		3.4	The
                                            Parties agree that the principles set out in this Clause 3 are fundamental to the governance
                                            of the Company and the Subsidiaries in existence on the First Completion Date or constituted
                                            thereafter and each Party undertakes not to commit any act or omission that would violate
                                            or prejudice the spirit and intent of this Clause 3. Further, the Company and the Founders
                                            undertake to observe the principles set out in this Clause 3 and ensure that they take all
                                            necessary steps and do or cause to be done all acts, deeds and things, as are required to
                                            ensure compliance with this Clause 3. If any other provision of the Transaction Documents
                                            conflict with the provisions of this Clause 3, the provisions of this Clause 3 shall prevail
                                            and shall be given effect.

 

		3.5	Notwithstanding
                                            anything contained herein, the Founders shall ensure that the Company shall not approve any
                                            matter that constitutes a Reserved Matter in relation to any of the Subsidiaries (whether
                                            at a Board or Shareholders level) unless the provisions of Clause 3.3 are observed. Accordingly,
                                            Reserved Matters in relation to each Subsidiary shall be discussed by the Company and the
                                            Founders with the Shareholders, and on receipt of prior written approval of the relevant
                                            Shareholders, the same shall be approved by the Subsidiary.

 

		3.6	Subject
                                            to Applicable Law, the rights and obligations of the Parties under this Clause 3 shall be
                                            equally applicable to the Subsidiaries.

 

		4	PRE-EMPTIVE
                                            RIGHTS FOR NEW ISSUES OF SHARES

 

		4.1	Subject
                                            to Clause 3.3 (Reserved Matters) (irrespective of the price per Ordinary Share of such Dilution
                                            Instruments), in the event the Company is desirous of issuing any Dilution Instruments (the
                                            “Additional Capital”) to any Person (including a Shareholder) (the “Offeree”),
                                            then such Additional Capital shall be first offered by the Company to the Investors and the
                                            Founders (“Right Holders”), on a pro-rata basis, in proportion to their
                                            inter se shareholding, on a Fully Diluted Basis, on the same terms and conditions
                                            on which any Additional Capital is offered to the Offeree in accordance with the procedure
                                            set forth in this Clause 4.

 

		4.2	In
                                            the event that the Company proposes to issue Additional Capital, the Company shall provide
                                            a written notice to the Right Holders, specifying the following particulars (the “Notice
                                            of Offer”):

 

		4.2.1	The
                                            Company’s bona fide intention to offer such Additional Capital to the Right Holders;

 

		4.2.2	The
                                            number and class of such Additional Capital proposed to be issued;

 

		4.2.3	The
                                            price per Share for the proposed issuance of Additional Capital;

 

    35

     

    

 

		4.2.4	The manner and time of payment of the subscription amount towards the Additional Capital;

 

		4.2.5	The pro rata share of the Right Holders, calculated on a Fully Diluted Basis (“Pre-emptive Shares”);

 

		4.2.6	The terms and conditions subject to which the Company proposes to offer such Additional Capital; and

 

		4.2.7	The date of the proposed issuance of the Additional Capital.

 

(collectively, the above
are referred to as the “Offered Terms”).

 

		4.3	Upon receipt of the Notice of Offer, each Right Holder shall be entitled to subscribe to all or some of
its Pre-emptive Shares on the Offered Terms. Each of the Right Holders shall have the right to accept the Offered Terms within 20 (twenty)
Business Days from the date of the Notice of Offer (“Acceptance Period”). In the event that any of the Right Holders
accept the Notice of Offer within the Acceptance Period, the Company shall complete the issuance and allotment of such portion of the
Pre-emptive Shares in favour of such Right Holder(s) upon payment for such Shares within 30 (thirty) Business Days from the date of receipt
of the notice of acceptance of the Offered Terms from the Right Holder(s).

 

		4.4	Where a Right Holder: (i) does not subscribe to all or some of the Pre-emptive Shares that they are entitled
to; or (ii) fails to deliver a notice of acceptance of the Offered Terms under this Clause 4 within the Acceptance Period; or (iii) rejects
the Notice of Offer, each of the Investors who have issued an acceptance notice under Clause 4.3 (“Pre-emptive Participating
Investor”), shall have a right to subscribe to the unsubscribed portion of the Pre-emptive Shares (“Mop-Up Right”)
on a pro-rata basis, in proportion to their inter se shareholding in the Company on a Fully Diluted Basis. The Company shall within
14 (fourteen) Business Days from the Acceptance Period (“Further Offered Terms Notice”), provide a written notice to
the Investors, specifying the number of the unsubscribed Pre-emptive Shares and the respective portion of the unsubscribed Pre-emptive
Shares that the Pre-emptive Participating Investors are entitled to subscribe (“Further Offered Terms”). The Pre-emptive
Participating Investors shall have the right to accept the Further Offered Terms within 14 (fourteen) Business Days from the receipt of
the Further Offered Terms Notice. In the event that the Pre-emptive Participating Investors accept the Further Offered Terms, the Company
shall complete the issuance and allotment of such unsubscribed portion of the Pre-emptive Shares as specified in the Further Offered Terms
Notice as the case may be, within 14 (fourteen) Business Days from the date of receipt of the notice of acceptance of the Further Offered
Terms. For the avoidance of any doubt, it is clarified that the Founders shall not have the Mop-Up Right, and such right shall only be
available to the Pre-emptive Participating Investor(s).

 

		4.5	Each of the Investors shall have the right to assign their right to subscribe to the Pre-emptive Shares
under the Offered Terms or the Further Offered Terms in favour of one or more of their Affiliates. In each case where the Affiliates are
exercising the right to subscribe to the Pre-emptive Shares assigned by the Investor such Affiliate shall execute the Deed of Adherence.

 

    36

     

    

 

		4.6	In the event (i) the Pre-emptive Shares are not subscribed to by the Right Holders in the manner and within
the time period specified in Clause 4.3; (ii) the Pre-emptive Participating Investors do not (either in full or in part) exercise their
Mop-Up Right or assign their right to do so to any Affiliate in the manner and within the time period specified in Clause 4.4, then the
Company shall have the right, within 30 (thirty) Business Days following the expiration of the time period for accepting the Further Offered
Terms as set out in Clause 4.4, to issue and allot the Additional Capital (to the extent unsubscribed by the Right Holders) to the Offeree
on terms no different (and not more favourable terms) than the Offered Terms. Any issuance and allotment of Additional Capital on or after
the expiry of the time period under this Clause 4.6 shall again be subject to this Clause 4 as a proposed fresh issuance of Additional
Capital.

 

		4.7	For the avoidance of any doubt, it is clarified that the provisions of this Clause 4 shall not apply to
the following:

 

		(a)	Issue of Ordinary Shares in any initial public offering (including a QIPO);

 

		(b)	Issue of Ordinary Shares contemplated to be issued in accordance with Warrants and/or Employee RSUs which
have been authorized for issue as per the Employee RSU Pool from time to time;

 

		(c)	[deleted]

 

		(d)	[deleted];

 

		(e)	[deleted]

 

		(f)	Issue of Ordinary Shares upon conversion of Series A Preference Shares, Series B Preference Shares, Series
C Preference Shares, Series D Preference Shares, and Series U Preference Shares pursuant to the terms of the respective Preference Shares;

 

		(g)	Issue of Shares to Shareholders pursuant to any bonus issues, stock splits, consolidations or similar
events;

 

		(h)	Issue of Shares pursuant to Clause 5 (Anti-Dilution); and

 

		(i)	Any other matter as may be approved pursuant to item 12 under Part B of Schedule 4 (Reserved Matters)
in accordance with Clause 3.3.

 

    37

     

    

 

		4A.	EXPIRATION OF FURTHER RIGHT TO SUBSCRIBE OF GPC

 

		4A.1	The Parties hereby agree and acknowledge that GPC’s right
to subscribe to additional Shares for a total consideration of up to USD 25,000,0000 (United States Dollar Twenty Five Million) in accordance
with the Series D Subscription Agreement ”) has expired.

 

		5	ANTI-DILUTION

 

		5.1	Notwithstanding anything contained herein, if at any time after the First Completion Date, the Company
issues to any Person, any Dilution Instruments at a price (or deemed price including) per Ordinary Share that is lower than the then effective
conversion price for the Series A Preference Shares, Series B Preference Shares, Series C Preference Shares, Series D Preference Shares
and/or (from Closing Date) Series U Preference Shares (“Dilutive Issuance”), then the holders of Series A Preference
Shares, Series B Preference Shares, Series C Preference Shares, Series D Preference Shares and/or (from Closing Date) Series U Preference
Shares shall be entitled to a broad based weighted average anti-dilution protection, in accordance with the terms and procedure described
in Schedule 5. The initial conversion price of the Preference Shares as on the Closing Date shall be USD62.81 per Series A Preference
Share, USD377.76 per Series B Preference Share, USD666.67 per Series C Preference Share , USD666.67 per Series D Preference Share and
USD731.35 per Series U Preference Share. For the avoidance of any doubt, it is clarified that any anti-dilution adjustments to the Series
C Holders on account of the issuance and allotment of the Series D Preference Shares shall not dilute the Series D Holders.

 

		5.2	The anti-dilution protection shall be effected by an adjustment to the agreed conversion price of each
class of Preference Shares, as applicable, as set forth in Schedule 5, or if such conversion price adjustment as set forth in Schedule
5 is not permitted by Applicable Law, any other manner permitted under Applicable Law as would have the same substantive effect. The conversion
prices of each class of the Preference Shares shall also be subject to proportional adjustment upon the occurrence of any subdivision,
share splits, combination etc. of the Ordinary Shares, as appropriate, or such other mechanism permissible by Applicable Law to provide
for such protection.

 

		5.3	In the event that any class of the Preference Shares have already been converted into Ordinary Shares,
or if the conversion of the Preference Shares does provide the relevant Investor all of the Shares that it is entitled to as per the formula
set out in Schedule 5, then the Company shall, subject to Applicable Law, be under an obligation to issue to the relevant Investor such
additional number of Shares, at the lowest price permissible under Applicable Law, such that the broad-based weighted average price per
Ordinary Share paid by such Investor is equal to the subscription price applicable to such Preference Shares, as the case may be, in accordance
with Schedule 5. The Company agrees and undertakes that it shall not issue any new Shares in contravention of the provisions of this Clause
5. The Company shall pay all Taxes due and payable by the Company relating to the issue of additional Shares pursuant to Clause 5.3.

 

		5.4	In the event that the Company proposes to undertake an issuance of Dilution Instruments that would result
in the anti-dilution provisions herein being effected, the Company shall notify the Preference Shareholders of the extent of adjustment
required (calculated in accordance with the terms and procedure in Schedule 5). Only after the holders of Preference Shares and the Company
agree upon the extent of adjustment required shall the Company undertake such issuance. If there is a difference of opinion between the
Company and the holders of Preference Shares, or in the event (i) the holders of Preference Shares cannot fully exercise any rights under
Clause 5, or are prevented or restricted from fully exercising their rights under Clause 5 above, in relation to any Dilutive Issuance,
for any reason(s) whatsoever; or (ii) the holders of Preference Shares are unable to exercise their rights under Clause 5, on account
of any act of commission or omission on the part of the Founders or the Company, then the Company shall not make or undertake such Dilutive
Issuance without the prior written consent of each of the holders of Preference Shares and the Parties shall undertake all such efforts
to reach an alternative proposal whereby the commercial intent of Clause 5 may be achieved.

 

		6	PLEDGE, BORROWINGS & FUNDING

 

		6.1	The Parties hereto expressly agree that in the event the Company or Subsidiaries proposes to borrow funds
from any Person, including but not limited to banks and financial institutions, the Investors shall not be asked, or be required to give
any warranties, letter of comfort or guarantees, of any nature whatsoever for any loans or with regard to any aspect of the business or
functioning of the Company or the Subsidiaries.

 

    38

     

    

 

		6.2	It is further agreed that the Investors shall not be required to pledge their Shares or provide any support
to any Third Party, including but not limited to lenders of the Company or the Subsidiaries.

 

		7	EMPLOYEE RSU PLAN 

 

		7.1	Any amendments to the Employee RSU Plan, including references to an increase in the Employee RSU Pool,
determination or variation of the issue/exercise price or terms of vesting shall be in accordance with this Agreement and be subject to
Clause 3.3 (Reserved Matters).

 

		7.2	All employees of the Company who shall purchase or receive options to purchase Shares under the Employee
RSU Plan following the Effective Date shall be required to execute a share purchase agreement or an option agreement providing for vesting
of the option shares, in the manner stated in the Employee RSU Plan.

 

		7.3	The Employee RSUs granted shall vest as follows:

 

		7.3.1	Up to 25% (twenty five percent) of the Employee RSUs granted under the accompanying letter of grant of
such options shall vest at the end of 1 (one) year from the date of such grant; and

 

		7.3.2	Up to 6.25% (six point two five percent) of the Employee RSUs granted under the accompanying letter of
grant of such options shall vest at the end of each quarter after the end of 1 (one) year from the date of such grant.

 

Accordingly, all such Employee RSUs
will vest within a period of 4 (four) years from such grant.

 

It is clarified that, in the interest
of acquiring suitable human resources, subject to the provisions of this Agreement, Employee RSUs that may be granted to incoming employees,
may contain terms pursuant to which such options may vest in a manner such that their cumulative vesting shall at all times be equal to
or lesser than the threshold vesting limits set out under Clauses 7.3.1 and 7.3.2 above.

 

		7.4	The exercise price of the stock options granted to the Founders shall be in accordance with the terms
of the Employee RSU Plan. The stock options granted to the Founders may be exercised in the manner provided for in the plan under which
the same is granted.

 

		8	NON-COMPETE UNDERTAKING

 

		8.1	During the period commencing on the Effective Date and for 1 (one) year after the later of (i) the Founder
ceasing to be employed by or serve as a Director of the Company or any Subsidiary; or (ii) such Founder ceasing to hold any Shares in
the Company, such Founder shall, as individuals, employees, consultants, independent contractors, partners, shareholders, members or in
association with any other Persons, or in any manner whatsoever, except on behalf of the Company or the Subsidiaries:

 

		8.1.1	not, whether directly or indirectly through any of their Affiliates or their nominees, commence, carry
on or engage in or hold any interest or be associated in any capacity, in any activity or business that is similar or would compete with
the Core Business or would adversely affect the Company or the Subsidiaries interests in any manner;

 

    39

     

    

 

		8.1.2	not set up, solicit business on behalf of, render any services to, engage in, guarantee any obligations
of, extend credit to, or invest in, become a shareholder of, or have any ownership interests or other affiliation in, any business or
other endeavour, (whether directly or indirectly), which is engaged in the business of the similar nature as the Core Business or is competitive
with the Company and/or the Subsidiaries;

 

		8.1.3	not assume management or lead responsibility in any other business of a similar nature or competitive
with the Core Business, without obtaining the prior written approval of Investors representing not less than 75% (seventy five percent)
of their inter-se shareholding, voting on an As If Converted Basis;

 

		8.1.4	attempt in no manner to solicit, render services to or for, or accept from, anyone who is/was a client
or customer of the Company or the Subsidiaries (whether present or future), any Business of the type performed by the Company and/or the
Subsidiaries, or persuade or attempt in any manner to persuade any client or customer of the Company and/or the Subsidiaries to cease
to do Core Business or to reduce the amount of Core Business which any such client or customer has customarily done or is reasonably expected
to do with the Company or the Subsidiaries, whether or not the relationship between the Company or the Subsidiaries and such client or
customer, as the case may be, was originally established in whole or in part through the Founders’ efforts;

 

		8.1.5	not interfere or seek to interfere or take such steps as may interfere with the continuance of supplies
to the Company or any Subsidiary (or the terms relating to such supplies) from any suppliers who have been supplying goods or services
to the Company or any Subsidiary;

 

		8.1.6	not be connected as a shareholder, director, officer or employee, partner, lender, guarantor or advisor
of or consultant to, or in any executive capacity with, any corporation, limited liability company, partnership or other entity or Person
that engages in the Core Business, or competes in any business with the Company or any Subsidiary;

 

		8.1.7	not become advisors to or consultants or disclose any confidential information to any competitor or any
entity involved in the same line of Core Business;

 

		8.1.8	not, either on his own account or for any Person, solicit or assist anyone else to employ any: (i) employee
(including Key Employee) of the Company or any Subsidiary; (ii) person, firm, corporation or other form of entity who at any time during
the 12 (twelve) months period prior to the date of such employment or retention was an employee of or consultant to the Company or any
Subsidiary, to leave his or her employment, induce or attempt to induce any such employees to terminate or breach his or her employment
agreement with the Company or any Subsidiary, or itself, directly or indirectly, hire or engage in any other manner, any employee (including
Key Employees); and

 

		8.1.9	not take any specific actions to, directly or indirectly, solicit, cause in any part or knowingly encourage
any then-existing clients and/or suppliers of the Company or any Subsidiary to cease doing business in whole or in part with the Company
or any Subsidiary, or solicit, cause in any part or knowingly encourage any of the then existing clients and/or suppliers of the Company
or any Subsidiary to do business with any Person other than the Company or any Subsidiary or itself, directly or indirectly, deal with
such clients and/or suppliers that affects the business they do with the Company and/or Subsidiaries.

 

    40

     

    

 

		8.2	The restrictions set out in Clause 8.1 shall be collectively known as the “Protective Covenants”.

 

		8.3	The Parties acknowledge that: (i) the duration, type and periods of the Protective Covenants imposed in
the provisions of this Clause 8 are fair and are reasonably required in order to protect and maintain the legitimate business interests
and the goodwill associated with the Business; (ii) the time, scope, geographic area and other provisions of this Clause 8 have been specifically
negotiated by sophisticated commercial parties; (iii) such undertakings are material for the willingness of the Investors to invest in
the Company, and the Founders, being Shareholders, stand to benefit from the investment by the Investors; and (iv) the Founders have various
other skill sets which, if deployed, would not result in a breach of their respective undertakings hereunder. It is clarified that in
interpreting the scope of this Clause 8, it is understood that the Founders shall not take any action either directly or through any Affiliate
which may breach the obligations set out here in this Clause 8. The Founders agree that any breach of the obligations set out in this
Clause 8 shall be deemed to be a material breach hereunder. Notwithstanding the limitation of this provision by Applicable Law for the
time being in force, each of the Founders undertakes at all times to observe and be bound by the spirit of this Clause 8.

 

		8.4	If any of the Protective Covenants contained in this Clause 8 or any part thereof, is held to be unenforceable
by reason of it extending for an unreasonably long period of time, or over a wide geographical area, or by reason of it being otherwise
unreasonably extensive, the Parties agree that such Protective Covenants shall be deemed to be modified so as to permit its enforcement
to the extent permissible under Applicable Law. In the event of any determination by a court or arbitration panel as to the extent of
permissibility of this Clause 8, the resulting modified covenant shall only apply with respect to the operation of such Protective Covenants
in the particular jurisdiction in or for which such adjudication is made.

 

		8.5	Each of the Protective Covenants are separate, distinct and severable. All rights, remedies and benefits
expressly provided for in this Agreement are cumulative and are not exclusive of any rights, remedies or benefits provided for by Applicable
Law or in this Agreement, and the exercise of any remedy by a party hereto shall not be deemed an election to the exclusion of any other
remedy (any such claim by the other party being hereby waived). Subject to Applicable Law, the Founders agree that the Company and each
Investor shall be entitled to relief including without limitation, interim injunction, restraining order, or such other equitable relief
as a court of competent jurisdiction may deem necessary or appropriate to restrain the Founders from violating this Clause 8. The unenforceability
of any of the Protective Covenants shall not affect the validity or enforceability of any other Protective Covenants or any other provision
of the Transaction Documents. Subject to Applicable Law, the duration of the Protective Covenants shall be extended during any period
in which the Founders are in violation of any of such Protective Covenants, and all such restrictions shall automatically be extended
by the period of the Founders’ violation of any such restrictions. The Founders expressly waive any right to assert inadequacy of
consideration as a defence to enforcement of the covenants set forth in this Clause 8.

 

		8.6	The Company and the Founders undertake that, except with the prior written consent of Investors representing
not less than 75% (seventy five percent) of their inter-se shareholding, voting on an As If Converted Basis, they and their respective
Affiliates shall not directly or indirectly carry on any business that is the same or similar to the Core Business other than through
the Company or its Subsidiaries, and all new projects and businesses relating to the Core Business shall only be undertaken by the Company
or any Subsidiary. The Company and its Subsidiaries shall be the sole and exclusive vehicle for the Founders for the Core Business. The
Founders shall ensure that all opportunities for new projects and businesses relating to the Core Business that are developed or sourced
by, or offered to, the Founders shall be referred exclusively to the Company or any Subsidiary. Nothing contained in this Clause 8 shall
affect a Founder in respect of whom the non-compete period as prescribed in this Clause 8 has expired.

 

    41

     

    

 

		8.7	Each of the Founders shall and shall cause the Key Employees to, devote substantially all of their time
to the management and operations of the Company. The Founders shall ensure that each of the Key Employees executes employment agreements
with the Company containing non-compete restrictions no less stricter than those set out in the existing employment agreements of the
Company.

 

		8.8	For the avoidance of any doubt, it is clarified that the Protective Covenants contained in this Clause
8 shall not apply to the following:

 

		8.8.1	the Founder(s), investing in, becoming a shareholder of, or having any ownership interests in (including
by way of beneficial holding): (i) any entity listed on any stock exchange provided that the ownership interest of the Founder(s) comprises
less than 5% (five percent) of the total shareholding of such entity; and/or (ii) any un-listed entity, which is not a competitor of the
Company, where the ownership interest of the Founder(s) comprises less than 5% (five percent) of the total shareholding of such entity.
It is clarified that the Founder(s) shall not assume any role and /or responsibility in relation to the entities under (i) and (ii) above;

 

		8.8.2	the Founder(s) assuming any responsibility, association or role (which is not managerial, or strategic)
with any organisation in the capacity of a mentor or, any association/membership with industry bodies, think-tanks or similar organizations,
where the Founder does not receive any material compensation to discharge his responsibilities.

 

		9	EXIT COMMITMENT

 

		9.1	The Company and the Founders shall make commercially reasonable efforts to provide an exit to the Investors
commencing from the First Completion Date until the second year anniversary of the First Completion Date and thereafter make best efforts
to provide an exit to the Investors (“Exit”) on or before the expiry of 4 (four) years from the First Completion Date,
or 31 May 2023, whichever is later (the “Exit Period”), by undertaking either:

 

		9.1.1	a QIPO, in accordance with Clause 10; or

 

		9.1.2	a Strategic Sale, in accordance with Clause 11.

 

		9.2	If the Company and the Founders fail to provide an Exit to the Investors prior to the expiry of the Exit
Period or Extended Exit Period (if applicable), pursuant to Clause 10 or Clause 11 and in accordance with the terms stipulated thereunder,
the Investors shall be entitled to exercise their exit rights under other provisions of this Agreement, including under Clause 12.

 

		9.3	All costs relating to the obligations of the Company under Clauses 10, 11 and 12 shall be borne by the
Company.

 

		9.4	It is clarified that the Company and the Founders shall be obligated to do all such acts and deeds as
may be necessary to provide an Exit to the Investors, including but not limited to providing all necessary and relevant information, voting
at the relevant meeting of the Board or the meeting of the Shareholders, obtaining all necessary consents and approvals, if any and ensuring
compliance with Applicable Law, in a timely manner, and provide all assistance to the Investors to cause the consummation of the transactions
specified in Clauses 10, 11, and 12. It is further clarified that for the purposes of this Clause 9, the Company and the Founders shall
have discharged their obligations of giving an Exit to each Investor, if each such Investor gets a bona fide opportunity to completely
exit the Company before the expiry of the Exit Period. For the sake of clarity, a ‘bona fide opportunity’ will refer to an
exit opportunity offered by the Company that is made on a good faith and best efforts basis and affords a complete exit opportunity for
the Investors in respect of which, the Company on a good faith and best efforts basis attempts to consummate the transaction.

 

    42

     

    

 

		9.5	Notwithstanding anything to the contrary contained herein, the proceeds from any Exit whether under Clause
10 (QIPO), 11 (Strategic Sale) or 12 (Exit Default Rights) shall at all times be distributed as per the distribution waterfall set out
in Clause 13.

 

		10	QIPO

 

		10.1	The decision to undertake a QIPO (including the determination of the timing of the QIPO being not later
than the expiry of the Exit Period) shall be made by the Company subject to the terms of this Agreement and the Constitution, having due
regard to the prevailing market conditions.

 

		10.2	The Company shall, and the Founders and the Company shall make all commercially reasonable efforts to
conduct such a QIPO within a period of 1 (one) year from the date of receipt of such approval which is granted pursuant to Clauses 3.3
(Reserved Matters).

 

		10.3	QIPO Procedure 

 

		10.3.1	Subject to the provisions of the Applicable Laws, a QIPO may be either through: (i) a new issue of Shares;
or (i) an offer for sale of the Shares held by the Shareholders (“OFS”); or (iii) a combination of (i) and (ii) both.

 

		10.3.2	In the event that a QIPO is through an OFS, or a combination of a new issue of the Shares and an OFS,
the Parties undertake to exercise their respective voting rights (at the Board and Shareholder level) and to take all steps reasonably
necessary for the Company to undertake such QIPO. In such case, subject to Applicable Laws:

 

		(i)	the Series D Investors shall have the right (but not the obligation) to offer all or some of their respective
shareholding in the Company in priority to all other classes of Shareholders. The Founders and the Company shall ensure that the Series
D Investors shall be entitled to include up to 100% (one hundred percent) of its Shares in the QIPO.

 

		(ii)	if the number of Shares held by the Shareholders (including the Series D Holders) to be offered in the
QIPO exceeds the permitted number of Shares that can be offered in an OFS under the Applicable Law, then the number of Shares held by
the Shareholders (other than the Series D Holders) shall be decreased on a pro-rata basis out of the total number of Shares held between
them on an As If Converted Basis that can be offered under an OFS in accordance with the Applicable Law.

 

    43

     

    

 

		10.3.3	In connection with any QIPO, the Founders and the Company confirm and undertake to do the following:

 

		(a)	Ensure that the total offer of Shares to the public shall constitute not less than such percentage (as
prescribed under then prevalent rules and Applicable Law) of the total post issue paid-up Share Capital to comply with the listing requirements
of the Recognised Stock Exchange;

 

		(b)	Provide all material information and ensure compliance with all applicable provisions of the guidelines,
listing rules, the listing agreement of the Recognised Stock Exchange and other regulations existent at the time of a QIPO and subsequent
listing of the Shares for trading on a Recognised Stock Exchange;

 

		(c)	Indemnify and hold harmless the Investors against any and all Losses associated with such QIPO, including
without limitation, any such Losses associated with any material misstatement or omission in any information provided by the Company in
connection with such QIPO or any actual or alleged violation of Applicable Law;

 

		(d)	The Recognised Stock Exchange(s) on which the Shares offered by the Investors shall be listed, the timing,
pricing, appointment of the lead manager, the underwriter and the appointment of an investment bank of international repute as book runner
for the offering shall be appointed only after obtaining the prior written approval of GPC;

 

		(e)	Subject to Clauses 3.3 and 10.3.2, the number of Shares that are offered and the manner in which such
Shares are to be offered at the listing on any Recognised Stock Exchange(s) will be determined based on mutual agreement between the Founders,
TV, CMDB, Sequoia and the Series D Investors in consultation with the lead manager, the underwriter and the investment bank appointed;

 

		(f)	The Company agrees to indemnify and hold harmless the Investors for including their Shares in such secondary
offering from and against Losses caused by any untrue statement of a fact contained in any statement or prospectus relating to such secondary
offering, or caused by any omission to state therein a fact required to be stated therein or necessary to make the statements therein
not misleading;

 

		(g)	The QIPO will be underwritten unless otherwise agreed to by GPC;

 

		(h)	The Investors shall, in connection with the QIPO, not be required to give any representations, warranties,
covenants, guarantees or indemnities to any underwriter, broker, Recognised Stock Exchange or any Governmental Authority or other Peron
other than in relation to the title of Shares being sold as part of the OFS in the QIPO;

 

		(i)	The Investors shall not be considered to be a promoter or part of the promoter group of the Company unless
specifically required under Applicable Law. The Company shall ensure that no Investor is required to undertake any obligations in relation
to any disclosures made in any offering document or related documents;

 

    44

     

    

 

		(j)	The Shares held by the Investors will not be subject to any lock-in unless specifically required under
Applicable Law. In the event the Shares of the Company are required to be locked-in otherwise than by reason of Applicable Law requirements
(including any lock-in imposed by the underwriter in connection with such QIPO), then the Founders and other shareholders (excluding the
Series B Investors, the Series C Investors, the Series D Investors and the Series U Investor) will first offer their Shares to the extent
required. In the event the Shares offered by the Founders and other shareholders (excluding Investors) are insufficient to meet the lock-in
requirements, the Shares of the Investors will be offered on a pro-rata basis until the balance lock-in requirements are satisfied;

 

		(k)	In the event that the Company undertakes a QIPO under this Clause 10.3, such number of Shares as may be
required in addition to the Shares to fulfil the mandatory minimum offer size requirement for achieving a QIPO and listing under Applicable
Law shall be provided by the Investors or the Founders as mutually agreed by them. The Company shall obtain such Consents and Governmental
Approvals as may be necessary to complete a QIPO if such QIPO is to be undertaken under this Clause 10; and

 

		(l)	Subject to Applicable Law, all costs and expenses relating to a QIPO, including statutory filing, underwriting,
and registration fees, printing costs and fees for advisors and managers to a QIPO, shall be borne by the Company. The Parties acknowledge
and agree that the Company shall be responsible and liable for, subject to Applicable Law, principles governing financial assistance,
for any breach of representations, warranties, covenants, obligations and undertakings set forth in any agreement, instrument and other
document in relation to a QIPO.

 

		11	STRATEGIC SALE

 

		11.1	In the event that the Company and the Founders are desirous of providing the Investors with an Exit by
effecting a Strategic Sale any time during the Exit Period subject to the affirmative consent pursuant to Clause 3.3, the Founders or
the Company, as the case may be, shall deliver a notice to the Investors (the “Strategic Sale Notice”), setting out:

 

		11.1.1	The exact nature of the transaction proposed;

 

		11.1.2	The identity of the Person with which the Company proposes to conduct the Strategic Sale;

 

		11.1.3	In the event that the Strategic Sale is through:

 

		(a)	A merger, the salient terms of the scheme of merger;

 

		(b)	Any transaction which involves a sale of Shares or any other securities, the price and other terms on
which the Shares or any other securities are proposed to be sold; and

 

		(c)	A sale of Assets of the Company or the Material Subsidiaries, the price and other terms on which the Assets
of the Company or the Material Subsidiaries are proposed to be sold;

 

		11.1.4	The time for completion of the Strategic Sale as best estimated by the Founders; and

 

		11.1.5	Any other material terms of the proposed Strategic Sale.

 

		11.2	Upon receiving the Strategic Sale Notice, the Investors may request the Company and the Founders to provide
such other information as may be requested by them.

 

    45

     

    

 

		11.3	The Company and the Founders shall, in good faith, consider all offers relating to a Strategic Sale that
are brought to its notice by the Investors, however, the Company and the Founders shall in no event be obligated to accept any such offers.

 

		11.4	The Series D Investors shall have the option (but not the obligation) to offer their Preference Shares
for sale in the Strategic Sale in priority to the other Shareholders, with each of the other Investors having the right to offer their
Preference Shares on a pro rata basis to their inter se shareholding in the Preference Shares of the Company, provided that to
the extent the number of Shares to be sold in the Strategic Sale exceeds the aggregate number of Preference Shares offered by the Series
A Investors, Series B Investors, Series C Investors, Series D Investors and Series U Investor, the right to offer such surplus number
of Shares as are to be sold in the Strategic Sale shall be allocated between the Shareholders on a basis pro-rata to the number of Ordinary
Shares held by the Series A Investors, Series B Investors, Series C Investors, Series D Investors and Series U Investor and the Shares
held by the other Shareholders.

 

		11.5	Each of the Investors shall indicate the number of Shares that such Investor proposes to offer in such
Strategic Sale.

 

		11.6	The Company and the Founders shall make commercially reasonable efforts necessary to complete the Strategic
Sale on the terms and within the time period set out in the Strategic Sale Notice or such extended time period as may be required to obtain
any Governmental Approvals. In the event that a Strategic Sale has not been completed within the time period as aforesaid, then the Company
and the Founders shall restart the process under this Clause 11 by sending a fresh Strategic Sale Notice.

 

		11.7	In the event a Strategic Sale Notice (issued pursuant to Clause 11.1) has been issued 45 (forty-five)
days prior to the expiry of the Exit Period, the Company and the Founders shall have an additional period of 6 (six) months from the expiry
of the Exit Period to consummate the Strategic Sale and provide an Exit to the Investors. The Exit Period, in such scenario, shall be
deemed to have been extended (“Extended Exit Period”) and during such Extended Exit Period the Company and the Founders
will undertake best efforts to ensure that such Strategic Sale is consummated. For the avoidance of any doubt, it is clarified that, notwithstanding
anything contained herein, the Exit Period shall not be extended except pursuant to this Clause 11.7.

 

		11.8	All costs and expenses relating to the Strategic Sale including the expenses relating to the appointment
of an independent merchant banker and other professional advisors and the stamp duty (if any) payable under Applicable Law shall be borne
entirely by the Company.

 

		11.9	The Investors shall not be required to provide any guarantees or indemnities, or be subject to any restrictive
covenants pursuant to, or be required to bear any costs and expenses related to a Strategic Sale, provided that each of the Investors
shall make customary representations and warranties (other than representations and warranties relating to the business and operations
of the Company) with regard to the Strategic Sale, relating to the title to their shareholding in the Company.

 

		11.10	The Parties agree and acknowledge that if the Strategic Sale is effected
through a sale of all or substantially all of the outstanding shares, or a sale of all or substantially all of the Assets of any Material
Subsidiary(ies), the obligation on Company and Founders to provide an Exit shall be deemed to be completed only when the proceeds from
such Strategic Sale have been received by the Shareholders, subject to the distribution waterfall under Clause 13.

 

    46

     

    

 

		12	EXIT DEFAULT RIGHTS

 

		12.1	If prior to the expiry of the Exit Period, the Company does not or is unable for any reason to provide
an Exit to the Investors, in accordance with Clause 10 or Clause 11, then without prejudice to the other remedies available under Applicable
Law, GPC (“Exit Default Triggering Investor”) and/or the other Existing Investors (“Other Exit Default Triggering
Investor(s)”) shall be eligible / entitled to exercise any of the rights mentioned in Clauses 12.2 to 12.3 (“Exit Default
Rights”) in the manner provided below.

 

		12.2	For the avoidance of doubt, it is hereby clarified that:

 

		(a)	the Exit Default Triggering Investor shall be at a liberty to exercise any of the available Exit Default
Rights without following any specific sequence and without obtaining any approvals from any Shareholder (whether under Clause 3.3 (Reserved
Matters) or otherwise). For the sake of abundant clarity, nothing in Clause 3.3 (Reserved Matters) or Schedule 4 or anywhere under this
Agreement will impair the right of the Exit Default Triggering Investor to trigger its Exit Default Rights or require prior approval of
any other Investor;

 

		(b)	the Other Exit Default Triggering Investors shall have the right to exercise the Exit Default Rights only
in the manner stated herein below;

 

		(c)	the Exit Default Triggering Investor and the Other Exit Default Triggering Investors shall have the right
to independently exercise their respective Exit Default Rights, subject to the manner stated herein below;

 

		(d)	subject to the Exit Default Rights of the Exit Default Triggering Investor, each of the Other Exit Default
Triggering Investors shall exercise their Exit Default Rights with prior approval of the Shareholders holding, in aggregate, no less than
65% (sixty five percent) of the Shares with Preference Shareholders voting on an As If Converted Basis; and

 

		(e)	if the exercise of the Other Shareholders’ Trade Sale Right leads to a change of Control, then GPC
shall have the sole right to exercise the CoC Tag Right and the proceeds from such Exit shall be distributed as per the distribution waterfall
set out in Clause 13.

 

		12.3	Buy-Back Option

 

		12.3.1	GPC’s Buy-Back Option

 

		(a)	Subject to Applicable Law, the Exit Default Triggering Investor shall have the right to exercise its right
to require the Company to buy back some or all of the Shares held by the Exit Default Triggering Investor (“GPC Outstanding Shares”)
(the “GPC Buy-Back Option”).

 

		(b)	Any exercise of the GPC Buy-Back Option by the Exit Default Triggering Investor will not require any approval
of the other Investors.

 

    47

     

    

 

		12.3.2	Other Exit Default Triggering Investors’ Buy-Back Option

 

Subject to Applicable Law and subject
to obtaining prior approval of 65% (sixty five percent) of the Shareholders on an As If Converted Basis, the Other Exit Default Triggering
Investors shall have the right to exercise their right to require the Company to buy back some or all of the Shares held by the Other
Exit Default Triggering Investor(s) (“Other Shareholders’ Outstanding Shares”) (the “Other Shareholders’
Buy-Back Option”).

 

		12.3.3	Procedure for Buy-Back Option

 

		(a)	The Exit Default Triggering Investor or the Other Exit Default Triggering Investors, as the case may be,
exercising their respective Buy-Back Option shall notify the Company of its decision to exercise its Buy Back Option by delivering a written
notice (the “Buy-Back Notice”). The Buy-Back Notice shall state the number of Shares covered by the exercise of the
Buy-Back Option (“Buy-Back Shares”).

 

		(b)	Subject to compliance with Applicable Laws, the Buy-Back Shares held by the Exit Default Triggering Investor
or the Other Exit Default Triggering Investors, as the case may be, shall be bought back by the Company within a period of 45 (forty five)
Business Days from the date of the Buy-Back Notice; provided further that the Company shall make all efforts to seek and obtain all applicable
Governmental Approvals within such 45 (forty five) Business Days period. In the event that all the Shares held by the Exit Default Triggering
Investor or the Other Exit Default Triggering Investors, as the case may be, cannot be bought back by the Company solely due to the operation
of Applicable Law, and if on the date of the Buy-Back Notice, the number of Shares held by the Exit Default Triggering Investor or the
Other Exit Default Triggering Investors, as the case may be, that may then be legally bought back by the Company is less than the number
of Buy-Back Shares held by the Exit Default Triggering Investor or the Other Exit Default Triggering Investors, as the case may be, to
be bought back (the difference being “Outstanding Exit Default Triggering Investor Shares”), then such Outstanding
Exit Default Triggering Investor Shares shall be carried forward and be bought back as soon as the Company has legally available funds
for, or otherwise becomes legally capable of completing, such buy-back. Subject to the approval of the Exit Default Triggering Investor
or the Other Exit Default Triggering Investors, as the case may be, the Founders may participate in any buy-back by the Company.

 

		12.3.4	For the avoidance of any doubt, it is clarified that the issuance of a Buy Back Notice by the Exit Default
Triggering Investor or Other Exit Default Triggering Investors (as the case may be) shall be without prejudice to the rights of the Exit
Default Triggering Investor or Other Exit Default Triggering Investors (as the case may be) who have not issued the Buy-Back Notice.

 

    48

     

    

 

		12.3.5	Nothing in this Clause 12.3 shall limit or restrict the Exit Default Triggering Investor from exercising
its option to require the Company to redeem its Series D Preference Share(s) in accordance with Paragraph 4 of Schedule 10 (as the case
may be), and it is clarified that, the Exit Default Triggering Investor shall have priority in redemption of its Series D Preference Shares
over the other Investors.

 

		12.3.6	Notwithstanding anything contained herein, the Exit provided to the Exit Default Triggering Investor and/or
Other Exit Default Triggering Investors (as the case may be) the under Clause 10 (QIPO), 11 (Strategic Sale) or 12 (Exit Default Right)
shall be deemed to be a Liquidation Event and the proceeds from any Exit whether under Clause 10, 11 or 12 shall at all times be distributed
as per the distribution waterfall set out in Clause 13.

 

		12.3.7	Each of the Founders shall vote and cause the other Shareholders including the other Investors to take
all necessary steps (including obtaining statutory approvals, conversion of Preference Shares and voting their Shares) in favour of any
proposal intended to implement the provisions of Clause 12.3, including: (i) exercising voting rights attached to their Shares in favour
of the transaction; (ii) not exercising any approval or voting rights connection therewith in a manner contrary to the closing of the
transaction.

 

		12.4	Trade Sale

 

		12.4.1	GPC’s Trade Sale Right 

 

The Exit Default Triggering Investor
shall have the right to transfer some or all its Shares to any Third Party (“GPC Potential Buyer”) (“GPC Trade
Sale Right”).

 

		12.4.2	Other Exit Default Triggering Investors’ Trade Sale Right

 

Subject to obtaining prior approval of
65% (sixty five percent) of the Shareholders on an As If Converted Basis, the Other Exit Default Triggering Investor(s) shall have the
right to transfer some or all their respective Shares to any Third Party (“Other Shareholders’ Potential Buyer”)
(“Other Shareholders’ Trade Sale Right”).

 

		12.4.3	GPC’s Drag Along Right 

 

		(a)	Subject to the Founders’ Right of First Offer and the GPC Drag Along Right being exercised at the
Exit Drag Price (subject to the distribution waterfall as set out in Clause 13), in the event the Exit Default Triggering Investor exercises
the GPC Trade Sale Right under this Clause 12.4, the Exit Default Triggering Investor, shall have the right (but not the obligation) to
transfer any or all Shares held by it to a Potential Buyer and compel any or all Shareholders (including the Investors and Founders) (“GPC
Dragged Shareholders”) to transfer any or all Shares held by such Dragged Shareholders (“GPC Drag Shares”)
as may be indicated by the Exit Default Triggering Investor (“GPC Drag Along Right”).

 

		(b)	The Parties agree and acknowledge that the GPC Dragged Shareholders will not be required to bear any costs
and expenses related to the sale of the GPC Drag Shares (except any duty, levy or expense charged in relation to the underlying sale agreement/documentation
as well as charges for bankers and advisers of such GPC Dragged Shareholders), or provide any representation, warranty or covenant in
relation to such sale, provided that each of the GPC Dragged Shareholders shall make customary representations and warranties regarding
their title to the GPC Drag Shares. It is clarified that the representations and warranties provided by any Investor (including the Exit
Default Triggering Investor) pursuant to the applicability of this Clause 12.4.3(b) (a “Covered Investor”) shall not
be any more onerous than the representations and warranties provided by the other Covered Investors. Further, no Covered Investor will
be subject to any joint and several liability in respect of any representation, warranty or covenant made by the Company pursuant to transactions
envisaged under this Clause 12.4.3 and the total liability of such Covered Investor pursuant to such transaction(s) (except for fraud
or misrepresentation on the part of such Investors) will not exceed 100% (one hundred percent) of the sale proceeds received by the respective
Covered Investor from such sale.

 

    49

     

    

 

		(c)	The Parties further agree that the Company shall bear all costs and expenses in relation to any diligence
to be conducted on the Company pursuant to exercise of rights under Clause 12.4. The Founders shall be required to provide representations,
warranties and indemnities as may be required by the Potential Buyer in respect of the business and operations of the Company (including
title to their Shares, wherever relevant).

 

		(d)	Notwithstanding anything stated herein, in the event the Exit Default Triggering Investor exercises its
GPC Drag Along Right, the Other Exit Default Triggering Investors shall be restricted from issuing a Buy-Back Notice and/or Drag Along
Notice.

 

		12.4.4	Other Exit Default Triggering Investors’ Drag Along Right

 

		(a)	Subject to the Founders’ Right of First Offer, in the event the Other Exit Default Triggering Investors
exercises its Other Shareholders’ Trade Sale Right under this Clause 12.4, the Other Exit Default Triggering Investors, shall have
the right (but not the obligation) to transfer any or all Shares held by them to an Other Shareholders’ Potential Buyer and compel
any or all Shareholders (except GPC) (“Other Shareholders’ Dragged Shareholders”) to transfer any or all Shares
held by such Other Shareholders’ Dragged Shareholders (“Other Shareholders’ Drag Shares”) as may be indicated
by the Other Exit Default Triggering Investor (“Other Shareholders’ Drag Along Right”).

 

		(b)	Notwithstanding anything to the contrary contained herein, the Other Exit Default Triggering Investors
shall not have any right to compel GPC to transfer any or all Shares held by GPC in case the Other Exit Default Triggering Investors exercise
their Other Shareholders’ Drag Along Right.

 

		12.4.5	Procedure for Drag Along Right

 

		(a)	On exercise of the Drag Along Right, the Exit Default Triggering Investor or the Other Exit Default Triggering
Investors, as the case may be, shall send a written notice to the Company, Shareholders and the Founders requiring the Dragged Shareholders
(including the Investors) to transfer the Dragged Shares, to the Potential Buyer along with the Shares held by the Exit Default Triggering
Investor or the Other Exit Default Triggering Investors, as the case may be (the “Drag Along Notice”), provided that
the terms and conditions on which the Dragged Shareholders are required to sell their Shares shall be the same as the terms and conditions
(subject to the distribution waterfall under Clause 13) on which the Exit Default Triggering Investor or the Other Exit Default Triggering
Investors, as the case may be, are proposing to sell their Shares in such proposed sale. It is clarified that the Drag Along Right shall
be deemed to be a Liquidation Event and the proceeds from such sale shall at all times be distributed as per the distribution waterfall
set out in Clause 13.

 

		(b)	The Drag Along Notice shall set out the identity of the Potential Buyer, the consideration payable per
Share, a summary of the material terms of such proposed transfer and the number of Dragged Shares that are required to be transferred
to the Potential Buyer.

 

		(c)	Upon receipt of a Drag Along Notice, the Dragged Shareholders shall:

 

		(i)	Within 15 (fifteen) Business Days from the date of the Drag Along Notice, transfer the Dragged Shares
as specified in the Drag Along Notice, free of any Encumbrance, on the same terms and conditions as the Exit Default Triggering Investor
or the Other Exit Default Triggering Investor, as the case may be;

 

		(ii)	Be bound by the Drag Along Notice, such that each of them shall be required to transfer the Dragged Shares
to the Potential Buyer.

 

    50

     

    

 

		(d)	The Dragged Shareholders and the Company shall take all necessary actions (including any action that may
be reasonably requested of them by the Exit Default Triggering Investor or Other Exit Default Triggering Investors (as the case may be))
to cause the consummation of the transactions mentioned in this Clause 12.4, including: (i) exercising voting rights attached to their
Shares in favour of the transaction; (ii) not exercising any approval or voting rights in connection therewith in a manner contrary to
the closing of the transaction; and (iii) doing of all such acts, deeds and things and exercising of such rights under the relevant contracts
as may be required to ensure that the valuation of the Company does not suffer due to the exercise of the Drag Along Right by the Exit
Default Triggering Investor or the Other Exit Default Triggering Investors, as the case may be.

 

		(e)	If a Shareholder fails, refuses or is otherwise unable to comply with its obligations under Clause 12.4,
then the Company shall have the authority and be obliged to designate a Person to execute and perform the necessary transfer on such Shareholder’s
behalf. The Company may receive and hold the purchase consideration in trust for such Shareholder and cause the Potential Buyer to be
registered as the holder of the Dragged Shares being sold by the relevant Shareholder. The receipt by the Company of the purchase consideration
shall be a good discharge to the Potential Buyer (who shall not be bound to see to the application of this amount).

 

		(f)	Notwithstanding anything contained herein (including in this Clause 12.4.5), any sale to a Potential Buyer
pursuant to this Clause 12.4 shall constitute a Liquidation Event, the aggregate proceeds shall at all times be distributed as per the
distribution waterfall set out in Clause 13.

 

		(g)	Notwithstanding anything contained herein, the Drag Along Rights of any Investor shall not operate against
Cisco unless the proposed sale to the Potential Buyer satisfies the following requirements (“Cisco Requirements”):

 

		(i)	the purchase price per Share paid to Cisco shall not be any less than that received by the other Shareholders;

 

		(ii)	the purchase consideration for the sale of Shares must be in cash or in freely tradable equity securities;

 

		(iii)	any representation, warranties or covenants that Cisco would be required to provide is strictly limited
to those that relate to confidentiality and its ownership of the Shares that are to be sold;

 

		(iv)	Cisco will not be subject to any joint and several liability in respect of any representation, warranty
or covenant made by the Company or other Investors;

 

		(v)	Cisco’s liabilities in the sale (except for fraud or misrepresentation on the part of Cisco) will
not exceed 100% (one hundred percent) of the sale proceeds received by Cisco from the sale provided that if a lower liability cap applies
to the other sellers, Cisco’s liabilities shall similarly be capped at the lower liability cap threshold or amount that is proportionate
to the number of shares sold by Cisco out of the total number of shares sold in the sale. Any terms relating to payment of the sale proceeds
to the Cisco, including escrow terms, shall not be less favorable than the terms offered to the other Investors and any escrow or holdback
from Cisco shall not exceed 100% (one hundred percent) of Cisco’s share of the sale proceeds;

 

		(vi)	Cisco shall not be required to amend, extend, enter into or terminate any contractual relationship with
the Company, the Potential Buyer or their respective Affiliates, except for existing arrangements which provide for an extension, modification
or termination upon the consummation of the proposed sale of Shares;

 

    51

     

    

 

		(vii)	Cisco shall not be required to agree to any non-compete and non-solicit covenants;

 

		(viii)	Cisco shall not be obliged to incur any out of pocket expenditure prior to the consummation of the proposed
sale of Shares, and shall not be obliged to bear any expenses incurred in connection with the consummated sale except to the extent that
such expenses are incurred for the benefit of all the Company's Shareholders, and are paid by the Company or the party to such sale;

 

		(ix)	Cisco will not be required to execute any joinder agreement or similar agreement where it is a party to
the definitive agreements in respect of such sale, except where the terms of such document to be executed by Cisco are limited to the
following: (A) setting out Cisco’s agreement to the sale of Shares in the Company by Cisco to the Potential Buyer at a price and
upon terms which comply with the Cisco Requirements; (B) representations and warranties given by Cisco are solely in respect of the ownership
of its Shares; and (C) containing any other requirements expressly set out in the Cisco Requirements; and

 

		(x)	Any amendments to the Cisco Requirements are subject to Cisco’s express consent in writing.

 

		(h)	In the event that the terms offered by the Potential Buyer do not satisfy the Cisco Requirements set out
in Clause 12.4.5(g) above but the other Shareholder wishes to proceed with the sale to the Potential Buyer the Company shall have the
option, exercisable before completion of the sale to the Potential Buyer, to redeem or buy-back, as applicable, all (and not only some)
of: (i) the then outstanding Series C Preference Shares held by Cisco for a redemption amount or price per Share at (A) the Exit Price
or (B) the price per Preference Share to be paid by the Potential Buyer to the other Investors, whichever is the higher; and (ii) the
Ordinary Shares held by Cisco for a redemption amount or price per share equal to the price per Ordinary Share to be paid by the Potential
Buyer to the other Investors (together such Series C Preference Shares and Ordinary Shares held by Cisco comprising the “Cisco
Stake”) provided that if the Company exercises this option, completion of such redemption or buy-back of the Cisco Stake and
payment of the full redemption amount or price for the Cisco Stake shall take place simultaneously with the completion of the proposed
sale of Shares by the other Investors, the Founders and the other Shareholders who have been dragged to the Potential Buyer.

 

		12.4.6	Founder’s Right of First Offer

 

		(a)	If, the Exit Default Triggering Investor or the Other Exit Default Triggering Investors, as the case may
be, has exercised its Trade Sale Right and seeks to exercise its Drag Along Right, such Exit Default Triggering Investor or the Other
Exit Default Triggering Investors, as the case may be, shall first be required to offer the Dragged Shares (including the Shares sought
to be transferred by the Exit Default Triggering Investor or the Other Exit Default Triggering Investors, as the case may be, to the Potential
Buyer) to the Founders to exercise their rights of first offer (“Rights of First Offer”) as follows:

 

		(i)	Prior to exercising the Drag Along Rights, the Exit Default Triggering Investor or the Other Exit Default
Triggering Investors shall first give a written notice to offer the Dragged Shares (hereinafter referred to as “ROFO Notice”)
to the Founders (“ROFO Offerees”) on a pro-rata basis to their inter-se shareholding calculated on a Fully Diluted
Basis. The ROFO Notice shall state (A) the number of Ordinary Shares or Preference Shares proposed to be transferred (hereinafter referred
to as the “ROFO Shares”); and (B) the number and class of Ordinary Shares and Preference Shares that the Exit Default
Triggering Investor or the Other Exit Default Triggering Investors, as the case may be, own at that time on a Fully Diluted Basis.

 

		(ii)	The ROFO Offerees acting together shall be entitled to respond to the ROFO Notice by serving a written
notice (the “Offer Notice”) on the Exit Default Triggering Investor or the Other Exit Default Triggering Investors,
as the case may be, communicating the terms (“ROFO Terms”) at which the ROFO Offerees wish to purchase all (and not
some) of the ROFO Shares, including the price for such purchase, prior to the expiry of 10 (ten) days from the date of receipt of the
ROFO Notice (the “Offer Period”).

 

    52

     

    

 

		(iii)	The Exit Default Triggering Investor or the Other Exit Default Triggering Investors, as the case may be,
shall respond to all timely Offer Notices by serving a written notice (the “Response Notice”) on the ROFO Offerees,
communicating to them whether the ROFO Terms are acceptable, within 25 (twenty five) days from the date of receipt of the Offer Notice.
If acceptable, the Parties shall do all things to consummate the sale and purchase of the ROFO Shares within 20 (twenty) Business Days
of the issuance of the Response Notice.

 

		(iv)	ROFO Shares may be transferred to any Person at any price, and on any terms, if a duly completed and binding
Offer Notice is not received by the Exit Default Triggering Investor or the Other Exit Default Triggering Investors, as the case may be,
within the Offer Period. In such an event, Exit Default Triggering Investor or the Other Exit Default Triggering Investors (as the case
may be) shall be entitled to exercise their Drag-Along Rights.

 

		(v)	If a duly completed and binding Offer Notice is received by the Exit Default Triggering Investor or the
Other Exit Default Triggering Investors, as the case may be, within the Offer Period, then the ROFO Shares may be transferred to either
the ROFO Offerees at the ROFO Terms, or to any other Person but only if such transfer is on the same or inferior price as compared with
the ROFO Terms in any manner.

 

		(vi)	Where a Party requires prior legal, governmental, regulatory or shareholder consent for acquiring the
ROFO Shares pursuant to this Agreement, then, notwithstanding any other provision of this Agreement, that Party shall only be obliged
to acquire the ROFO Shares once such consent or approval is obtained, and the Parties shall use their reasonable endeavours to obtain
any such required approvals.

 

		(b)	It is clarified that if the Exit Default Triggering Investor or the Other Exit Default Triggering Investor
choose to exercise its Trade Sale Right without recourse to the Drag-Along Right, the Founders shall not be entitled to exercise their
Rights of First Offer.

 

		(c)	Without prejudice to the applicability of this Clause 12.4.6, in the event of any transfer of Shares by
an Investor pursuant to Clause 16, the Investor shall be required to give the Founders a Right of First Offer pursuant to the provisions
of this Clause 12.4.6. The provisions of Clause 12.4.6(a) shall apply mutatis mutandis wherein the terms: “Exit Default Triggering
Investor or the Other Exit Default Triggering Investors” shall be substituted by “Transferring Investor”.

 

		12.4.7	Notwithstanding anything contained herein any sale to a Potential Buyer pursuant to this Clause 12.4 shall
constitute a Liquidation Event, the aggregate proceeds shall at all times be distributed as per the distribution waterfall set out in
Clause 13.

 

		12.4.8	Except for transactions pursuant to exercise by the Exit Default Triggering Investor or Other Exit Default
Triggering Investor(s) of their drag along rights pursuant to Clause 12.4.3 or Clause 12.4.4, all Investors shall have the option (but
not the obligation) to participate in any transaction resulting from the valid exercise of the Exit Default Rights and Trade Sale Rights
by the Exit Default Triggering Investor or Other Exit Default Triggering Investor(s), and where they choose to so participate, the proceeds
of such transaction shall be distributed to all participating Investors (including holders of corresponding Ordinary Shares upon conversion
of any Preference Share) in accordance with the terms hereof including Clauses 12 and 13 hereof, as applicable. For clarity, (a) all Investors
shall also be entitled to receive the proceeds of any transaction pursuant to exercise of the GPC Drag Along Right or the Other Shareholders’
Drag Along Right to the extent of the Preference Shares being transferred thereupon, (b) the Exit Default Triggering Investor or the Other
Exit Default Triggering Investor(s) shall provide the Buy-Back Notice to all Investors concurrently with the provision of such Notice
to the Company, (c) the Exit Default Triggering Investor or the Other Exit Default Triggering Investor(s) shall provide to all Investors
prompt notice of exercise of the GPC Trade Sale Right or the Other Shareholders’ Trade Sale Right, as applicable, and (d) subject
to the preferential rights and terms under this Agreement, each of the Founders and the other Shareholders including the other Investors
shall vote and take all necessary steps (including obtaining statutory approvals, conversion of Preference Shares and voting their Shares)
in favour of any proposal intended to implement the provisions of Clause 12.4.8.

 

    53

     

    

 

		13	LIQUIDATION PREFERENCE 

 

		13.1	Upon occurrence of a Liquidation Event, the proceeds available for distribution upon the occurrence of
a Liquidation Event (which, in the event of a Liquidation Event under Clauses 1.1.108 (a), (b) or (c), shall be calculated after settlement
of all claims) (“Liquidation Proceeds”) shall be distributed as provided for in this Clause 13.

 

		13.2	In case the Liquidation Event occurs on or prior to 31 August 2022, the Company shall distribute the Liquidation
Proceeds, in the manner set out below to the Preference Shareholders in the following order:

 

		(i)	first, to the holders of Series D Preference Shares, who are not Electing Shareholders, a sum representing
the applicable Series D Preference Amount in relation to Series D Preference Shares (“Series D LP 1”);

 

		(ii)	second, to the holders of Series A Preference Shares, Series B Preference Shares, Series C Preference
Shares, and Series U Preference Shares, in each case who are not Electing Shareholders, on a pari passu basis, a sum representing
the applicable Series A Preference Amount, Series B Preference Amount, Series C Preference Amount and Series U Preference Amount, in relation
to the Series A Preference Shares, the Series B Preference Shares, the Series C Preference Shares and the Series U Preference Shares respectively
(“Other Investors LP 1”);

 

		(iii)	third, to the holders of Ordinary Shares and the Electing Shareholders (in the event such Electing Shareholders
have elected to give up their right to receive the Preference Amount), on a pro-rata basis by reference to the number of Ordinary Shares
held or deemed to be held by such holders out of the total number of Ordinary Shares on an As If Converted Basis, a sum representing X,
where,

 

X = [Series D LP 1 + Other Investors
LP 1] * [(Shareholding of non-recipients of distributions pursuant to Clauses 13.2(i) and 13.2(ii)) / (Shareholding of recipients of distributions
pursuant to Clauses 13.2(i) and 13.2(ii))]

 

It is clarified that in connection
with a Liquidation Event involving a sale or swap of shares in the Company, if applicable, the Liquidation Proceeds resulting from such
Liquidation Event shall only be distributed amongst the holders of the Ordinary Shares and the Preference Shareholders who have participated
in that Liquidation Event by tendering their shares for sale or swap, and shall be distributed amongst them in the order of priority set
out above, in proportion to the number of shares tendered for sale or swap in that Liquidation Event.

 

		(iv)	Any remaining Liquidation Proceeds after payment under Clauses 13.2 (i), 13.2 (ii), and 13.2 (iii) shall
be distributed amongst all the Shareholders (including the holders of Preference Shares) in proportion to their respective shareholding.

 

    54

     

    

 

		13.3	In case the Liquidation Event occurs after 31 August 2022, the Company shall distribute the Liquidation
Proceeds, in the manner set out below to the Preference Shareholders in the following order:

 

		(i)	first, to the holders of Series D Preference Shares, who are not Electing Shareholders, a sum representing
the applicable Series D Preference Amount in relation to Series D Preference Shares (“Series D LP 2”);

 

		(ii)	second, to the holders of Series A Preference Shares, Series B Preference Shares Series C Preference Shares,
and Series U Preference Shares, in each case who are not Electing Shareholders, on a pari passu basis a sum representing the applicable
Series A Preference Amount, Series B Preference Amount, Series C Preference Amount, and Series U Preference Amount respectively (“Other
Investors LP 2”);

 

		(iii)	third, to the holders of Ordinary Shares and the Electing Shareholders (solely in the event such Electing
Shareholders have elected to give up their right to receive the Preference Amount), on a pro-rata basis by reference to the number of
Ordinary Shares held or deemed to be held by such holders out of the total number of Ordinary Shares on an As If Converted Basis, a sum
representing X, where,

 

X = [Series D LP 2 + Other Investors
LP 2] * [(Shareholding of non-recipients of distributions pursuant to Clauses 13.3(i) and 13.3(ii)) / (Shareholding of recipients of distributions
pursuant to Clauses 13.3(i) and 13.3(ii))]

 

It is clarified that in connection
with a Liquidation Event involving a sale or swap of shares in the Company, if applicable, the Liquidation Proceeds resulting from such
Liquidation Event shall only be distributed amongst the holders of the Ordinary Shares and the Preference Shareholders who have participated
in that Liquidation Event by tendering their shares for sale or swap, and shall be distributed amongst them in the order of priority set
out above, in proportion to the number of shares tendered for sale or swap in that Liquidation Event.

 

		(iv)	Any remaining Liquidation Proceeds after payment under Clauses 13.3(i), 13.3(ii), and 13.3(iii) and shall
be distributed amongst all the Shareholders (including the holders of Preference Shares) in proportion to their respective shareholding.

 

		13.4	“Preference Amount” in respect of a Preference Share shall be an amount as set out
as Series D LP 1 or Series D LP 2 and Other Investors LP 1 or Other Investors LP 2, as the case may be, plus any declared but unpaid dividends
on the relevant Preference Share.

 

		13.5	If in a Liquidation Event, the proceeds are insufficient to pay the Preference Amount in full to the Preference
Shareholders, they will be paid first towards satisfaction of the payment of Series D LP 1 or Series D LP 2 (as the case may be), followed
by a pro rata distribution amongst the holders of Series A Preference Share, Series B Preference Share, Series C Preference Share and
Series U Preference Share in proportion of the remaining Preference Amount (after payment of Series D LP 1 or Series D LP 2, as the case
may be) that each such Preference Shareholder is otherwise entitled to receive.

 

		13.6	Where a Liquidation Event will take place, the Company will as soon as reasonably practical give advance
written notice to the Preference Shareholders of the targeted completion date of such Liquidation Event, the estimated Liquidation Proceeds
and a tabulation of the estimated amount of Liquidation Proceeds payable in respect of each class of Shares on the basis that there are
no Electing Shareholders (such date being the “Liquidation Notice”). Upon receipt of the Liquidation Notice, each Preference
Shareholder shall have the right, within a period of 7 (seven) Business Days from receipt of the Liquidation Notice, to request for further
information from the Company in order for such Preference Shareholder to assess whether to make an election (“Liquidation Clarification
Request”). If any Liquidation Clarification Request is issued, the Company shall provide the information requested to all Preference
Shareholders within 7 (seven) Business Days from the receipt of Liquidation Clarification Request (“Liquidation Clarification
Notice”). If any Preference Shareholder elects to give up their preferential right to receive the Preference Amount and participate
instead with the holders of Ordinary Shares on an As If Converted Basis, it shall provide a notice in writing to the Company and the other
Preference Shareholders within 7 (seven) Business Days of the Company providing: (a) the Liquidation Notice or, (b) if a Liquidation Clarification
Request is served, Liquidation Clarification Notice (such electing Preference Shareholders, the “Electing Shareholders”).
The election to give up the liquidation preference shall be personal to each Preference Shareholder. For the purpose of determination
of the entitlement of the shareholders of the Company, the Preference Shareholders who are Electing Shareholders shall be deemed to be
holders of Ordinary Shares calculated on an As If Converted Basis.

 

    55

     

    

 

		13.7	If some and not all of the Shares are sold or transferred in a Liquidation Event, the distribution order
as set out above in Clauses 13.2 and 13.3 (as the case may be) will apply accordingly as between the Shareholders who participate in the
Liquidation Event by selling their Shares.

 

		13.8	The Parties hereby agree and undertake to fully co-operate with each other in making the payment of the
Preference Amount (as mentioned in Clauses 13.2 and 13.3) in the order and manner provided above and to do all such things as may be reasonably
necessary and that they shall use and employ all commercially reasonable efforts to ensure that payment of the amounts are made in accordance
with this Clause 13 as applicable, including taking all steps to inform the Person responsible for distribution of any amount on account
of a Liquidation Event to reallocate any such distribution in accordance with this Agreement and to give full effect to this Clause 13.
The Parties covenant that they shall do all reasonable acts, deeds and things to obtain any Governmental Approvals and Consents in a timely
manner such that the Liquidation Preference can be made to the Preference Shareholders within the time periods mentioned above.

 

		14	REINSTATEMENT OF RIGHTS

 

		14.1	Notwithstanding anything contained elsewhere in this Agreement, in the event that:

 

		14.1.1	An offer document (or equivalent document, by whatever name called) is filed with the competent authority
in connection with any proposed QIPO (or a subsequent IPO) which, prior to such filing, has necessitated the conversion or an alteration
of the class or the rights attached to any class of Preference Shares (such alterations being, collectively, the “Conforming
of Rights”); and

 

		14.1.2	Within 6 (six) months of the filing of such offer document (or equivalent document, by whatever name called)
(the “Listing Date”), the QIPO (or a subsequent IPO) does not complete such that the entire issued, paid-up and subscribed
Share Capital is not admitted to trading on a Recognised Stock Exchange by the expiry of the Listing Date,

 

then the Company and the Founders
shall undertake all necessary actions to ensure that the holders of Series A Preference Shares, Series B Preference Shares, Series C Preference
Shares, Series D Preference Shares and/or Series U Preference Shares, as the case may be, are placed in the same position, and possess
the same preferential and other rights, each of them had the benefit of, immediately prior to the Conforming of Rights.

 

		14.2	The Company and Founders undertake and covenant to the Investors that they shall, within 3 (three) months
of the Listing Date (if a QIPO or a subsequent IPO has not closed by that date) or, if earlier, the date on which the process of a QIPO
or a subsequent IPO is cancelled, discontinued or postponed, take all such actions and do all such things as may be requested by the Investors
and as otherwise required, which steps shall include without limitation:

 

		14.2.1	Buy back the Ordinary Shares issued to the Investors pursuant to any proposed QIPO or IPO, and to reissue
such Series A Preference Shares, Series B Preference Shares, Series C Preference Shares, Series D Preference Shares and/or Series U Preference
Shares, as the case may be, (along with all rights that were attached to the Series A Preference Shares, Series B Preference Shares, Series
C Preference Shares, Series D Preference Shares and/or Series U Preference Shares, as the case may be, immediately prior to the Conforming
of Rights);

 

		14.2.2	Entry into any contractual arrangements necessary or in the reasonable opinion of the Investors, desirable
for the purposes of ensuring that the rights attaching to the reissued Series A Preference Shares, Series B Preference Shares, Series
C Preference Shares, Series D Preference Shares and/or Series U Preference Shares, as the case may be, are the same as those that are
attached to the Series A Preference Shares, Series B Preference Shares, Series C Preference Shares, Series D Preference Shares and/or
Series U Preference Shares, as the case may be, immediately prior to the Conforming of Rights;

 

		14.2.3	The alteration of the Constitution to include all of the rights attaching to the reissued Series A Preference
Shares, Series B Preference Shares, Series C Preference Shares, Series D Preference Shares and/or Series U Preference Shares, as the case
may be, that were attached to the Series A Preference Shares, Series B Preference Shares, Series C Preference Shares, Series D Preference
Shares and/or Series U Preference Shares, as the case may be, immediately prior to the Conforming of Rights; and

 

		14.2.4	All such other measures as shall be necessary to restore the rights enjoyed by the Investors prior to
the conversion of the Preference Shares into Ordinary Shares.

 

    56

     

    

 

		15	TRANSFER OF SHARES BY THE FOUNDERS AND THE OTHER SHAREHOLDERS

 

		15.1	As long as any Investor continues to hold any Shares in the Company, the Founders or any other Shareholder
(other than the Investors) shall not be entitled to transfer their Shares, in any form whatsoever, whether collectively or individually,
whether directly or indirectly, unless the Investors provide a written consent to the Founders. Provided that the Founders or any other
Shareholder (other than the Investors) shall, subject to the various rights of the Investors under Clause 15.3 (Right of First Refusal),
and 15.4 (Tag Along Right) be entitled to sell up to a maximum of 10% (ten percent) (“Permitted Transfer”) of those
Ordinary Shares held by each of them as on the First Completion Date without any consent.

 

		15.2	Nothing contained in Clause 15.1 shall apply to any transfer of Shares pursuant to exercise of the rights
by the Exit Default Triggering Investor or the Other Exit Default Triggering Investors.

 

		15.3	Right of First Refusal

 

		15.3.1	If the Founders or any other Shareholder, other than the Investors (the “Transferor Shareholder”)
decides to transfer all or any portion of their Shares in the Company (the “ROFR Sale Shares”) to any bona fide
third party (the “Intending Purchaser”), then the Transferor Shareholder(s) shall grant the Investors (“ROFR
Holder”) a prior right to purchase the ROFR Sale Shares in proportion to their then inter se shareholding in the Company
on a Fully Diluted Basis (“Right of First Refusal”).

 

		15.3.2	The Transferor Shareholder shall give a written notice (“ROFR Notice”) to each Investor
prior to transferring the ROFR Sale Share to the Intending Purchaser. The ROFR Notice shall contain (i) the name of the Intending Purchaser;
(ii) number of the Shares owned by the Transferor Shareholder and the number of ROFR Sale Shares intended to be transferred to the Intending
Purchaser; (iii) the proportionate entitlement of each Investor; (iv) the price and the terms of payment; (v) the manner of payment and
date of consummation of transaction; (vi) a confirmation that (A) the Intending Purchaser has been made aware of the Right of First Refusal
and the Tag Along Right of the Investors and the obligations of the Transferor Shareholders hereto and (B) no consideration, tangible
or intangible, is being provided to the Transferor Shareholder which will not be reflected in the above stated consideration (including
a refund or a discount); and (vii) any other terms and conditions (collectively the “ROFR Terms”).

 

		15.3.3	The Investors (“ROFR Accepting Investor”) shall be entitled to respond to the ROFR
Notice by serving a written notice (the “Offer Acceptance Notice”) on the relevant Transferor Shareholders within a
period of 20 (twenty) Business Days from the date of receipt of the ROFR Notice (the “ROFR Acceptance Period”) specifying
its acceptance to exercise the Right Of First Refusal as set out in the ROFR Notice. As long as Investors are willing to purchase all
or a portion of the ROFR Sale Shares offered to them on the terms specified in the ROFR Notice either by itself or through its nominees
or Affiliates, the Transferor Shareholders shall not transfer the ROFR Sale Shares to the Intending Purchaser or any other Person, other
than the Investors or their respective nominees or Affiliates (as the case may be).

 

		15.3.4	Upon receipt of the ROFR Acceptance Notice, the relevant Transferor Shareholders shall complete the purchase
and transfer of such number of the ROFR Sale Shares as specified in the ROFR Acceptance Notice, at the same price and on the same terms
as are mentioned in the ROFR Notice, within 30 (thirty) Business Days from the date of the ROFR Acceptance Notice.

 

    57

     

    

 

		15.3.5	The Company and the Transferor Shareholders shall provide representations, warranties, covenants and indemnities
in relation to the transfer of the ROFR Sale Shares to the ROFR Accepting Investors and any respective Affiliate and nominee of the ROFR
Accepting Investors similar to representations and warranties sought to be provided to the Intending Purchaser for such ROFR Sale Shares
and which are at least consistent with those provided under the Series D Subscription Agreement. Provided that if only some and not all
of the Investors exercise their right under this Clause 15.3 and deliver an ROFR Acceptance Notice, such ROFR Accepting Investors shall
have the right to purchase the unelected portion of ROFR Sale Shares offered to the other Investor (other than the ROFR Accepting Investors),
on a pro-rata basis to their inter se shareholding.

 

		15.3.6	Subject to Clause 15.4 below, the Transferor Shareholders shall be free to transfer the ROFR Sale Shares
not acquired by the ROFR Accepting Investors pursuant to their Right of First Refusal to the Intending Purchaser, within a period of 30
(thirty) Business Days after the expiry of the ROFR Acceptance Period (the “Free Sale Period”), on the same terms and
conditions and for no less than the consideration as specified in the ROFR Notice, subject to execution of a Deed of Adherence by the
Intending Purchaser.

 

		15.3.7	The Transferor Shareholder shall be required to furnish to the Investors, the necessary documentation
evidencing the completion of the transfer of the ROFR Sale Shares to the Intending Purchaser within 10 (ten) Business Days from the expiry
of the Free Sale Period and the terms of such transfer including the price at which the ROFR Sale Shares were transferred. In the event
the transfer by the Transferor Shareholders is not completed within the Free Sale Period, the transfer shall again be subject to the provisions
of this Clause 15.3.

 

		15.3.8	Where the Investor(s) require prior legal, governmental, regulatory or Shareholder consent for acquiring
the ROFR Sale Shares pursuant to this Agreement, then, notwithstanding any other provision of this Agreement, the Investors shall only
be obliged to acquire the ROFR Sale Shares once such consent or approval is obtained, and such Investor shall use its best efforts to
obtain any such required approvals at the earliest and the Founders and the Company shall offer reasonable assistance for the same.

 

		15.3.9	The Investors’ election to exercise or not to exercise the Right of First Refusal with respect to
a particular proposed transfer shall not adversely affect their Right of First Refusal with respect to any other transfer by the Transferor
Shareholders.

 

		15.3.10	Nothing in this Clause 15.3 shall apply to any transfer of Shares pursuant to exercise of the rights by
the Exit Default Triggering Investor or the Other Exit Default Triggering Investors under Clause 12.

 

    58

     

    

 

		15.4	Tag-Along Right

 

		15.4.1	Subject to Clause 15.5, in the event the Transferor Shareholders propose to transfer any part of their
shareholding in the Company, then the Transferor Shareholders shall ensure that each ROFR Holder has a right to sell the Shares held by
the ROFR Holders under the same terms and conditions specified in the ROFR Notice, together with the ROFR Sale Shares (“Tag Along
Right”) and the Transferor Shareholders shall be bound by the Tag Along Right of the ROFR Holders.

 

		15.4.2	The ROFR Notice shall also contain an offer from the Intending Purchaser to purchase such number of the
Shares of the ROFR Holders out of their total shareholding (“Tag Shares”) which, vis-à-vis the Transferor Shareholders,
is proportionate to the number of ROFR Sale Shares to the Intending Purchaser out of the total shareholding of such Transferor Shareholder
(calculated on an As If Converted Basis), except when such transfer by Transferor Shareholders leads to a change of Control, in which
case Series D Investors shall be entitled to transfer their entire shareholding in accordance with Clause 15.5 in the Company.

 

		15.4.3	Upon receipt of the ROFR Notice, the ROFR Holders shall be entitled to (but shall not have any obligation
to) transfer any or all of their respective Tag Shares to the Intending Purchaser, at the ROFR Terms mentioned in the ROFR Notice, by
sending a written notice of acceptance (“Tag Along Acceptance Notice”) within the ROFR Acceptance Period. The Tag Along
Acceptance Notice shall indicate the respective number of Tag Shares, which the ROFR Holders desire to transfer to the Intending Purchaser.

 

		15.4.4	If the ROFR Holders send the Tag Along Acceptance Notice to the Transferor Shareholders, within the ROFR
Acceptance Period, then the Transferor Shareholders shall ensure that the Intending Purchaser purchases the respective Tag Shares, on
the terms and conditions set out in the ROFR Notice, simultaneously with the ROFR Sale Shares of the Transferor Shareholders.

 

		15.4.5	If the Tag Along Acceptance Notice is not sent by any of the ROFR Holders before the expiry of the ROFR
Acceptance Period, the offer shall be deemed to have been rejected and subject to Clause 15.2, the Transferor Shareholders shall, thereafter,
be free to transfer the ROFR Sale Shares, within the Free Sale Period but after the expiration of the ROFR Acceptance Period, to the Intending
Purchaser on the same price and conditions no more favourable than the ROFR Terms. The Intending Purchaser shall execute a Deed of Adherence
simultaneously with the purchase of the ROFR Sale Shares.

 

		15.4.6	The ROFR Holders who have issued the Tag Along Acceptance Notice (“Tag Accepting Investors”)
shall not be required to make any representation, provide any covenants or undertakings, grant any indemnifications or incur any obligations
to the Intending Purchaser or any other Person in respect to the business and operations of the Company. The Transferor Shareholders shall
ensure that all of the terms of the proposed transfer, offered by the Intending Purchaser, are also offered to the ROFR Holders, for the
same consideration and upon the same terms and conditions as applicable to the ROFR Sale Shares.

 

    59

     

    

 

		15.4.7	In the event, for any reason, the Intending Purchaser proposing to acquire the ROFR Sale Shares is unable
to or refuses to acquire the Tag Shares (or any part thereof) simultaneously with the ROFR Sale Shares, then, at the option of the Tag
Accepting Investors, the Transferor Shareholders shall not be entitled to transfer any of the Shares held by them in the Company to such
Intending Purchaser.

 

		15.4.8	If the Transferor Shareholders transfers hereunder any series, class or type of Shares then held by them,
and the Tag Accepting Investors do not hold any of such series, class or type, the Intending Purchaser shall have to acquire whatever
series, class or type of security held by the Tag Accepting Investors along with the ROFR Sale Shares.

 

		15.4.9	On transfer of the Tag Shares, the Transferor Shareholders shall cause such certificates or other instruments
to be transferred and delivered to the Intending Purchaser, and the Intending Purchaser shall simultaneously remit, or shall cause to
be remitted, to the Tag Accepting Investors, that portion of the proceeds of the transfer to which the Tag Accepting Investors are entitled
to, by way of wire transfer or such other method as may be acceptable to such Tag Accepting Investors. If the proceeds of the transfer
includes consideration other than cash, the cash equivalent value of the non-cash consideration shall be determined by a Big Four Auditor
mutually nominated by the Tag Accepting Investors and Founders, which determination shall be binding upon the Tag Accepting Investors
and the Transferor Shareholders, in the absence of any fraud or error, and the Tag Accepting Investors shall be entitled to the non-cash
equivalent of that portion of the proceeds of the transfer to which the Transferor Shareholders are entitled.

 

		15.4.10	Each Tag Accepting Investor shall be entitled to convert the Series B Preference Shares and/or Series
C Preference Shares and/or Series D Preference Shares and/or Series U Preference Shares, as the case may be, into Ordinary Shares in accordance
with the provisions of this Agreement to enable it to exercise its rights under Clause 15.4, if such conversion is required, and the Company
and Founders undertake to perform all acts and deeds necessary to facilitate such conversion. Any time limits set out in Clause 15.4 shall
stand extended by the period required by the Tag Accepting Investors to convert the Series B Preference Shares and/or Series C Preference
Shares and/or Series D Preference Shares and/or Series U Preference Shares, as the case may be, into Ordinary Shares.

 

		15.4.11	The Transferor Shareholders shall not make the proposed sale other than in the manner as set out in this
Clause 15 and if purported to be made, such sale shall be void and shall not be binding on the Company and shall be deemed to be a breach
of the terms of this Agreement.

 

		15.4.12	Nothing in Clause 15.4 shall apply to any transfer of Shares pursuant to exercise of the rights by the
Exit Default Triggering Investor or the Other Exit Default Triggering Investors under Clause 12.

 

    60

     

    

 

		15.5	CoC Tag Along Rights

 

		15.5.1	In the event of a proposed transfer or a series of bona fide connected, proposed transfer of Shares
(“CoC Shares”) by any Shareholder (“CoC Selling Shareholder”) that results in any Person (including
a Shareholder and/or its Affiliates) (“CoC Purchaser”) gaining Control (each a “CoC Tag Triggering Event”),
GPC shall have the right (but not the obligation to) to transfer up to all of its Shares to the CoC Purchaser (the “CoC Tag Right”).
For the avoidance of doubt, it is clarified that GPC shall be entitled to exercise its CoC Tag Right if the Other Exit Default Triggering
Investors exercise any of their Exit Default Rights which results in a CoC Tag Triggering Event. Once GPC elects to exercise the CoC Tag
Right, the other Investors shall upon electing to do so (such electing Investor referred as “Other CoC Exiting Investor”)
and subject to GPC exercising its CoC Tag Right to the full extent in accordance with Clause 15.5, have the right to exercise the CoC
Tag Right as set out in Clause 15.5. It is clarified that the right to exercise the CoC Tag Right shall exist with respect to the Other
CoC Exiting Investor even if GPC chooses not to exercise its CoC Tag Right by not issuing a CoC Acceptance Notice within CoC Acceptance
Period.

 

		15.5.2	The CoC Selling Shareholder shall, 45 (forty five) Business Days prior to agreeing to consummate the transaction
with the CoC Purchaser, provide a written notice (“CoC Sale Notice”) to GPC and the Other CoC Exiting Investor. The
CoC Sale Notice shall contain (i) the name and other details of the CoC Purchaser; (ii) the price and the terms of payment (including
the aggregate cash commitment of the CoC Purchaser); (iii) the number of the Shares owned by the CoC Selling Shareholder and the number
of Shares intended to the transferred to the CoC Purchaser; (iv) the manner of payment and date of consummation of transaction; (v) a
confirmation that (A) the CoC Purchaser has been made aware of the CoC Tag Right of GPC and the Other CoC Exiting Investors; and (B) no
consideration, tangible or intangible, is being provided to the Transferor Shareholder which will not be reflected in the above stated
consideration (including a refund or a discount); and (vi) any other terms and conditions.

 

		15.5.3	The CoC Purchaser shall have an obligation to purchase from GPC, such number of Shares as may be decided
by GPC, to be sold pursuant to Clause 15.5 (“GPC CoC Shares”) and subject to the completion of such sale of GPC CoC
Shares to the CoC Purchaser, the CoC Purchaser shall also have an obligation to purchase on a pro rata basis such number of Shares (“Other
Investor CoC Shares”) as may be decided to be sold pursuant to Clause 15.5 by the Other CoC Exiting Investors. For the avoidance
of any doubt, it is clarified that the CoC Purchaser will purchase only such number of Other Investor CoC Shares for which sufficient
cash is available from its aggregate cash commitment after discharging the commitment towards purchase of the GPC CoC Shares.

 

		15.5.4	In the event GPC and/or the Other CoC Exiting Investor elect to exercise their respective CoC Tag Right,
it shall send a written notice of acceptance (“CoC Acceptance Notice”) within 30 (thirty) Business Days of receipt
of the CoC Sale Notice (“CoC Acceptance Period”), indicating the number of GPC CoC Shares or Other Investor CoC Shares
that GPC or Other CoC Existing Investor respectively intend to transfer to the CoC Purchaser.

 

		15.5.5	If GPC and/or the Other CoC Exiting Investor send the CoC Acceptance Notice to the CoC Selling Shareholders,
within the CoC Acceptance Period, then the CoC Selling Shareholders shall ensure that the CoC Purchaser purchases all the GPC CoC Shares
and subject to Clause 15.5.3, purchase the Other Investor CoC Shares on the terms and conditions set out in the CoC Sale Notice, simultaneously
with the purchase of the Shares of the CoC Selling Shareholder.

 

		15.5.6	Subject to Clause 15.5.3, if the CoC Purchaser refuses to purchase the GPC CoC Shares and the Other Investor
CoC Shares, the CoC Selling Shareholder shall not sell any of their Shares to such CoC Purchaser unless and until simultaneously with
the purchase of the Shares of the CoC Selling Shareholders, the CoC Purchaser purchases the GPC CoC Shares and the Other Investor CoC
Shares. For the sake of clarity, no Other Investor CoC Shares shall be sold to the CoC Purchaser unless all of the GPC CoC Shares are
purchased by the CoC Purchaser.

 

    61

     

    

 

		15.5.7	If GPC and/ or the Other CoC Exiting Investor do not exercise their respective CoC Tag Right within the
CoC Acceptance Period, the CoC Selling Shareholders shall be free to transfer the CoC Shares, within a period of 20 (twenty) Business
Days after the expiry of CoC Acceptance Period, to the CoC Purchaser on the same terms and conditions as specified in the CoC Notice,
failing which the procedure set out in Clause 15.5 shall be repeated. The exercise or election to not exercise its CoC Tag Right under
Clause 15.5 shall not adversely affect GPC’s or Other CoC Exiting Investor’s right with respect to any transfers of the same
or other CoC Shares.

 

		15.5.8	Neither GPC nor the Other CoC Exiting Investor shall be required to make any representation, provide any
covenants or undertakings, grant any indemnifications or incur any obligations to the CoC Purchaser or any other Person in respect to
the business and operations of the Company. The CoC Selling Shareholders shall ensure that all of the terms of the proposed transfer,
offered by the CoC Purchaser, are also offered to GPC and the Other CoC Exiting Investor, for the same consideration and upon the same
terms and conditions as applicable to the CoC Shares.

 

The provisions of Clause 15.4.8 to
Clause 15.4.10 shall apply mutatis mutandis to Clause 15.5 wherein the terms: (i) “Intending Purchaser” shall be substituted
by “CoC Purchaser”; (ii) “Transferor Shareholder” shall be replaced by “CoC Selling Shareholder”;
(iii) “ROFR Sale Shares” shall be replaced with “CoC Shares”; (iv) “Tag Shares” shall be replaced
by “GPC CoC Shares” and/or “Other Investor CoC Shares” as the case may be; and (v) “Tag Accepting Investor”
shall be replaced with “GPC” and/or “Other CoC Exiting Investor”, as the case may be.

 

		15.6	The Company shall not register any transfer of Shares in violation of the provisions of this Agreement,
and shall not recognise as a Shareholder or owner of Shares or accord any rights (whether relating to payment of dividend or voting) to
the purported transferee of any Shares in violation of the provisions of this Agreement. Any transfer of Shares in violation of the provisions
of this Agreement shall be void, shall not be binding on the Company and the Company shall not permit any such transfer on its books.

 

		15.7	Notwithstanding anything contained herein, any sale to an Intending Purchaser pursuant to Clauses 15.4
and 15.5 shall constitute a Liquidation Event and the aggregate proceeds shall at all times be distributed as per the distribution waterfall
set out in Clause 13.

 

		16	TRANSFER OF SHARES BY THE INVESTOR

 

		16.1	Subject to Clause 12.4.6 (Founder’s Right of First Offer) and Clause 16.2 (in relation to
any transfer of Series U Preference Shares, or any corresponding Ordinary Shares upon conversion of any Series U Preference Shares), the
Shares held by the Investors shall at all times be freely transferable (including creation of any Encumbrance/pledge/lien thereon) along
with the rights attached to such Shares under the Transaction Documents, at all times to any Person (including Affiliates) without the
prior consent of any Person, including the Company or the Founders.

 

    62

     

    

 

		16.2	If any holder of any Series U Preference Shares (or any corresponding Ordinary Shares upon conversion
of any of its Series U Preference Shares) proposes to transfer such Shares to any person, such transfer shall at all times be subject
to:

 

		(a)	Clause 12.4.6 (Founder’s Right of First Offer);

 

		(b)	the transferee executing a Deed of Adherence (if it is not already a Party to this Agreement) prior to
effecting the transfer, pursuant to which such person agrees to be bound by this Agreement as an Investor holding Series U Preference
Shares (or any corresponding Ordinary Shares which have been converted from Series U Preference Shares); and

 

		(c)	if the transferee is deemed by the Board to be a competitor of the Company, and provided the Board approves
such transfer in writing, the transferee shall hold the Shares subject to a non-disclosure agreement with the Company, and with such limitations
on; (i) information rights under Clause 17; (ii) board observation rights under Clause 3.1.7; and (iii) inspection rights under Clause
18 as the Company deems necessary at its sole discretion to protect the interests of the Company, its Affiliates and its Investors and,
during the pendency of such competition, such person shall be deemed to have waived (A) the board observation rights under Clause 3.1.7,
(B) the information rights under Clause 17 and (C) the inspection rights under Clause 18.

 

Any transfer of Shares in contravention
of this Clause 16.2 shall be void and shall not be binding on the Company and shall be deemed to be a breach of the terms of this Agreement.

 

		16.3	The Company and the Founders undertake to do all reasonable acts and deeds as may be necessary to give
effect to any transfer of Shares held by the Investors. The Founders and the Company agree to cooperate with the Investors and its proposed
transferee in respect of any such transfer of Shares, including with respect to any due diligence that may be conducted by the proposed
transferee and provide all necessary information relating to the Company.

 

		17	INFORMATION RIGHTS

 

		17.1	The Company shall deliver to each of the Investors (including to Telstra Corporation Limited at the sole
discretion of TV), the following information in forms acceptable to the Investors so long as such Investor continues to hold Shares in
the Company:

 

		17.1.1	Unaudited monthly financial statements, including cash flow statements certified by the chief financial
officers, monthly operational reports/management information system reports (MIS) of the Company and the Subsidiaries in a form as agreed
between the senior management of the Company and Series D Investors after 25 (twenty-five) days of the end of each month;

 

		17.1.2	Unaudited quarterly financial statements, including cash flow statements, consolidated statements of income
certified by the chief financial officers of the Company and the Subsidiaries as well as changes in Shareholders’ equity including
for the period between beginning of the current fiscal year to the end of such quarter within 30 (thirty) Business Days of the end of
each quarter;

 

    63

     

    

 

		17.1.3	Audited financial statements, including cash flow statements of the Company and the Subsidiaries within
180 (one hundred and eighty) days of the end of the relevant financial year;

 

		17.1.4	Subject to Applicable Law, minutes of the Board and Shareholders’ meetings of the Company and the
Subsidiaries, within 15 (fifteen) days of the concerned meeting;

 

		17.1.5	The draft budget for each Financial Year including operating and capital budgets (in the form that is
eventually tendered to the Board) and within 30 (thirty) Business Days prior to commencement of each Financial Year;

 

		17.1.6	Annual operating financial budget and annual business plan as approved by the relevant board within 7
(seven) days of the relevant Board Meeting approving the same;

 

		17.1.7	Notification of any key management changes or changes/cancellation of material contracts and any such
event which are likely to have a material impact on the business of the Company or the Subsidiaries, within 15 (fifteen) days of such
change;

 

		17.1.8	Notification of any material litigation and any such event which is expected to result in a material litigation;

 

		17.1.9	The details of ARR of the Company for every quarter in a format as agreed with the Series D Investors
within 7 (seven) Business Days after the end of each quarter;

 

		17.1.10	Quarterly business review report in a form as agreed between the senior management of the Company and
the Series D Investors;

 

		17.1.11	Notification about any change in senior managerial position or terms of contracts with senior managerial
personnel (and reasons therefor) within 15 (fifteen) days of occurrence of such change, where the term senior managerial personnel shall
mean any employee of the Company or its Subsidiaries who holds the position of a CXO or is paid a base or fixed salary of more than USD
350,000 (United States Dollars Three Hundred Fifty Thousand) per annum;

 

		17.1.12	Notification(s) of any such events which are likely to have a material impact on the business of the Company
and its Subsidiaries, immediately when the Founder and/ or senior managerial personnel acquires knowledge of it; and

 

		17.1.13	Such additional information about financial or regulatory affairs as may be requested by the Investors.

 

		17.2	The Company shall deliver to Cisco the financial statements in the form required by Cisco and as set out
in Annexure C.

 

    64

     

    

 

		17.3	The Company shall provide and deliver to Sequoia the following:

 

		(a)	quarterly/half-yearly submission of financial and business information on Sequoia’s designated portal
at scheduled intervals as per the timelines shared by Sequoia;

 

		(b)	any other relevant information that may be reasonably required by Sequoia including business plans, capital
expenditure budgets and management reporting information, within 10 (ten) days of such request.

 

		17.4	It is clarified that the information provided to any specific Investors pursuant to this Clause 17, shall
not differ in substance. In the event the Company provides any additional information (whether qualitatively or quantitatively) to any
specific Investor, then the Company shall concurrently deliver the same quality and type of information to all other Investors under this
Clause 17.

 

		18	RIGHT OF INSPECTION

 

		18.1	So long as an Investor continues to hold any Shares in the Company, it shall, at all times, by giving
a notice in writing of at least 3 (three) Business Days, be entitled to carry out inspection of site, stores, accounts, documents, records,
premises, and equipment and all other property of the Company or its Subsidiaries during normal working hours through its authorised representatives
and agents and the Company and its Subsidiaries shall use reasonable efforts to provide such information, data, documents, evidence as
may be required for the purpose of and in the course of such inspection in connection therewith. The Investor shall be entitled, at its
own cost and expense, to consult independently with the statutory auditors of the Company and its Subsidiaries regarding the financial
affairs of the Company and the Subsidiaries. It shall be the responsibility of the Founders to ensure that the obligations under this
Clause 18 are given full effect.

 

		19	REPRESENTATION AND WARRANTIES

 

		19.1	Each Party represents and warrants to the other Parties hereto that:

 

		19.1.1	It has the full power and authority to enter into, execute and deliver this Agreement and to perform its
obligations and the transactions contemplated hereby and, if such Party is not a natural Person, (i) such Party is duly incorporated or
organised with limited liability; (ii) is validly existing under the laws of the jurisdiction of its incorporation or organisation; and
(iii) has full corporate power and authority to enter into and perform its obligations under this Agreement.

 

		19.1.2	The execution and delivery by such Party of this Agreement and the performance by such Party of its obligations
and the transactions contemplated hereunder have been duly authorised by all necessary corporate or other action of such Party and therefore
constitutes a legal, valid and binding obligation of each Party, enforceable against them in accordance with this Agreement.

 

		20	FINANCIAL ACCOUNTING AND AUDITS

 

		20.1	The Company and the Subsidiaries shall maintain true and accurate financial and accounting records of
all operations in accordance with all relevant statutory and accounting standards and the policies provided under the Applicable Law from
time to time adopted by the Board. The financial statements and accounts of the Company and the Subsidiaries shall be prepared in English
and shall be audited on an annual basis.

 

    65

     

    

 

		21	OTHER COVENANTS

 

		21.1	Notwithstanding anything contained in this Agreement, none of the rights available to an Investor shall
cease to exist if such Investor's shareholding falls below the Threshold Shareholding as a result of a partial sale by such Investor due
to a Trigger Event.

 

		21.2	Unless stated otherwise, any and all rights available to the Investors in the Company under this Agreement
or the Subscription Agreements shall be mutatis mutandis also be available to the Investors in the Subsidiaries. To clarify, at
the option of such Investor all rights under Clauses 3, 9, 10, 11 and 12 may be exercised at the Subsidiaries level and the Founders,
the Company and Subsidiaries shall take all actions necessary to enable the exercise of such rights as required by the Investors.

 

		21.3	The Founders and the Company undertake to provide all reasonable support to the Investors in the event
the Investors seek to provide the Shares held by them as underlying security for any issuance of derivative instruments by the Company
to be listed on a Recognised Stock Exchange, provided that an exit of any or all of the Investors through listing of such derivative instruments
shall not in any manner prejudice the right of the Founders to list the securities held by them in the Company. Upon the exercise of such
right to list derivative instruments, the Investor who has exercised such right shall cease to have the following rights if such Investor
ceases to own a majority of the derivative instruments so issued:

 

		(a)	Reserved Matters; and

 

		(b)	Exit Rights.

 

		21.4	Notwithstanding any of the rights available to the Investors under this Agreement, in the event any new
investors proposes to subscribe to any Shares in the Company, then the rights to be provided to such new investors shall be mutually discussed
and agreed to by the Founders and the Investors.

 

		21.5	The Founders and the Company hereby undertake to ensure that all terms and conditions of Applicable Law
regulating foreign investment and exchange control, as prevalent from time to time, are complied with.

 

		21.6	Insurance 

 

		21.3.1	The Company and the Subsidiaries shall maintain comprehensive liability, fire, earthquake, extended coverage
and other appropriate insurance coverage with respect to the Business in a form and amount acceptable to each Series B Investor and Series
D Investor.

 

		21.3.2	The Company and the Subsidiaries shall maintain adequate directors’ and officers’ liability
insurance for all the members of its Board (including each of the Investor Directors), in a form and amount acceptable to each Investor
Director and nominating Investor.

 

		21.7	The Company shall and the Founders shall cause the Company and the Subsidiaries to comply with Applicable
Law in the conduct of its business and affairs and shall conduct itself and operate in accordance with good industry practices, the terms
of Applicable Law, and any approvals received in terms thereof.

 

    66

     

    

 

		21.8	The Company and the Founders undertake that the Investors and their respective Affiliates shall not be
named or deemed as ‘promoters’ or ‘sponsors’ of the Company and/or the Subsidiaries nor shall any declaration
or statement be made to this effect, either directly or indirectly, in filings with regulatory or Governmental Agency, offer documents
or otherwise without the prior written consent of each Investor in writing. The Company and the Founders further undertake that the Investors,
their officials, employees, nominee Directors, managers, representatives or agents shall not be named or deemed as an ‘occupier’
or ‘officer in charge’ under any Applicable Law. In the event any Governmental Agency takes a view or draws an inference that
any of the Investors or its respective Affiliates or its officials, employees, nominee directors, managers, representatives or agents,
is a ‘sponsor’, ‘occupier’ or ‘officer in charge’, then the Company and/or the Founders shall co-operate
with the Investors to make such representations and make full disclosures to the Investors or such body or authority as may be required
by the Investors to dispel or correct such inference or view under the Applicable Law.

 

		21.9	The Company and its officers, Directors, employees and agents shall, and the Founders shall cause the
Company to engage only in legitimate business and ethical practices in commercial operations and in relation to Governmental Agencies.
None of the Company or any of its officers, Directors, employees or agents shall otherwise pay, offer, promise or authorise the payment,
directly or indirectly, of any monies or anything of value to any government official or employee or any political party for the purpose
of influencing any act or decision of such official or of any Governmental Agency to obtain or retain business, or direct business to
any Person.

 

		21.10	The Company shall act in good faith and take all steps and make all filings with the relevant Governmental
Agency, as are necessary, from time to time, to maintain all Authorisations that it requires for the conduct of its business and operations.

 

		21.11	The Parties hereby acknowledge and agree that the Company is and shall be maintained as a ‘private
limited company’ and any conversion or action that would result in conversion of the Company to a public limited company (except
QIPO in accordance with the terms of this Agreement) shall be subject to the consent requirements in accordance with this Agreement and
the Applicable Law.

 

		21.12	The Company, the Subsidiaries and the Founders shall act in good faith and shall pay all the taxes (direct
and indirect), duties, cess, fees or any other amount payable (whether by way of tax or otherwise) as determined by the Government Agency
or any regulatory authority in Singapore (and other relevant Jurisdictions), under the Applicable Law of Singapore (and other relevant
Jurisdictions), provided that the Company, and the Subsidiaries may not pay taxes, duties, cess, fees and any other amount which they
reasonably believe they are not liable to pay under Applicable Law and which liability as determined by the Government Agency or any regulatory
authority is being disputed by them in a legal proceeding. Further, the Company, the Subsidiaries and the Founders shall take all steps
to make the necessary tax filings under the Applicable Law (including but not limited to the return of income for the relevant financial
years, withholding tax returns, etc.).

 

		21.13	The Annual Budget and Business Plan for each Financial Year shall be discussed and approved by the Board,
which approval will require an affirmative vote by the Investors, no later than 20 (twenty) Business Days before the beginning of such
Financial Year. Upon the execution of this Agreement, the Founders, the Company and Subsidiaries shall take all steps necessary, including
the exercise of their rights at General Meetings and causing the Founder Directors to exercise their rights at meetings of the Board,
to ensure that the Company and the Subsidiaries operate the Business in accordance with the terms of the Annual Budget and the Business
Plan agreed from time to time.

 

    67

     

    

 

		21.14	United States Tax Covenants

 

		21.14.1	To the extent the Company is not a CFC as defined in Section 957 of the Code as of the date of this Agreement,
the Company shall not, without the prior written consent of each Investors, issue or allot any equity interest in the Company to any Person
if following such transaction the Company, in the reasonable opinion of the Investors, would be a CFC.

 

		21.14.2	Not later than 2 (two) months following the end of the Company's taxable year, the Company shall provide
the following information to the Investors: (i) the Company's capitalization table as of the end of such taxable year, and (ii) a complete
and accurate report, prepared by U.S. counsel acceptable to CMDB, regarding the Company's status as a CFC. In addition, the Company shall
provide the Investors with access to other Company information as may be required to determine the Company's status as a CFC, to verify
whether the Company was a CFC for each fiscal year and to determine whether any Investor or any of its Partners is required to include
any amount of the Company's undistributed earnings in its gross income for U.S. federal income tax purposes, and to allow each Investor
and its Partners to otherwise comply with applicable U.S. federal income tax laws.

 

		21.14.3	The Company shall make due inquiry with its U.S. tax advisors at least annually regarding the Company's
status as a CFC and whether any Investor is required to include any gross income on its U.S. federal income tax return due the Company's
status as a CFC. If the Company is, in the reasonable opinion of the Company's tax advisors or the reasonable opinion of the Investors,
a CFC, the Company shall: (a) use reasonable efforts to avoid generating any income of a character that would be includible in the gross
income of any Investor or any of its respective Partners under Section 951 of the Code and (b) to the extent permitted by law, pay to
each Investor (whether by way of distribution or otherwise) and its respective Partners, as applicable, an amount equal to 50% (fifty
percent) of the undistributed earnings of the Company that are included in the gross income of such Investor and any of its respective
Partners pursuant to Section 951 of the Code. Payment under this provision shall be made to each Investor and any of its respective Partners,
as applicable, not later than 60 (sixty) days following the end of such Investor’s taxable years.

 

		21.14.4	The Company shall use commercially reasonable efforts to avoid being PFIC. The Company shall make due
inquiry with its U.S. tax advisors at least annually regarding the Company's status as a PFIC and if the Company becomes a PFIC, or if
there is a likelihood of the Company being a PFIC for any taxable year, the Company shall promptly notify the Investors of such status
or risk, as the case may be. The Company shall, as soon as reasonably practicable following the end of each taxable year of the Company
(but in no event later than 60 (sixty) days following the end of each taxable year) provide the Investors and its respective Partners,
as applicable, with an accurate and complete PFIC annual information statement in the form as per the Applicable Law (“PFIC Annual
Information Statement”).

 

    68

     

    

 

		21.14.5	If the Investors or any of its respective partners makes a QEF Election pursuant to Section 1295 of the
Code with respect to its investment in the Company and the Investors or such Partner is required to include an amount in gross income
for a particular taxable year pursuant to Section 1293 of the Code, the Company shall, to the extent permitted by law, pay such Investor
and its Partners (whether by way of a distribution or otherwise) 50% (fifty percent) of the amount that the Investor and its Partners
is required to include in their respective gross income as set forth in a properly completed PFIC Annual Information Statement for such
year. Payment under this Clause shall be made to each Investor and its Partners, as applicable not later than 60 (sixty) days following
the end of the taxable year of such Investor or its Partner in which such amount is required to be included in the gross income of such
Investor, as the case may be.

 

		21.14.6	The Company shall make or refrain from making (and shall cause its Subsidiaries to make or refrain from
making) any U.S. tax election that the Investors request the Company or its Subsidiaries to make or refrain from making.

 

		21.14.7	If the tax advisors of the Investors or its respective Partners determine that they are subject to U.S.
information and reporting requirements that require the disclosure of information about the Company, the Subsidiaries or Company's or
any Subsidiary’s transactions not readily available to the Investor or its Partners, the Company agrees to provide such information
to such Investor and its Partners as may be necessary to allow the Investor and its Partners to fulfil their U.S. tax reporting obligations.

 

		21.14.8	To the extent any consent, affirmative vote, or other action is required by the Company, its officers
or Directors, or any of the Shareholders to implement the provisions of this Clause 21, such consent, vote or other action is hereby given
or will be given at the applicable time and the Company, its officers and directors, and each Shareholder shall fully cooperate in carrying
out the provisions of this Clause 21 as required after the First Completion Date.

 

		21.14.9	The term "Partner" means each Affiliate, shareholder, partner, member or other equity holder
of the Investors, if applicable, and any person holding an option to acquire a share, partnership interest, membership interest or other
equity interest in the Investors and any direct or indirect equity owner of such shareholder, partner, member, other equity holder or
option holder.

 

		21.14.10	Without prejudice to the requirements under Clause 3.3, the Company, the Subsidiaries and the Founders
hereby undertake that any transactions with Related Parties shall be conducted at commercially justifiable terms and at an arm’s
length basis.

 

		21.14.11	The Company and the Subsidiaries shall not enter into any banking or non-banking transaction with Green
Dot Corporation or any of its subsidiaries or Affiliates including Next Estate Communications and Bonneville Bancorp, without the prior
written consent of Sequoia.

 

		21.15	The Company and the Subsidiaries covenant and undertake that it shall not and shall not permit any of
its Affiliates or any of its or their respective directors, officers, managers, employees, independent contractors, representatives or
agents to promise, authorise or make any payment to, or otherwise contribute any item of value to, directly or indirectly, to any third
party, including any Non-U.S. Official (as defined in the FCPA) in each case, in violation of the Prevention of Corruption Act (Cap. 241)
of Singapore, the FCPA, U.K. Bribery Act, 2010, PCA or any other applicable anti-bribery or anti- corruption laws. The Company and the
Subsidiaries further covenant and undertake that it shall and shall cause each of its Affiliates to cease all of its or their respective
activities, as well as remediate any actions taken by the Company, the Subsidiaries or Affiliates, or any of their respective directors,
officers, managers, employees, independent contractors, representative or agents in violation of the FCPA or PCA or U.K. Bribery Act,
2010 or any other applicable anti-bribery or anti-corruption laws. The Company and the Subsidiaries further covenant and undertake that
it shall and shall cause each of its Affiliates to maintain systems of internal controls (including, but not limited to, accounting systems,
purchasing systems and billing systems) to ensure compliance with the FCPA or PCA or the U.K. Bribery Act, 2010 or any other applicable
anti-bribery or anti- corruption laws.

 

    69

     

    

 

		22	ESG COVENANTS

 

 The Company shall and the Founders shall cause the Company and its Subsidiaries to:

 

		22.1.1	comply with the ESG Reporting Requirements at all times, in a form and manner acceptable to GPC. In the
event GPC reasonably determines that the Company and/or Founders are materially non-compliant with any of the ESG Requirements, the Company
and the Founders shall work with GPC on a good faith basis to develop and agree upon a corrective action plan setting forth specific remediation
measures to address such non-compliance. The Company and the Founders further covenant that they shall work with GPC on a good faith basis
to implement such plan within a mutually agreed upon timeframe;

 

		22.1.2	make best efforts to adopt and implement (a) the ESG Management System including deploying employees with
sufficient expertise and seniority as is necessary for the purpose; (b) policies and procedures in accordance with ESG best practices
including compliance with IFC Performance Standards and ILO Conventions; and (c) anti-corruption, anti-bribery and anti-money laundering
policies including a code of ethics and a whistle-blowers’ policy; and

 

		22.1.3	ensure that their respective officers, employees, Directors and agents undergo annual training sessions
on (a) managing ESG risks and ESG Requirements; and (b) applicable anti-corruption, anti-bribery and anti-corruption laws, in a form and
manner acceptable to GPC.

 

	23	TERMINATION AFTER CLOSING
	 	 

 

		23.1	This Agreement may, subject always to Clause 23.5 hereunder, be terminated in the manner and to the extent
stated below:

 

		23.1.3	with respect to any Party upon such Party and their Affiliates ceasing to hold any Shares (in the manner
permitted hereunder), automatically and without requiring any notice;

 

		23.1.4	pursuant to Clause 24.2.

 

    70

     

    

 

		23.2	Without prejudice to the foregoing, this Agreement may be terminated at any time by the mutual written
agreement of the Parties.

 

		23.3	Terminations under Clause 23.1 shall only be effective against and vis-à-vis the Investor
so terminating or the Investor who ceases to hold any Shares. It is clarified that the Agreement will continue in full force and effect
in respect of the other Parties.

 

		23.4	The rights and obligations of the Parties under this Agreement, which either expressly or by their nature
survive the termination of this Agreement, shall not be extinguished by termination of this Agreement, regardless of the means of termination.

 

		23.5	Notwithstanding anything contained in Clause 23.1 herein above, each of the Investors shall be entitled
to all the rights and remedies which are available to such Investors under Applicable Law, equity or otherwise including such other rights
and remedies as may be mutually agreed between the Parties in this Agreement. The rights specified in this Clause 23.5 shall be in addition
to and not in substitution for any other remedies, including a claim for damages that may be available to the Investor.

 

		23.6	The rights and obligations of the Parties under this Agreement, which either expressly (as are mentioned
under Clause 31.16 (Survival)) or by their nature survive the termination of this Agreement, shall not be extinguished by termination
of this Agreement, regardless of the means of termination, including the obligations of the Founders under Clause 8 (Non-Compete Undertaking).
Without prejudice to the generality of the foregoing, any existing liabilities of a Party or rights accrued in favour of a Party under
any of Clauses 19 (Representations & Warranties), 23 (Termination after Closing) and 24 (Trigger Event) shall
continue to survive post the expiry or termination of this Agreement. Any provision and obligation of the Parties relating to or governing
their acts, which expressly or by its nature survives termination or expiration of this Agreement, shall be enforceable with full force
and effect notwithstanding such termination or expiration, until it is satisfied in full or unless its nature expires.

 

		23.7	Notwithstanding anything contained hereinabove:

 

		23.7.1	If pursuant to an IPO or a QIPO, any of the Series B Investors sell some or all of their Shares held by
such Series B Investor to a Third Party purchaser(s), such Third Party purchaser(s) shall not be entitled to affirmative rights under
any provisions of this Agreement including affirmative rights on Reserved Matters. Further, from the date when any of the Series B Investors
cease to individually hold more than 5% (five percent) of the shareholding of the Company, such Series B Investor shall cease to have
any affirmative rights on Reserved Matters.

 

		23.7.2	Subsequent to an IPO or a QIPO, all transfer restrictions imposed on the Founders under Clause 15 shall
cease to apply.

 

		23.7.3	Subsequent to an IPO or a QIPO, the information rights shall be governed by and subject to applicable
regulations relating to entities whose Shares are listed.

 

    71

     

    

 

		24	TRIGGER EVENT

 

		24.1	In the event of a Trigger Event, the Existing Investors shall intimate the Company or the Founders in
writing by issuing a notice of such default (the “Default Notice”).

 

		24.2	Upon occurrence of a Trigger Event as detailed in the Default Notice, which has remained uncured for 30
(thirty) Business Days from the date of receipt of Default Notice, (i) the Investors may at their sole discretion, notwithstanding the
other rights of Investor hereto, terminate the Transaction Documents to which they are a party (other than the rights granted to the holders
of Series U Preference Shares under this Agreement); and (ii) the Exit Default Triggering Investor or the Other Exit Default Triggering
Investors may trigger all Exit Default Rights under Clause 12. The trigger of such Exit Default Rights shall require the consent of Investors
representing not less than 75% (seventy five percent) of their inter-se shareholding, voting on an As If Converted Basis. Upon
the valid trigger of such Exit Default Rights, the Series U Holder shall have the rights provided in Clause 12.4.8 above.

 

		24.3	Notwithstanding anything contained in Clause 24.2 herein above, the Investors shall be entitled to all
the rights and remedies which are available to the Investors under Applicable Law, equity or otherwise including such other rights and
remedies as may be mutually agreed between the Parties in the Transaction Documents. The rights specified in this Clause 24 shall be in
addition to and not in substitution for any other remedies, including a claim for damages that may be available to the Investors.

 

		25	SPECIFIC PERFORMANCE 

 

		25.1	All Parties shall be entitled to an injunction, a restraining order, a right for recovery, a suit for
specific performance or such other equitable relief as a court of competent jurisdiction may deem necessary or appropriate, to restrain
the other Parties from committing any violation of Applicable Law or the Transaction Documents or to enforce the performance of the covenants,
representations and obligations contained in this Agreement.

 

		25.2	These injunctive remedies are cumulative and are in addition to any other rights and remedies that the
Investors may have at Applicable Law or in equity, including without limitation, a right for damages.

 

		26	NOTICE

 

		26.1	Except as may be otherwise provided herein, all notices, requests, waivers and other communications made
pursuant to the Transaction Documents shall be in writing and signed by or on behalf of the Party giving it. Such notice shall be served
by sending it by facsimile to the number set forth in Schedule 3 or by delivering it by hand, mail or courier to the address set forth
therein. In each case it shall be marked for the attention of the relevant Party set forth in Schedule 3.

 

		26.2	Any notice so served shall be deemed to have been duly given (i) in case of delivery by hand, when hand
delivered to the other Party; or (ii) when sent by facsimile, upon transmission; or (iii) when sent by mail with acknowledgment due, where
7 (seven) Business Days have elapsed after deposit in the mail with certified mail receipt requested postage prepaid; or (iv) when delivered
by courier on the 2nd (second) Business Day after deposit with an overnight delivery service, postage prepaid, with next Business Day
delivery guaranteed, provided that the sending Party receives a confirmation of delivery from the delivery service provider; or (v) for
electronic mail notification with return receipt requested, upon the obtaining of a valid return receipt from the recipient.

 

    72

     

    

 

		26.3	Each Person making a communication hereunder by facsimile shall promptly confirm by telephone, regular
mail or electronic mail to the Person to whom such communication by facsimile was addressed, each communication made by it by facsimile
pursuant hereto but the absence of such confirmation by telephone, regular mail or electronic mail shall not affect the validity of any
such facsimile communication.

 

		27	CONFIDENTIALITY

 

		27.1	Each Party shall keep all information relating to each other Party, including information relating to
the transactions herein and this Agreement (collectively referred to as the “Information”) confidential.

 

		27.2	None of the Parties shall issue any public release or public announcement or otherwise make any disclosure
concerning this Agreement, the Transaction Documents and/or the transactions herein, without the prior approval of the other Parties;
provided however, that nothing in this Agreement shall restrict any of the Parties from disclosing any information as may be required
under Applicable Law subject to providing a prior written notice of 10 (ten) Business Days to the other Parties.

 

		27.3	Subject to Applicable Law, such prior notice shall also include (i) details of the Information intended
to be disclosed along with the text of the disclosure language, if applicable; and (ii) the disclosing Party shall also cooperate with
the other Parties to the extent that such other Parties may seek to limit such disclosure, including taking all reasonable steps to resist
or avoid the applicable requirement, at the request of the other Parties.

 

		27.4	Nothing in this Clause 27 shall restrict any Party from disclosing
Information for the following purposes:

 

		27.4.1	To the extent that such Information is in the public domain other than by breach of this Agreement;

 

		27.4.2	To the extent that such Information is required to be disclosed by any Applicable Law, stated policies
or standard practice of the Investor or which is required to be disclosed to any Governmental Agency to whose jurisdiction such Party
is subject or with whose instructions it is customary to comply;

 

		27.4.3	To the extent that any Information is later acquired by such Party from a source not obligated to any
other Party hereto or its Affiliates, to keep such Information confidential;

 

		27.4.4	The Investors shall have the right to prepare an information memorandum (without requiring the consent
of the Founders or the Company) and disclose the same to prospective purchasers and advisors in relation to any sale of Shares for the
purpose of selling their Shares to prospective purchasers of the Shares in each case only where such Persons or entities are under appropriate
non-disclosure obligations;

 

		27.4.5	Insofar as such disclosure is reasonably necessary to such Party’s employees, directors or professional
advisers, provided that such Party shall procure that such employees, directors or professional advisors treat such Information as confidential;

 

		27.4.6	To the extent that any of such Information was previously known or already in the lawful possession of
such Party, prior to disclosure by any other Party hereto; and

 

		27.4.7	To the extent that any information, materially similar to the Information has been independently developed
by such Party without reference to any Information furnished by any other Party hereto.

 

    73

     

    

 

		27.5	In addition and notwithstanding the foregoing, the Investors shall always be permitted, whether during
the term of this Agreement or any time after, to disclose confidential Information of the Company and the Subsidiaries to any Person that
is an Affiliate of the Investor; or to whom the Investor is selling any of its Shares, subject to procuring similar confidentiality undertakings
from the Person(s) to which such confidential Information is disclosed, as required, for such confidential Information.

 

		27.6	Any public release or public announcement (including any press release, conference, advertisement, announcement,
professional or trade publication, mass marketing materials or otherwise to the general public) containing references to the Investors,
as may be the case, or their investment made by the Investors in the Company, shall require the prior written consent of each of the Investors
and the Founders, as may be the case. Any request for such prior written consent shall be made at least 2 (two) weeks prior to any public
release or announcement.

 

		28	GOVERNING LAW

 

		28.1	This Agreement shall be governed by and be construed in accordance with the laws of Delaware, without
regard to the principles of conflicts of laws.

 

		29	DISPUTE RESOLUTION

 

		29.1	If any dispute or difference arises between any of the Parties hereto during the subsistence of this Agreement
or thereafter, in connection with the validity, interpretation, implementation or alleged breach of any provision of the Transaction Documents
or regarding any question, including the question as to whether the termination of the Transaction Documents by any Party hereto has been
legitimate, the Parties hereto shall endeavour to settle such dispute amicably. The attempt to bring about an amicable settlement is considered
to have failed as soon as one of the Parties hereto, after reasonable attempts, which attempt shall continue for not less than 30 (thirty)
days, gives a written notice thereof of 30 (thirty) days to the other Party in writing.

 

		29.2	Except for Claims for injunctive relief or any other form of specific performance, all disputes, differences
and claims arising out of or in connection with the Transaction Documents including, any question regarding its existence, validity, construction,
performance, termination or alleged violation which is not resolved under Clause 29.1 herein above shall be referred to and finally resolved
by arbitration in Singapore in accordance with the SIAC Rules for the time being in force, which rules are deemed to be incorporated by
reference in this Clause 29. A Party seeking to commence arbitration under this Clause 29 shall first serve a written notice, specifying
the matter or matters to be so submitted to arbitration, on the other Parties hereto.

 

		29.3	The seat of such arbitration shall be in Singapore and all proceedings shall be conducted in the English
language.

 

		29.4	The Parties that are party to each dispute (“Disputing Parties”) shall jointly appoint
a sole arbitrator mutually acceptable to the Disputing Parties. In the event of failure to agree upon a sole arbitrator within 30 (thirty)
days from the date of notice referred to Clause 29.2 herein above, one arbitrator each shall be appointed by each of the Disputing Parties.
The arbitrators so appointed shall appoint the final arbitrator who shall act as the chairman of the arbitration tribunal, and who shall
have a casting vote in the event of deadlocks or ties. In the event that the arbitral panel is not constituted within 60 (sixty) days
of raising of any disputes, the Disputing Parties shall forthwith approach the Singapore International Arbitration Centre, which shall
appoint 1 (one) arbitrator in accordance with the rules prescribed by the Singapore International Arbitration Centre, who shall be the
sole arbitrator.

 

    74

     

    

 

		29.5	All claims and counterclaims shall, to the extent such claims or counterclaims are known at the time any
arbitration is commenced, shall be consolidated and determined in the same arbitration proceedings.

 

		29.6	Deposits to cover the costs of arbitration shall be shared equally by the Disputing Parties. The award
rendered by the arbitrator or arbitrators shall, in addition to dealing with the merits of the case, fix the costs of the arbitration
and decide which of the Parties shall bear such costs or in what proportions such costs shall be borne by the Parties hereto.

 

		29.7	The award rendered by the arbitrator or arbitrators shall be final, conclusive and binding on all Parties
to this Agreement, whether or not such Parties have taken part in the arbitration, and shall be subject to a forced execution in any court
of competent jurisdiction.

 

		29.8	Each Party shall co-operate in good faith to expedite, to the maximum extent practicable, the conduct
of any arbitral proceedings commenced under this Agreement.

 

		29.9	Nothing shall preclude any Party from seeking interim or permanent equitable or injunctive relief, or
both, from the competent courts, having jurisdiction to grant relief on any disputes or differences arising from this Agreement. The pursuit
of equitable or injunctive relief shall not be a waiver of the duty of the Parties to pursue any remedy (including for monetary damages)
through arbitration as described in this Clause 29.

 

		30	SHARE EXCHANGE

 

		30.1	Simultaneous with the the Proposed Distribution, each Party to this Agreement holding ordinary shares
in the share capital of Near Sing and/or any preference shares in the share capital of Near Sing, issued by Near Sing on the terms and
conditions set forth in the Constitution of Near Sing (the Existing Near Sing Shares” and the holders of such shares, “Existing
Near Sing Shareholders”) shall be deemed to exchange each Near Sing ordinary share and each Near Sing preference share for a
number of shares of Company Common Stock and Company Preferred Stock as set forth on Part A of Schedule 1 (the “Share Exchange”
and the shares being delivered to the Shareholders in connection with the Share Exchange are referred to herein as the “Company
Shares”). Each Party agrees that the Share Exchange shall be deemed to have occurred simultaneously without any further action
or notice by any Party in connection with the Proposed Distribution and without the payment of any other consideration by any Party hereto.
The share capitalization and the shareholdings of each holder of shares of Ordinary Shares and Preference Shares shall be as set forth
on Part B of Schedule 1.

 

    75

     

    

 

		30.2	Each Existing Near Sing Shareholder severally, and not jointly, hereby represents and warrants to
the Company and Near Sing, all of which representations and warranties are true, complete, and correct in all respects as of the Execution
Date and the Effective Date, as follows:

 

		30.2.1	Such Existing Near Sing Shareholder has the right, power, legal capacity and authority to enter into and
perform such Existing Near Sing Shareholder’s obligations under this Agreement; and no approvals or consents are necessary in connection
with it. All of the Existing Near Sing Shares owned by such Existing Near Sing Shareholder are owned free and clear of all liens, pledges,
encumbrances, changes, restrictions or known claims of any kind, nature or description.

 

		30.2.2	The Existing Near Sing Shares owned by such Existing Near Sing Shareholder will be cancelled pursuant
to Proposed Distribution and at the time of the Proposed Distribution such Existing Near Sing Shares shall be free and clear of any encumbrances
and from all taxes, liens and charges with respect to the transfer thereof and such Existing Near Sing Shares shall be fully paid and
non-assessable with the holder being entitled to all rights accorded to a holder of such shares of the capital stock of Near Sing.

 

		30.2.3	Each such Existing Near Sing Shareholder understands that the Company Shares received by the Shareholder
in the Share Exchange have not been registered under the Securities Act of 1933, as amended (the “Securities Act”)
or any other applicable securities laws. Each such Existing Near Sing Shareholder also understands that the Company Shares are being offered
and issued pursuant to an exemption from the registration requirements of the Securities Act and other applicable securities laws. Each
such Existing Near Sing Shareholder acknowledges that Near Sing and the Company will rely on such Existing Near Sing Shareholder’s
representations, warranties and certifications set forth herein for purposes of determining such Existing Near Sing Shareholder’s
suitability as an investor in the Company and for purposes of confirming the availability of the available exemptions from the Securities
Act and other applicable securities laws.

 

		30.2.4	Each such Existing Near Sing Shareholder represents that such Existing Near Sing Shareholder is an “accredited
investor” within the meaning of Rule 501(a) of the Securities Act.

 

		30.2.5	Each such Existing Near Sing Shareholder understands that the Company Shares may not be offered, sold
or otherwise transferred except in compliance with the registration requirements of the Securities Act and any other applicable securities
laws or pursuant to an exemption therefrom, and in each case in compliance with the conditions set forth in this Agreement. Each such
Existing Near Sing Shareholder acknowledges and is aware that the Company Shares may not be sold pursuant to Rule 144 adopted under the
Securities Act unless certain conditions are met and until such Shareholder has held the Company Shares for the applicable holding period
under Rule 144.

 

		30.2.6	If such Existing Near Sing Shareholder is not a United States person (as defined by Section 7701(a)(30)
of the Code, such Existing Near Sing Shareholder hereby represents that such Existing Near Sing Shareholder has satisfied itself as to
the full observance of the laws of its jurisdiction in connection with any invitation to purchase the Company Shares or any use of this
Agreement, including (i) the legal requirements within its jurisdiction for the purchase of the Company Shares, (ii) any foreign exchange
restrictions applicable to such purchase, (iii) any government or other consents that may need to be obtained in connection with such
purchase, and (iv) the income tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale
or transfer of the Company Shares.  The Share Exchange and such Existing Near Sing Shareholder’s continued beneficial ownership
of the Company Shares will not violate any applicable securities or other laws of Shareholder’s jurisdiction.

 

    76

     

    

 

		30.2.7	Such Existing Near Sing Shareholder represents that such Existing Near Sing Shareholder is not subject
to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act.

 

		30.3	Each Existing Near Sing Shareholder agrees that, in order to ensure compliance with the restrictions referred
to this Clause 30, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any.

 

		30.4	Each Existing Near Sing Shareholder has reviewed with such Existing Near Sing Shareholder’s own
tax advisors the federal, state, local and foreign tax consequences of the Contribution, the Share Exchange and the transactions contemplated
by this Agreement. Each Existing Near Sing Shareholder is relying solely on such advisors and not on any statements or representations
of the Company or any of its agents. Each Existing Near Sing Shareholder understands that such Existing Near Sing Shareholder (and not
the Company or Near Sing) shall be responsible for such Existing Near Sing Shareholder’s own tax liability that may arise as a result
of the Contribution, the Share Exchange or the transactions contemplated by this Agreement.

 

		30.5	Each Existing Near Sing Shareholder agrees to return such Existing Near Sing Shareholder’s share
certificates for the Existing Near Sing shares, and perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged,
and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Company or Near Sing to
effect cancellation of the Existing Near Sing shares pursuant to the Proposed Distribution or comply with any reporting or other legal
obligations

 

		30.6	Proceeds from the Winding-up/Liquidation of Dormant Subsidiaries will be used to cover the liquidation
expenses of the entities. Any amount received from the Winding-up/Liquidation of Dormant Subsidiaries above USD 100,000 may only be distributed
to those persons or entities who were shareholders of Near Sing immediately prior to completion of the Proposed Distribution.

 

		30.7	The A&R COI, in substantially form attached hereto as Schedule 12, was duly authorized by the board
of directors of the Company and its stockholders in accordance with the Act and the Bylaws of the Company and filed the A&R COI with
the Secretary of State of Delaware prior to the date of the Proposed Distribution. 

 

		31	MISCELLANEOUS

 

		31.1	No Party, acting solely in its capacity as a Shareholder, shall act as an agent of the Company or have
any authority to act for or to bind the Company.

 

		31.2	Each of the rights of the Parties under this Agreement are independent, cumulative and without prejudice
to all other rights available to them, and the exercise or non-exercise of any such rights shall not prejudice or constitute a waiver
of any other right of a Party, whether under this Agreement or otherwise. In particular, all rights of the Investors, except as otherwise
provided, are not joint and may be exercised by either or all of the Investors, respectively. Notwithstanding anything contained in this
Agreement, any changes or modification to the rights or any obligations of the Investors shall be only with the prior approval of such
Investor.

 

    77

     

    

 

		31.3	Nothing contained in this Agreement shall constitute or be deemed to constitute a partnership between
the Parties, and no Party shall hold himself out as an agent for the other Parties.

 

		31.4	This Agreement may be executed in any number of originals or counterparts, each in the like form and all
of which when taken together shall constitute one and the same document, and any Party may execute this Agreement by signing any one or
more of such originals or counterparts.

 

		31.5	No amendment or variation of this Agreement shall be binding on any Party unless such variation is in
writing and duly signed by all the Parties.

 

		31.6	No Assignment 

 

		31.6.1	Subject to the provisions of this Agreement, this Agreement is personal to the Company and the Founders
and shall not be capable of assignment by either the Company or the Founders; and

 

		31.6.2	The Parties hereby agree that notwithstanding anything to the contrary in this Agreement, the Investors
may, at their sole discretion, assign any of their rights under this Agreement to any of their Affiliates. An assignment of rights under
this Agreement to a Third Party shall be only upon transfer of shareholding of the Investor to such Third Party, provided that such Third
Party executes a Deed of Adherence. Upon communication of any such assignment, the Company shall acknowledge such transferee’s rights
in writing.

 

		31.7	The Parties agree that, having regard to all the circumstances, the covenants contained herein are reasonable
and necessary for the protection of the Parties and their Affiliates. If any such covenant is held to be void and as going beyond what
is reasonable in all the circumstances, but would be valid if amended as to scope or duration or both, the covenant shall apply with such
minimum modifications regarding its scope and duration as may be necessary to make it valid and effective.

 

		31.8	No waiver of any breach of any provision of this Agreement shall constitute a waiver of any prior, concurrent
or subsequent breach of the same or any other provisions hereof, and no waiver shall be effective unless made in writing and signed by
an authorised representative of the waiving Party.

 

		31.9	If for any reason whatsoever, any provision of this Agreement is or becomes, or is declared by a court
of competent jurisdiction to be, invalid, illegal or unenforceable, then the Parties shall negotiate in good faith to agree on such provision
to be substituted, which provisions shall, as nearly as practicable, leave the Parties in the same or nearly similar position to that
which prevailed prior to such invalidity, illegality or unenforceability. In the event that any provisions of this Agreement are considered
illegal or becomes, or is declared by a court of competent jurisdiction to be, invalid, illegal or unenforceable, then such provisions
shall be stricken from this Agreement and the remainder of this Agreement shall be enforced as if such invalid, illegal or unenforceable
clause or provisions had (to the extent not enforceable) never been contained in this Agreement. It is hereby clarified that if the illegality
has retrospective effect then such provision will be deemed to be ineffective from its incorporation in the Agreement.

 

    78

     

    

 

		31.10	The Company shall pay all costs, taxes and other incidental fees and expenses and the stamp duty in respect
of execution, delivery and performance of this Agreement and the Shares held or acquired by the Investors and any other securities issued
pursuant to this Agreement including issuance of Shares upon conversion of the Series B Preference Shares and/or Series C Preference Shares
and/or Series D Preference Shares and/or Series U Preference Shares.

 

		31.11	This Agreement, along with the other Transaction Documents, constitutes the whole agreement between the
Parties relating to the subject matter hereof and replaces and supersedes any prior arrangements whether oral or written, relating to
such subject matter including the Existing Shareholders' Agreement. The Parties agree that in the Existing Shareholders Agreement shall
be null and void and have no effect whatsoever with effect from the Closing Date. No Party has relied upon any representation or warranty
in entering this Agreement other than those expressly contained herein.

 

		31.12	Each of the Company and the Founders shall, at any time and from time to time upon the written request
of the Investors promptly and duly execute and deliver all such further instruments and documents, and do or procure to be done all such
acts or things, as the Investors may reasonably deem necessary or desirable in obtaining the full benefits of this Agreement and of the
rights (including enforcement rights) and ownership herein granted.

 

		31.13	The provisions of this Agreement, the other Transaction Documents and the Charter Documents of the Company
(as far as possible) shall be interpreted in such a manner so as to give effect to all such documents, provided however, that in the event
of an inconsistency between this Agreement, the other Transaction Documents on the one hand and the Charter Documents of the Company on
the other hand, to the extent permitted by Applicable Law, provisions of this Agreement shall prevail as between the Parties and shall
govern their contractual relationship and the Parties shall cause the necessary amendments to the Charter Documents of the Company.

 

		31.14	All remedies of any Party under this Agreement whether provided herein or conferred by statute, civil
law, common law, custom, trade, or usage are cumulative and not alternative and may be enforced successively or concurrently.

 

		31.15	The Contracts (Rights of Third Parties) Act (Cap. 53B) of Singapore shall not apply to this Agreement
and, unless otherwise expressly provided herein, no person who is not a party to this Agreement shall have or acquire any right to enforce
any term of this Agreement pursuant to that Act.

 

		31.16	The provisions of Clause 8 (Non-Compete Undertaking), Clause 19 (Representations and Warranties),
Clause 26 (Notice), Clause 27 (Confidentiality), Clause 28 (Governing Law), Clause 29 (Dispute Resolution),
and Clause 31 (Miscellaneous) of this Agreement, shall survive the termination of this Agreement.

 

		31.17	Where any obligations, undertakings, agreement or covenants are set forth hereunder in relation to a Subsidiary,
it shall be deemed that the Company and the Founders have the obligation to ensure that the relevant Subsidiary complies with such obligation,
undertaking, agreement or covenant.

 

    79

     

    

 

[THE REMAINDER OF THIS PAGE HAS BEEN INTENTIONALLY
LEFT BLANK]

 

    80

     

    

 

This is the execution page of the Second Restated and Amended Shareholders’
Agreement entered into among the Company, the Founders and the Investors.

 

Signed and delivered for and on behalf of Near Pte. Ltd.

 

	 	 
	Name:
	Designation:
	Place:
	Date:

 

    81

     

    

 

This is the execution page of the Restated and Amended Shareholders’
Agreement entered into among the Company, the Founders and the Investors.

 

Signed and delivered by Mr. Anil Mathews

 

	 	 
	Place:
	Date:

 

    82

     

    

 

This is the execution page of the Restated and Amended Shareholders’
Agreement entered into among the Company, the Founders and the Investors.

 

Signed and delivered by Shobhit Shukla

 

	 	 
	Place:
	Date:

 

    83

     

    

 

This is the execution page of the Restated and Amended Shareholders’
Agreement entered into among the Company, the Founders and the Investors.

 

Signed and delivered for and on behalf of CMDB II

 

	 	 
	Name: Sateeta Jeewoolall Jessoo / Guy Russo
	Designation: Director
	Place: Mauritius
	Date:
	 

    84

     

    

 

This is the execution page of the Restated and Amended Shareholders’
Agreement entered into among the Company, the Founders and the Investors.

 

Signed and delivered for and on behalf of Sequoia Capital India
III Ltd.

 

	 	 
	Name:
	Designation:
	Place:
	Date:
	 

    85

     

    

 

This is the execution page of the Restated and Amended Shareholders’
Agreement entered into among the Company, the Founders and the Investors.

 

Signed and delivered for and on behalf of GB-V Growth Fund Investment
Limited Partnership

 

	 	 
	Name:
	Designation:
	Place:
	Date:

 

    86

     

    

 

This is the execution page of the Restated and Amended Shareholders’
Agreement entered into among the Company, the Founders and the Investors.

 

Signed and delivered for and on behalf of CISCO SYSTEMS INTERNATIONAL
BV

 

	 	 
	Name:
	Designation:
	Place:
	Date:

 

    87

     

    

 

This is the execution page of the Restated and Amended Shareholders’
Agreement entered into among the Company, the Founders and the Investors.

 

Signed and delivered for and on behalf of Telstra Ventures Fund
II, L.P.

 

	 	 
	Name:
	Designation:
	Place:
	Date:

 

    88

     

    

 

This is the execution page of the Restated and Amended Shareholders’
Agreement entered into among the Company, the Founders and the Investors.

 

Signed and delivered for and on behalf of OurCrowd International
Investment III L.P.

 

	 	 
	Name:
	Designation:
	Place:
	Date:

 

    89

     

    

 

This is the execution page of the Restated and Amended Shareholders’
Agreement entered into among the Company, the Founders and the Investors.

 

Signed and delivered for and on behalf of GPC NIV Ltd

 

	 	 
	Name: Don Seymour
	Designation:
	Place:
	Date:

    90

     

    

 

This is the execution page of the Restated and
Amended Shareholders’ Agreement entered into among the Company, the Founders and the Investors.

 

Signed and delivered for and on behalf of UM Legacy LLC

 

	 	 
	Name:
	Designation:
	Place:
	Date:

    91

     

    

 

Schedule 1

 

PART A – EXCHANGE OF SHARES OF NEAR PTE
LTD FOR SHARES OF NEAR INTELLIGENCE HOLDINGS INC. 

 

	Name of Shareholder	 	Ordinary Shares

of Near Pte Ltd

 Exchanged by

 Shareholder	 	 	Common Stock

 shares of Near

 Intelligence

Holdings Inc.

 Received in

 Exchange	 
	CECIL CAPITAL PTE LTD	 	 	47,178,894	 	 	 	47,178.894	 
	GODSPEED INVESTMENTS PTE LTD	 	 	14,400,000	 	 	 	14,400.000	 
	ORIENTAL INVESTMENT ADVISORS PTE LTD	 	 	9,600,000	 	 	 	9,600.000	 
	BINO CHACKO	 	 	300,000	 	 	 	300.000	 
	SEQUOIA CAPITAL INDIA III LTD	 	 	30,000	 	 	 	30.000	 
	CMDB II	 	 	30,000	 	 	 	30.000	 
	TELSTRA VENTURES FUND II, LP	 	 	425,000	 	 	 	425.000	 

 

	Name of Shareholder	 	Series A
 Preference shares
    of 
 Near Ptd Ltd

Exchanged by
 Shareholder	 	 	Series A

    Preferred Stock shares
 of Near Intelligence

Holdings Inc. 

Received in
 Exchange	 
	SEQUOIA CAPITAL INDIA III LTD	 	 	47,709,000	 	 	 	47,709.000	 
	CMDB II	 	 	47,709,000	 	 	 	47,709.000	 

 

	Name of Shareholder	 	Series B

Preference

shares of

 Near Ptd Ltd

Exchanged by

 Shareholder	 	 	Series B

Preferred

 Stock shares of

Near Intelligence

Holdings Inc.

 Received in

 Exchange	 
	SEQUOIA CAPITAL INDIA III LTD	 	 	6,618,000	 	 	 	6,618.000	 
	CMDB II	 	 	6,618,000	 	 	 	6,618.000	 
	GB-V GROWTH FUND INVESTMENT LIMITED PARTNERSHIP	 	 	13,236,000	 	 	 	13,236.000	 
	TELSTRA VENTURES FUND II, LP	 	 	23,163,000	 	 	 	23,163.000	 

 

    92

     

    

 

	Name of Shareholder	 	Series C
 Preference

    shares of Near Ptd Ltd

 Exchanged by Shareholder	 	 	Series C

Preferred Stock shares of Near Intelligence

 Holdings Inc.

 Received in

 Exchange	 
	GB-V GROWTH FUND INVESTMENT LIMITED PARTNERSHIP	 	 	981,951	 	 	 	981.951	 
	TELSTRA VENTURES FUND II, LP	 	 	981,951	 	 	 	981.951	 
	CISCO SYSTEMS INTERNATIONAL BV	 	 	2,945,854	 	 	 	2,945.854	 

 

	Name of Shareholder	 	Series D Preference

 shares of 

Near Ptd Ltd

Exchanged by

 Shareholder	 	 	Series D Preferred

 Stock shares of Near

 Intelligence Holdings Inc.

 Received in

 Exchange	 
	OURCROWD INTERNATIONAL INVESTMENT III LP	 	 	5,694,915	 	 	 	5,694.915	 
	GPC NIV LTD	 	 	85,500,000	 	 	 	85,500.000	 

 

	Name of Shareholder	 	Series U Preference

 shares of

 Near Ptd Ltd

Exchanged  by 

Shareholder	 	 	Series U Preferred

 Stock shares of Near

 Intelligence Holdings Inc.

 Received in

 Exchange	 
	UM LEGACY LLC	 	 	66,140,480	 	 	 	66,140.480	 

 

    93

     

    

 

PART B - SHAREHOLDERS OF THE FOLLOWING SHARE
EXCHANGE

 

	Name
    of Shareholder	 	Common	 	 	Warrants	 	 	RSUs	 	 	Series
    A Preferred	 	 	Series
    B Preferred	 	 	Series 
    C

Preferred	 	 	Series 
    D

Preferred	 	 	Series
    U Preferred	 	 	Total
    Preferred	 	 	Total	 	 	%	 
	RSU
    POOL	 	 	 	 	 	 	 	 	 	 	101,457.955	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	101,457.955	 	 	 	21.01	%
	CECIL
    CAPITAL PTE LTD	 	 	47,178.894	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	47,178.894	 	 	 	9.77	%
	GODSPEED
    INVESTMENTS PTE LTD	 	 	14,400.000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	14,400.000	 	 	 	2.98	%
	ORIENTAL
    INVESTMENT ADVISORS PTE LTD	 	 	9,600.000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	9,600.000	 	 	 	1.99	%
	BINO
    CHACKO	 	 	300.000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	300.000	 	 	 	0.06	%
	Sequoia
    Capital India III Ltd	 	 	30.000	 	 	 	 	 	 	 	 	 	 	 	47,709.000	 	 	 	6,618.000	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	54,327.000	 	 	 	54,357.000	 	 	 	11.25	%
	CMDB
    II (JP Morgan PEG)	 	 	30.000	 	 	 	 	 	 	 	 	 	 	 	47,709.000	 	 	 	6,618.000	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	54,327.000	 	 	 	54,357.000	 	 	 	11.25	%
	Global
    Brains	 	 	 	 	 	 	541.000	 	 	 	 	 	 	 	-	 	 	 	13,236.000	 	 	 	981.951	 	 	 	-	 	 	 	-	 	 	 	14,217.951	 	 	 	14,758.951	 	 	 	3.06	%
	Telstra
    Ventures	 	 	425.000	 	 	 	116.000	 	 	 	 	 	 	 	-	 	 	 	23,163.000	 	 	 	981.951	 	 	 	-	 	 	 	-	 	 	 	24,144.951	 	 	 	24,685.951	 	 	 	5.11	%
	Cisco	 	 	 	 	 	 	1,623.000	 	 	 	 	 	 	 	-	 	 	 	-	 	 	 	2,945.854	 	 	 	-	 	 	 	-	 	 	 	2,945.854	 	 	 	4,568.854	 	 	 	0.95	%
	OurCrowd	 	 	-	 	 	 	 	 	 	 	 	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	5,694.915	 	 	 	-	 	 	 	5,694.915	 	 	 	5,694.915	 	 	 	1.18	%
	GPC	 	 	-	 	 	 	 	 	 	 	 	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	85,500.000	 	 	 	-	 	 	 	85,500.000	 	 	 	85,500.000	 	 	 	17.70	%
	UM
    Investors	 	 	-	 	 	 	 	 	 	 	 	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	-	 	 	 	66,140.480	 	 	 	66,140.480	 	 	 	66,140.480	 	 	 	13.69	%
	Total	 	 	71,963.894	 	 	 	2,280.000	 	 	 	101,457.955	 	 	 	95,418.000	 	 	 	49,635.000	 	 	 	4,909.756	 	 	 	91,194.915	 	 	 	66,140.480	 	 	 	307,298.151	 	 	 	483,000.000	 	 	 	100.00	%

 

    94

     

    

 

Schedule 2

 

Details of Founders

 

	No.	 	Name	 	Age	 	Address for Notification
	1.	 	Anil Mathews	 	47 years	 	102, RJ Manor, 11/A, 7th Main, Koramangala 3rd Block, Bangalore 560034 

	2.	 	Shobhit Shukla	 	39 years	 	Villa 353, Adarsh Palm Retreat Villas, Bellandur, Outer Ring Road, Bangalore 560103

 

    95

     

    

 

Schedule 3

Notice Details

 

		1.	If to the Company:

		(a)	Name : Near Pte. Ltd.

		(b)	Address : 160 Robinson Road, #20-03, SBF Centre, Singapore 068914

		(c)	Attention : The Board of Directors

		(d)	Email : anil@near.com

 

		2.	If to Anil Mathews:

		(a)	Address: 102, RJ Manor, 11/A, 7th Main, Koramangala 3rd Block, Bangalore 560034

		(b)	Email : anil@near.com

 

		3.	If to Shobhit Shukla:

		(a)	Address: Villa 353, Adarsh Palm Retreat Villas, Bellandur, Outer Ring Road, Bangalore 560103

		(b)	Email : shobhit@near.com

 

		4.	If to CMDB:

		(a)	Name: CMDB II

		(b)	Address: International Financial Services Ltd., IFS Court, Twenty Eight, Cybercity, Ebene, Republic of
Mauritius

		(c)	Attention: Vickash Bissessur / Khalil Peerbocus

		(d)	Email : Vickash@ifsmauritius.com; khalil@ifsmauritius.com; ifs@ifsmauritius.com

 

		5.	If to Sequoia:

		(a)	Name : Sequoia Capital India III Ltd

		(b)	Address : 5th Floor, Ebene Esplanade, 24, Cybercity, Ebene, Mauritius

		(c)	Attention : The Directors

		(d)	Email : sequoia@internationalproximity.com

 

		6.	If to Global Brains:

		(a)	Name: GB-V Growth Fund Investment Limited Partnership

		(b)	Address: 10-11 Sakuragaoka-cho, Shibuya-Ku, Tokyo, 150-0031, Japan

		(c)	Attention: Takashi Kato

		(d)	Email: kato@globalbrains.co.jp

 

    96

     

    

 

		7.	If to TV:

		(a)	Name: Telstra Ventures Fund II, L.P.

		(b)	Address: North Suite 2, Town Mills, Rue Du Pre, St Peter Port, Guernsey, GY1 1LT

		(c)	Attention: The Company Secretary (Telstra Ventures)

		(d)	Email: Geoff@telstraventures.com

 

		8.	If to Cisco:

		(a)	Name: Cisco Systems International BV

		(b)	Address: State Street Corporation, Lafayette Corporate Center, 2 Avenue de Lafayette – LCC 2, Boston,
Massachusetts 02111-2900

		(c)	Attention: Jacob Musman

		(d)	Email: ramenon@cisco.com

		(e)	Telephone: 617-664-0192

 

		9.	If to GPC:

		(a)	Name: GPC NIV Ltd.

		(b)	Address: Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands

		(c)	Attention: Mr. Don Seymour

		(d)	Email: dmseymour@dmsoffshore.com

		(e)	Telephone: +3459490090

 

		10.	If to OurCrowd International III LP:

		(a)	Name: OurCrowd International III LP

		(b)	Address: 28 Derech Hebron, 9354214, Jerusalem, Israel

		(c)	Attention: Cali Chill, Adv., SVP, General Counsel and Corporate Secretary

		(d)	Email: cali@ourcrowd.com

		(e)	Telephone: 02-636-9304

 

		11.	If to Series U Investor:

		(a)	Name: UM Legacy LLC

		(b)	Address: 130 West Union Street, Pasadena, CA, 91103, United States of America

		(c)	Attention: Tom McGovern

		(d)	Email: legal@idealab.com

 

    97

     

    

 

Schedule 4

Reserved Matters

 

PART – A

 

LIST A MATTERS

 

		1.	Change in any rights or benefits provided to Series D Investors;

 

		2.	Capital expenditure or investment decisions by the Company or each of its Subsidiaries individually in
excess of USD 1,000,000 (United States Dollar One Million) or its equivalent or in excess of the amounts as agreed under the Business
Plan;

 

		3.	Incurrence of debt or Financial Indebtedness of above USD 10,000,000 (United States Dollar Ten Million)
(which limit shall be reduced by the amount of Financial Indebtedness existing as on the date of such Consent) or its equivalent including
creating a lien/mortgage over the Company’s or the Subsidiaries’ assets/property in excess of the above value or its equivalent;

 

		4.	Any commitment or agreement to do any of the foregoing;

 

		5.	Each of the Reserved Matters in this Part A of Schedule 4 with respect to any Material Subsidiary; and

 

		6.	Any change to the matters listed in this Part A of Schedule 4.

 

    98

     

    

 

PART – B

LIST B MATTERS

 

		1.	Any changes to the Share Capital, including issuance of Ordinary Shares, Ordinary Shares-linked instruments
(excluding Employee RSU already part of the Employee RSU Pool), option in any form to acquire/subscribe to Ordinary Shares, any Dilution
Instruments, share-splits, issuance of bonuses, reduction of capital, any reclassification or creation of new class or series of Shares.
For the avoidance of doubt, it is clarified that issuance of Shares pursuant to the provisions of the Merger Agreement regarding the Additional
Series U Preference Shares shall not be treated as a Reserved Matter and shall not require the prior approval of any of the Investors.

 

		2.	Alteration or changing the rights or preferences of any series of Preference Shares held by the Investors
to: (i) cancel or rescind any rights attached to any series of Preference Shares; (ii) amendment of Charter Documents which will result
in the cancellation or rescission. It is clarified that grant of superior rights to any class of Shares issued by the Company in any round
of financing after the First Completion Date shall not be construed as cancellation or rescission of rights attached to any series of
Preference Shares, and such will be deemed to be a List A Matter.

 

		3.	Any increase of Employee RSUs including any grant of new options thereunder and adoption of any new employee
equity incentive plan;

 

		4.	Any transactions (excluding under the scope of the respective employment contracts), involving the Company
or the Subsidiaries and Founders and/or Key Employees in excess of USD 250,000 (United States Dollar Two Hundred and Fifty Thousand) in
a Financial Year on a cumulative basis;

 

		5.	Payment of remuneration or commission or any other amounts to the Directors other than amounts approved
in employment contracts;

 

		6.	Changes to the accounting or tax policies or practices of the Company or the Subsidiaries;

 

		7.	Capital expenditure or investment decisions by the Company or each of its Subsidiaries, individually in
excess of USD 10,000,000 (United States Dollar Ten Million) or its equivalent or in excess of the amounts as agreed under the Business
Plan;

 

		8.	Any change in business, statement of business principles, commencement of a new line of business, or deviation
from the agreed Business Plan beyond 10% (ten percent);

 

		9.	Approval of the annual financial statements and the annual operating budget for any Financial Year;

 

		10.	Changes in the authorised number, of the Directors on the Board;

 

		11.	Delegation of authority or any of the powers of the Board to any individual or committee other than in
the ordinary course of business;

 

		12.	The grant or creation of any lien on any of its assets, other than as security for borrowings for the
business of the Company;

 

		13.	Change in remuneration or material terms of employment of the Founder;

 

		14.	Waiver of anti-dilution protection as set out in Clause 5 of this Agreement;

 

		15.	Any commencement or settlement of any material litigation, investigation, or proceeding by the Company
or the Subsidiaries or joint ventures;

 

    99

     

    

 

		16.	A merger, demerger, acquisition, change in Control, consolidation, reorganisation, or other transaction
or series of transactions in which the Company’s or the Subsidiaries’ shareholders (immediately prior to such transaction
or transactions) will not retain a majority of the voting power of the surviving entity immediately following such transaction after giving
effect to any conversion, exercise or exchange of any Shares convertible into or exercisable or exchangeable for, such Ordinary Shares,
including a Liquidation Event (but excluding a Strategic Sale in accordance with Clause 11 of this Agreement). For the avoidance of doubt,
this shall include any strategic alliance with any Third Party which results in investments in the Company, or the Subsidiaries or joint
ventures, or such Third Party, or exclusive rights other than rights granted in the ordinary course of business, acquisition of all or
substantially all of the properties, assets or stock of any other company or entity;

 

		17.	Any action relating to a QIPO, including appointment of advisors, determining the timing, pricing, and
place/stock exchange of an IPO;

 

		18.	Appointment or removal or change of the statutory or internal auditors;

 

		19.	Transfer of Shares or taking on record any Encumbrance/pledge/lien on the Shares, except as expressly
permitted in accordance with the terms of the Agreement;

 

		20.	Distribution of capital or profits by dividends, capitalisation of reserves or otherwise, other than in
accordance with the provisions of Clause 13 (Liquidation Preference) of this Agreement;

 

		21.	Any action that results in the redemption or buy-back of any Shares;

 

		22.	Approval of a Strategic Sale in accordance with the provisions of Clause 11 (Strategic Sale) of
this Agreement;

 

		23.	Calling of a Trigger Event and issuance of a Default Notice;

 

		24.	Conversion of the Company from a private company to a public company;

 

		25.	Any related party transactions involving the Company or the Subsidiaries or joint ventures or any transactions
with any Affiliate, Shareholder or Director, any transaction dealings by the Company or the Subsidiaries or any of their respective Directors
with any related party in excess of USD 750,000 (United States Dollar Seven Hundred Fifty Thousand) in one Financial Year on a cumulative
basis, except for the transactions between the Company and its Subsidiaries entered into in the ordinary course of business.

 

		26.	Determination, modification or revision to the terms of employment of any key managerial personnel (including
Key Employees) and hiring and termination of key managerial personnel (including Key Employees);

 

		27.	Incurrence of debt or Financial Indebtedness of above USD 10,000,000 (United States Dollar Ten Million)
(which limit shall be reduced by the amount of Financial Indebtedness existing as on the date of such Consent) or its equivalent including
creating a lien/mortgage over the Company’s or the Subsidiaries’ assets/property in excess of the above value or its equivalent;

 

		28.	Any commitment or agreement to do any of the foregoing;

 

		29.	Each of the Reserved Matters in this Part B of Schedule 4 with respect to any Material Subsidiary;

 

		30.	Any change to the matters listed in this Part B of Schedule 4.

 

    100

     

    

 

Schedule 5

Broad based weighted average anti-dilution protection

 

Part A - Series A Preference Shares:

 

		1.	Each time after First Completion Date, that the Company issues to any Person, any Dilution Instruments
at a price (or deemed price) per Ordinary Share that is lower than the then effective conversion price (“Series A Conversion
Price”) for the Series A Preference Shares (a “Series A Dilutive Issuance”), then the Series A Conversion
Price of the Series A Securities will be adjusted downward on a broad based weighted average basis, per the formula set out below:

 

		1.1.	The adjusted Series A Conversion Price of the Series A Preference Shares (“NCP-A”)
in each such instance will be calculated as follows:
	 	 	 

 

		(a)	NCP-A = [OCP x (SO + SP)] / (SO + SAP), where:

 

		(b)	OCP = prevailing Series A Conversion Price of the Series
A Preference Shares (before adjustment);

 

		(c)	SO = the aggregate of all the Ordinary Shares outstanding
immediately prior to the dilutive issuance reckoned on a Fully Diluted Basis;

 

		(d)	SP = The total consideration received (or deemed consideration
received as provided for in paragraph 2 below) by the Company from the subscriber of the dilutive issuance divided by OCP; and

 

		(e)	SAP = Number of Dilution Instruments (on a Fully Diluted
Basis) actually issued in the dilutive issuance.

 

		1.2.	If a large number of Series A Preference Shares have been converted to Ordinary Shares, then this anti-dilution
mechanism shall be accomplished as far as is possible under law by an adjustment to the Series A Conversion Price, and thereafter by issuing
such number of Ordinary Shares to the Series A Investors at the lowest price possible under Applicable Law, so as to give full effect
to the broad based weighted average anti-dilution rights per the formula set out above.

 

		1.3.	If all of the Series A Preference Shares have been converted to Ordinary Shares, then this anti-dilution
mechanism shall be accomplished by issuing such number of Ordinary Shares to the relevant bearers of the Series A Preference Shares at
the lowest price possible under Applicable Law, so as to give full effect to the broad based weighted average anti-dilution rights per
the formula set out above.

 

		1.4.	It is clarified that no upward adjustment to the Series A Conversion Price then in effect shall be made
pursuant to any Series A Dilutive Issuance.

 

		2.	In performing the foregoing calculations, the following provisions shall be applicable:

 

		2.1.	In the case of the issuance of Dilution Instruments for cash, the aggregate consideration shall be deemed
to be the amount of cash paid thereof before deducting therefrom any discounts, commissions or placement fees payable by the Company to
any underwriter or placement agent in connection with the issuance and sale thereof.

 

		2.2.	In the case of the issuance of Dilution Instruments for a consideration in whole or in part other than
cash, the consideration other than cash shall be deemed to be the fair market value thereof, as determined in good faith by a majority
of the Board.

 

		2.3.	The aggregate maximum number of Ordinary Shares deliverable upon conversion, exchange or exercise (assuming
the satisfaction of any conditions to convertibility, exchangeability or exercisability, including, without limitation, the passage of
time, but without taking into account potential anti-dilution adjustments) of any Dilution Instruments and subsequent conversion, exchange
or exercise thereof shall be deemed to have been issued at the time such securities were issued or such Dilution Instruments were issued
and for a consideration equal to the consideration, if any, received by the Company for any such Dilution Instruments, plus the minimum
additional consideration, if any, to be received by the Company (without taking into account potential anti-dilution adjustments) upon
the conversion, exchange or exercise of any Dilution Instruments.

 

		2.4.	Upon the termination or expiration of the convertibility, exchangeability or exercisability of any Dilution
Instruments, the applicable conversion price, to the extent in any way affected by or computed using such Dilution Instruments, shall
be recomputed to reflect the issuance of only the number of Ordinary Shares (and Dilution Instruments that remain convertible, exchangeable
or exercisable) actually issued upon the conversion, exchange or exercise of such Dilution Instruments.
	 	 	 

		2.5.	The Company shall issue any fractional Shares as necessary, and shall round up to the nearest 0.001 of
a Share.

 

    101

     

    

 

		3.	In the event that the Company undertakes any form of restructuring
of its Share Capital (“Capital Restructuring”) including but not limited to: (i) consolidation or sub-division or
splitting up of its Shares, (ii) issue of bonus Shares; (iii) issue of shares in a scheme of arrangement (including amalgamation or demerger);
(iv) reclassification of Shares or variation of rights into other kinds of securities; and (v) issue of rights over Shares, the number
of Ordinary Shares that each Series A Preference Share converts into and the Conversion Price for each such Ordinary Share shall be adjusted
accordingly in a manner that each of the bearers of the Series A Preference Share receives such number of Ordinary Shares that they would
have been entitled to receive immediately after occurrence of any such Capital Restructuring had the conversion of the Series A Preference
Shares occurred immediately prior to the occurrence of such Capital Restructuring.

 

Part B - Series B Preference Shares:

 

		1.	Each time after the First Completion Date, that the Company issues to any Person, any Dilution Instruments
at a price (or deemed price) per Ordinary Share that is lower than the then effective conversion price (“Series B Conversion
Price”) for the Series B Preference Shares (a “Series B Dilutive Issuance”), then the Series B Conversion
Price of the Series B Securities will be adjusted downward on a broad based weighted average basis, per the formula set out below:

 

		1.1.	The adjusted Series B Conversion Price of the Series B Preference Shares (“NCP-B”)
in each such instance will be calculated as follows:
	 	 	 

 

		(a)	NCP-B = [OCP x (SO + SP)] / (SO + SAP), where:

 

		(b)	OCP = prevailing Series B Conversion Price of the Series
B Preference Shares (before adjustment);

 

		(c)	SO = the aggregate of all the Ordinary Shares outstanding
immediately prior to the dilutive issuance reckoned on a Fully Diluted Basis;

 

		(d)	SP = The total consideration received (or deemed consideration
received as provided for in paragraph 2 below) by the Company from the subscriber of the dilutive issuance divided by OCP; and

 

		(e)	SAP = Number of Dilution Instruments (on a Fully Diluted
Basis) actually issued in the dilutive issuance.

 

		1.2.	If a large number of Series B Preference Shares have been converted to Ordinary Shares, then this anti-dilution
mechanism shall be accomplished as far as is possible under law by an adjustment to the Series B Conversion Price, and thereafter by issuing
such number of Ordinary Shares to the Series B Investors at the lowest price possible under Applicable Law, so as to give full effect
to the broad based weighted average anti-dilution rights per the formula set out above.

 

		1.3.	If all of the Series B Preference Shares have been converted to Ordinary Shares, then this anti-dilution
mechanism shall be accomplished by issuing such number of Ordinary Shares to the relevant bearers of the Series B Preference Shares at
the lowest price possible under Applicable Law, so as to give full effect to the broad based weighted average anti-dilution rights per
the formula set out above.

 

		1.4.	It is clarified that no upward adjustment to the Series B Conversion Price then in effect shall be made
pursuant to any Series B Dilutive Issuance.

 

		2.	In performing the foregoing calculations, the following provisions shall be applicable:

 

		2.1.	In the case of the issuance of Dilution Instruments for cash, the aggregate consideration shall be deemed
to be the amount of cash paid thereof before deducting therefrom any discounts, commissions or placement fees payable by the Company to
any underwriter or placement agent in connection with the issuance and sale thereof.

 

		2.2.	In the case of the issuance of Dilution Instruments for a consideration in whole or in part other than
cash, the consideration other than cash shall be deemed to be the fair market value thereof, as determined in good faith by a majority
of the Board.

 

		2.3.	The aggregate maximum number of Ordinary Shares deliverable upon conversion, exchange or exercise (assuming
the satisfaction of any conditions to convertibility, exchangeability or exercisability, including, without limitation, the passage of
time, but without taking into account potential anti-dilution adjustments) of any Dilution Instruments and subsequent conversion, exchange
or exercise thereof shall be deemed to have been issued at the time such securities were issued or such Dilution Instruments were issued
and for a consideration equal to the consideration, if any, received by the Company for any such Dilution Instruments, plus the minimum
additional consideration, if any, to be received by the Company (without taking into account potential anti-dilution adjustments) upon
the conversion, exchange or exercise of any Dilution Instruments.

 

		2.4.	Upon the termination or expiration of the convertibility, exchangeability or exercisability of any Dilution
Instruments, the applicable conversion price, to the extent in any way affected by or computed using such Dilution Instruments, shall
be recomputed to reflect the issuance of only the number of Ordinary Shares (and Dilution Instruments that remain convertible, exchangeable
or exercisable) actually issued upon the conversion, exchange or exercise of such Dilution Instruments.

 

    102

     

    

 

		2.5.	The Company shall issue any fractional Shares as necessary, and shall round up to the nearest 0.001 of
a Share.

 

		3.	In the event that the Company undertakes a Capital Restructuring, the number of Ordinary Shares that each
Series B Preference Share converts into and the Conversion Price for each such Ordinary Share shall be adjusted accordingly in a manner
that each of the bearers of the Series B Preference Share receives such number of Ordinary Shares that they would have been entitled to
receive immediately after occurrence of any such Capital Restructuring had the conversion of the Series B Preference Shares occurred immediately
prior to the occurrence of such Capital Restructuring.

 

Part C - Series C Preference Shares:

 

		1.	Each time after the First Completion Date, that the Company
issues to any Person, any Dilution Instruments at a price (or deemed price) per Ordinary Share that is lower than the then effective
conversion price (“Series C Conversion Price”) for the Series C Preference Shares (a “Series C Dilutive Issuance”),
then the Series C Conversion Price of the Series C Securities will be adjusted downward on a broad based weighted average basis, per
the formula set out below:

 

		a.	The adjusted Series C Conversion Price of the Series C Preference
Shares (“NCP-C”) in each such instance will be calculated as follows:

 

		i.	NCP-C = [OCP x (SO + SP)] / (SO + SAP), where:

 

		ii.	OCP = prevailing Series C Conversion Price of the Series C Preference Shares (before adjustment);

 

		iii.	SO = the aggregate of all the Ordinary Shares outstanding immediately prior to the dilutive issuance
reckoned on a Fully Diluted Basis;

 

		iv.	SP = The total consideration received (or deemed consideration received as provided for in paragraph
2 below) by the Company from the subscriber of the dilutive issuance divided by OCP; and

 

		v.	SAP = Number of Dilution Instruments (on a Fully Diluted Basis) actually issued in the dilutive issuance.

 

		b.	If a large number of Series C Preference Shares have been converted to Ordinary Shares, then this anti-dilution
mechanism shall be accomplished as far as is possible under law by an adjustment to the Series C Conversion Price, and thereafter by issuing
such number of Ordinary Shares to the Series C Investors at the lowest price possible under Applicable Law, so as to give full effect
to the broad based weighted average anti-dilution rights per the formula set out above.

 

		c.	If all of the Series C Preference Shares have been converted to Ordinary Shares, then this anti-dilution
mechanism shall be accomplished by issuing such number of Ordinary Shares to the relevant bearers of the Series C Preference Shares at
the lowest price possible under Applicable Law, so as to give full effect to the broad based weighted average anti-dilution rights per
the formula set out above.

 

		d.	It is clarified that no upward adjustment to the Series C Conversion Price then in effect shall be made
pursuant to any Series C Dilutive Issuance.

 

		2.	In performing the foregoing calculations, the following provisions shall be applicable:

 

		a.	In the case of the issuance of Dilution Instruments for cash, the aggregate consideration shall be deemed
to be the amount of cash paid therefor before deducting therefrom any discounts, commissions or placement fees payable by the Company
to any underwriter or placement agent in connection with the issuance and sale thereof.

 

    103

     

    

 

		b.	In the case of the issuance of Dilution Instruments for a consideration in whole or in part other than
cash, the consideration other than cash shall be deemed to be the fair market value thereof, as determined in good faith by a majority
of the Board.

 

		c.	The aggregate maximum number of Ordinary Shares deliverable upon conversion, exchange or exercise (assuming
the satisfaction of any conditions to convertibility, exchangeability or exercisability, including, without limitation, the passage of
time, but without taking into account potential anti-dilution adjustments) of any Dilution Instruments and subsequent conversion, exchange
or exercise thereof shall be deemed to have been issued at the time such securities were issued or such Dilution Instruments were issued
and for a consideration equal to the consideration, if any, received by the Company for any such Dilution Instruments, plus the minimum
additional consideration, if any, to be received by the Company (without taking into account potential anti-dilution adjustments) upon
the conversion, exchange or exercise of any Dilution Instruments.

 

		d.	Upon the termination or expiration of the convertibility, exchangeability or exercisability of any Dilution
Instruments, the applicable conversion price, to the extent in any way affected by or computed using such Dilution Instruments, shall
be recomputed to reflect the issuance of only the number of Ordinary Shares (and Dilution Instruments that remain convertible, exchangeable
or exercisable) actually issued upon the conversion, exchange or exercise of such Dilution Instruments.

 

		e.	The Company shall issue any fractional Shares as necessary, and shall round up to the nearest 0.001 of
a Share.

 

		3.	In the event that the Company undertakes a Capital Restructuring,
the number of Ordinary Shares that each Series C Preference Share converts into and the Conversion Price for each such Ordinary Share
shall be adjusted accordingly in a manner that each of the bearers of the Series C Preference Share receives such number of Ordinary
Shares that they would have been entitled to receive immediately after occurrence of any such Capital Restructuring had the conversion
of the Series C Preference Shares occurred immediately prior to the occurrence of such Capital Restructuring.

 

Part D - Series D Preference Shares:

 

		1.	Each time after the First Completion Date, that the Company
issues to any Person, any Dilution Instruments at a price (or deemed price) per Ordinary Share that is lower than the then effective
conversion price (“Series D Conversion Price”) for the Series D Preference Shares (a “Series D Dilutive Issuance”),
then the Series D Conversion Price of the Series D Securities will be adjusted downward on a broad based weighted average basis, per
the formula set out below:

 

		a.	The adjusted Series D Conversion Price of the Series D Preference
Shares (“NCP-D”) in each such instance will be calculated as follows:

 

		i.	NCP-D = [OCP x (SO + SP)] / (SO + SAP), where:

 

		ii.	OCP = prevailing Series D Conversion Price of the Series D Preference Shares (before adjustment);

 

		iii.	SO = the aggregate of all the Ordinary Shares outstanding immediately prior to the dilutive issuance reckoned
on a Fully Diluted Basis;

 

    104

     

    

 

		iv.	SP = the total consideration received (or deemed consideration received as provided for in paragraph 2
below) by the Company from the subscriber of the dilutive issuance divided by OCP; and

 

		v.	SAP = Number of Dilution Instruments (on a Fully Diluted Basis) actually issued in the dilutive issuance.

 

		b.	If a large number of Series D Preference Shares have been converted to Ordinary Shares, then this anti-dilution
mechanism shall be accomplished as far as is possible under law by an adjustment to the Series D Conversion Price, and thereafter by issuing
such number of Ordinary Shares to the Series D Investors at the lowest price possible under Applicable Law, so as to give full effect
to the broad based weighted average anti-dilution rights per the formula set out above.

 

		c.	If all of the Series D Preference Shares have been converted to Ordinary Shares, then this anti-dilution
mechanism shall be accomplished by issuing such number of Ordinary Shares to the relevant bearers of the Series D Preference Shares at
the lowest price possible under Applicable Law, so as to give full effect to the broad based weighted average anti-dilution rights per
the formula set out above.

 

		d.	It is clarified that no upward adjustment to the Series D Conversion Price then in effect shall be made
pursuant to any Series D Dilutive Issuance.

 

		2.	In performing the foregoing calculations, the following provisions
shall be applicable:

 

		a.	In the case of the issuance of Dilution Instruments for cash, the aggregate consideration shall be deemed
to be the amount of cash paid therefor before deducting therefrom any discounts, commissions or placement fees payable by the Company
to any underwriter or placement agent in connection with the issuance and sale thereof.

 

		b.	In the case of the issuance of Dilution Instruments for a consideration in whole or in part other than
cash, the consideration other than cash shall be deemed to be the fair market value thereof, as determined in good faith by a majority
of the Board.

 

		c.	The aggregate maximum number of Ordinary Shares deliverable upon conversion, exchange or exercise (assuming
the satisfaction of any conditions to convertibility, exchangeability or exercisability, including, without limitation, the passage of
time, but without taking into account potential anti-dilution adjustments) of any Dilution Instruments and subsequent conversion, exchange
or exercise thereof shall be deemed to have been issued at the time such securities were issued or such Dilution Instruments were issued
and for a consideration equal to the consideration, if any, received by the Company for any such Dilution Instruments, plus the minimum
additional consideration, if any, to be received by the Company (without taking into account potential anti-dilution adjustments) upon
the conversion, exchange or exercise of any Dilution Instruments.

 

		d.	Upon the termination or expiration of the convertibility, exchangeability or exercisability of any Dilution
Instruments, the applicable conversion price, to the extent in any way affected by or computed using such Dilution Instruments, shall
be recomputed to reflect the issuance of only the number of Ordinary Shares (and Dilution Instruments that remain convertible, exchangeable
or exercisable) actually issued upon the conversion, exchange or exercise of such Dilution Instruments.

 

		e.	The Company shall issue any fractional Shares as necessary, and shall round up to the nearest 0.001 of
a Share.

 

    105

     

    

 

		3.	In the event that the Company undertakes a Capital Restructuring, the number of Ordinary Shares that each
Series D Preference Share converts into and the Conversion Price for each such Ordinary Share shall be adjusted accordingly in a manner
that each of the bearers of the Series D Preference Share receives such number of Ordinary Shares that they would have been entitled to
receive immediately after occurrence of any such Capital Restructuring had the conversion of the Series D Preference Shares occurred immediately
prior to the occurrence of such Capital Restructuring.

 

Part E – Series U Preference Shares

 

		1.	Each time after the Closing Date, that the Company issues to any Person, any Dilution Instruments at a
price (or deemed price) per Ordinary Share that is lower than the then effective conversion price (“Series U Conversion Price”)
for the Series U Preference Shares (a “Series U Dilutive Issuance”), then the Series U Conversion Price of the Series
U Securities will be adjusted downward on a broad based weighted average basis, per the formula set out below:

 

		a.	The adjusted Series U Conversion Price of the Series U Preference Shares (“NCP-U”)
in each such instance will be calculated as follows:

 

		i.	NCP-U = [OCP x (SO + SP)] / (SO + SAP), where:

 

		ii.	OCP = prevailing Series U Conversion Price of the Series U Preference Shares (before adjustment);

 

		iii.	SO = the aggregate of all the Ordinary Shares outstanding immediately prior to the dilutive issuance
reckoned on a Fully Diluted Basis;

 

		iv.	SP = The total consideration received (or deemed consideration received as provided for in paragraph
2 below) by the Company from the subscriber of the dilutive issuance divided by OCP; and

 

		v.	SAP = Number of Dilution Instruments (on a Fully Diluted Basis) actually issued in the dilutive issuance.

 

		b.	If a large number of Series U Preference Shares have been converted to Ordinary Shares, then this anti-dilution
mechanism shall be accomplished as far as is possible under law by an adjustment to the Series U Conversion Price, and thereafter by issuing
such number of Ordinary Shares to the Series U Investor at the lowest price possible under Applicable Law, so as to give full effect to
the broad based weighted average anti-dilution rights per the formula set out above.

 

		c.	If all of the Series U Preference Shares have been converted to Ordinary Shares, then this anti-dilution
mechanism shall be accomplished by issuing such number of Ordinary Shares to the relevant bearers of the Series U Preference Shares at
the lowest price possible under Applicable Law, so as to give full effect to the broad based weighted average anti-dilution rights per
the formula set out above.

 

		d.	It is clarified that no upward adjustment to the Series U Conversion Price then in effect shall be made
pursuant to any Series U Dilutive Issuance.

 

    106

     

    

 

		2.	In performing the foregoing calculations, the following provisions shall be applicable:

 

		a.	In the case of the issuance of Dilution Instruments for cash, the aggregate consideration shall be deemed
to be the amount of cash paid therefor before deducting therefrom any discounts, commissions or placement fees payable by the Company
to any underwriter or placement agent in connection with the issuance and sale thereof.

 

		b.	In the case of the issuance of Dilution Instruments for a consideration in whole or in part other than
cash, the consideration other than cash shall be deemed to be the fair market value thereof, as determined in good faith by a majority
of the Board.

 

		c.	The aggregate maximum number of Ordinary Shares deliverable upon conversion, exchange or exercise (assuming
the satisfaction of any conditions to convertibility, exchangeability or exercisability, including, without limitation, the passage of
time, but without taking into account potential anti-dilution adjustments) of any Dilution Instruments and subsequent conversion, exchange
or exercise thereof shall be deemed to have been issued at the time such securities were issued or such Dilution Instruments were issued
and for a consideration equal to the consideration, if any, received by the Company for any such Dilution Instruments, plus the minimum
additional consideration, if any, to be received by the Company (without taking into account potential anti-dilution adjustments) upon
the conversion, exchange or exercise of any Dilution Instruments.

 

		d.	Upon the termination or expiration of the convertibility, exchangeability or exercisability of any Dilution
Instruments, the applicable conversion price, to the extent in any way affected by or computed using such Dilution Instruments, shall
be recomputed to reflect the issuance of only the number of Ordinary Shares (and Dilution Instruments that remain convertible, exchangeable
or exercisable) actually issued upon the conversion, exchange or exercise of such Dilution Instruments.

 

		e.	The Company shall issue any fractional Shares as necessary, and shall round up to the nearest 0.001 of
a Share.

 

		3.	In the event that the Company undertakes a Capital Restructuring,
the number of Ordinary Shares that each Series U Preference Share converts into and the Conversion Price for each such Ordinary Share
shall be adjusted accordingly in a manner that each of the bearers of the Series U Preference Share receives such number of Ordinary
Shares that they would have been entitled to receive immediately after occurrence of any such Capital Restructuring had the conversion
of the Series U Preference Shares occurred immediately prior to the occurrence of such Capital Restructuring.

 

    107

     

    

 

Schedule 6

 

Format of Deed of Adherence

 

THIS DEED OF ADHERENCE is made on {DATE} at {PLACE}

 

AMONG:

 

{Full details here} (hereinafter referred to as
“the Covenantor” or the “TRANSFEREE”) to whom shares of the Company have been transferred by {Full details here}
(“THE TRANSFERRING SHAREHOLDER”); and

 

{Full details here} (“THE CONTINUING SHAREHOLDERS
OF THE COMPANY”); and

 

Near Pte. Ltd. of [address] (“THE COMPANY”)

 

		1.	THIS DEED IS SUPPLEMENTAL to the Restated and Amended Shareholders’ Agreement (the “Agreement”)
made on {Date} between {INSERT DETAILS}, AND WITNESSES as follows:

 

		2.	The Covenantor hereby confirms that it has been supplied with a copy of the Agreement and the Constitution
of the Company and hereby covenants with each of the Continuing Shareholders of the Company and the Company to observe, perform and be
bound by all the terms thereof which were applicable to the Transferring Shareholder and are capable of applying to the Covenantor to
the intent and effect that the Covenantor shall be deemed with effect from the date on which the Covenantor is registered as a member
of the Company to be a Party to the Agreement.

 

		3.	The Covenantor hereby covenants that it shall not do any act or commit any omission that derogates from
the provisions of the Agreement or the Constitution of the Company.

 

		4.	This Deed shall be governed in all respect by the laws of Delaware.

 

		5.	EXECUTED and delivered as a deed the day and year first before written.

 

The signatories to this Deed of Adherence shall
be the Transferring Shareholder and the Transferee.

 

    108

     

    

 

Schedule 7

Terms of Series A Preference Shares

 

		1	VOTING

 

		1.1	From and after the First Completion Date, the voting rights of every Shareholder on every resolution placed
before the Company shall, to the extent permissible under Applicable Law, be one vote per 0.001 of a share on an As If Converted Basis.
The number of votes shall be subject to adjustment in the event that the number of Ordinary Shares to be issued upon conversion of the
Series A Preference Shares is subject to any increase or decrease pursuant to the Transaction Documents.

 

		1.2	Without prejudice to the rights of the Series A Investors under the Transaction Documents, each of the
Founders and the Company acknowledge that each Series A Investor has agreed to subscribe to Series A Preference Shares on the basis that
such Series A Investor shall be able to exercise voting rights on the Series A Preference Shares on an As If Converted Basis. In the event
(i) the Company is converted from a private company to a public company; or (ii) any Series A Investor is unable to exercise voting rights
on the Series A Preference Shares held by it due to Applicable Law or otherwise, until the conversion of such Series A Preference Shares
to Ordinary Shares, the Founders agree that they shall each vote on such number of Shares now or hereafter owned by them representing
the percentage shareholding of such Series A Investor in the Company, pursuant to the Series A Preference Shares held by such Series A
Investor, on an As If Converted Basis, whether beneficially or otherwise, or as to which they have voting power, in accordance with the
instructions of such Series A Investor at all meetings of the Shareholders of the Company or provide proxies without instructions to such
Series A Investor for the purposes of meetings of the Shareholders of the Company, such that such number of Shares (held by the Founders)
representing the shareholding of such Series A Investor in the Company, pursuant to the Series A Preference Shares held by such Series
A Investor, on an As If Converted Basis, determined in accordance with the Transaction Documents at the time of such voting, are voted
in the manner required by such Series A Investor.

 

		1.3	In pursuance of the provisions of Paragraph 1.2 above, the Founders jointly and severally, hereby irrevocably
appoint each Series A Investor as proxy and attorney-in-fact for the Founders and, for and on behalf of each Founder, each Series A Investor
is hereby authorised to vote or act by written consent in any manner as such Series A Investor may deem fit with respect to such Ordinary
Shares held by the Founders representing the percentage shareholding of such Series A Investor in the Company, pursuant to the Series
A Preference Shares held by such Series A Investor, on an As If Converted Basis and do and perform all such acts, deeds, matters and things
from time to time as may be necessary, desirable, or appropriate for or in connection with the powers conferred under this Paragraph 1.3.
The power herein vested may be exercised if and only if the Series A Investor is not able to exercise voting rights in respect of Series
A Preference Shares held by such Series A Investor on account of any provisions of Applicable Law.

 

		1.4	Notwithstanding anything herein contained, the provisions of paragraphs 1.2 and 1.3 shall only apply in
respect of Series A Preference Shares held by a Series A Investor and in respect of which voting rights cannot be exercised on account
of Applicable Law and to the extent that such voting rights are not available in respect of any resolution being considered by the Company.

 

    109

     

    

 

		2	DIVIDEND

 

		2.1	The holders of the Series A Preference Shares shall be entitled to receive on the Series A Preference
Shares, a non-cumulative and preferential dividend at the rate of 8% (eight percent) of the Series A Subscription Price of each Series
A Preference Share per annum in the event that dividend is declared by the Board in each Financial Year in which the Company has profits
available for distribution in accordance with Applicable Law, to be paid in preference and priority to the payment of dividend in respect
of all other Shares of the Company, present or future, except (i) Series B Preference Shares, Series C Preference Shares and Series U
Preference Shares shall be paid pari-passu, and (ii) Series D Preference Shares shall rank in priority, with the Series A Preference Shares
for the payment of dividends with the Series A Preference Shares. It is clarified that the Board shall determine as to whether dividend
should be declared in a given year and availability of profits shall not make it obligatory on the Company to declare any dividend.

 

		2.2	Notwithstanding the generality of the above, the Company shall not declare any dividend in respect of
Shares held by any other Shareholders (other than the preferential dividend on the Series A Preference Shares, Series B Preference Shares,
Series C Preference Shares, Series D Preference Shares and Series U Preference Shares), in excess of the dividend permissible to be paid
to the Series A Investors under Applicable Law with respect to the Series A Preference Shares held by each of the Series A Investors.

 

		2.3	In addition to the preferential dividend under paragraph 2.1, the holders of the Series A Preference Shares
shall be entitled to participate in any dividend declared by the Board to the holders of shares of any other class other than Series B
Preference Shares, Series C Preference Shares, Series D Preference Shares and Series U Preference Shares which have rights in preference
to or pari passu with Series A Preference Shares (including Ordinary Shares), on a pari passu basis on an As If Converted
Basis.

 

		3	CONVERSION OF SERIES A PREFERENCE SHARES

 

		3.1	The Series A Preference Shares unless redeemed earlier in accordance with paragraph 4 hereof or in accordance
with the Series A Subscription Agreement, shall be convertible into Ordinary Shares at the option of the holders of such Series A Preference
Shares in accordance with paragraph 3.2 below. Any Series A Preference Shares that have not been converted into Ordinary Shares shall
compulsorily convert into Ordinary Shares in accordance with paragraph 3.3 below, on the Automatic Series A Conversion Date in accordance
with the Transaction Documents.

 

		3.2	Right to Conversion

 

		3.2.1	The holders of the Series A Preference Shares shall have the right, at any time and from time to time
to require the Company, by written notice (the “Series A Conversion Notice”), to convert all or part of the Series
A Preference Shares, held by it into Ordinary Shares.

 

		3.2.2	Each 0.001 of a Series A Preference Share shall convert into 0.001 of an Ordinary Share, subject to further
adjustments in accordance with Schedule 5, without the holders of such Series A Preference Shares being required to pay any amount for
such conversion (“Series A Conversion Factor”).

 

    110

     

    

 

		3.2.3	The Ordinary Shares issued under this paragraph 3.2 shall: (a) rank pari passu with other then-outstanding
Ordinary Shares; (b) be duly authorised, validly issued and fully paid up; and (c) be issued free of Encumbrances.

 

		3.2.4	The Series A Conversion Notice shall be dated and shall comprise the following details:

 

		(a)	the number of Series A Preference Shares in respect of which the holder of such Series A Preference Share
is exercising its right under paragraph 3.2; and

 

		(b)	the number of Ordinary Shares that such Shares shall convert into pursuant to paragraph 3.2, with such
number of Ordinary Shares to be determined, for the avoidance of doubt, based upon such financial and corporate details of the Company
as are required to accurately calculate the same, which shall be provided by the Company to the relevant Series A Investors.

 

		3.2.5	Upon receiving the Series A Conversion Notice, the Company shall effect the following:

 

		(a)	Convene a meeting of the Board to be held not later than 21 (twenty one) days from the date of the Series
A Conversion Notice, in which meeting the Company shall approve:

 

		(i)	The conversion of such number of Series A Preference Shares as are mentioned in the Series A Conversion
Notice; and

 

		(ii)	The issuance and allotment of such number of Ordinary Shares as are mentioned in the Series A Conversion
Notice.

 

		(b)	Cancel the share certificates representing such number of Series A Preference Shares as are stated in
the Series A Conversion Notice. The Company and the Founders agree to do all such acts and deeds to give effect to the provisions of this
paragraph 3.2, including, if required, convening a meeting of the Board to approve the splitting of the share certificates representing
the Series A Preference Shares;

 

		(c)	Issue share certificates to the Series A Investors, to evidence such Series A Investors as the owner of
the Ordinary Shares issued upon conversion of such number of Series A Preference Shares as are mentioned in the Series A Conversion Notice;

 

		(d)	Update its register of members to reflect such Series A Investors as the owner of the Ordinary Shares
issued to it pursuant to the conversion of such number of Series A Preference Shares as are mentioned in the Series A Conversion Notice;
and

 

		(e)	Make all necessary filings, disclosures and procedures as required under Applicable Law or as required
by the Series A Investors including the return filed with the Singapore Accounting and Corporate Regulatory Authority in relation to the
allotment and issuance of Ordinary Shares and provide the Series A Investors with certified true copies of such forms duly filed with
the relevant authority along with receipts in respect of such fillings.

 

    111

     

    

 

		3.3	Automatic Conversion

 

		3.3.1	The Company shall convert all the Series A Preference Shares into Ordinary Shares, based on the Series
A Conversion Factor if at any time after the First Completion Date, (a) the Company undertakes a QIPO for the issue of Shares to the public,
or (b) a majority of the Series A Holders, consent in writing to convert their Series A Preference Shares into Ordinary shares. The Series
A Preference Shares shall convert into Ordinary Shares at the latest permissible time prior to the closing of the QIPO/IPO permitted under
Applicable Law for holding such Series A Preference Shares by the Series A Investors or within 21(twenty one) days from the date on which
CMDB and Sequoia consent in writing to convert their Series A Preference Shares into Ordinary shares, as the case may be (the “Automatic
Series A Conversion Date”).

 

		3.3.2	The Series A Preference Shares shall convert based on the Series A Conversion Factor determined on the
Automatic Series A Conversion Date immediately prior to such conversion.

 

		3.3.3	The Company and the Founders shall, subject to the Applicable Law, forthwith comply with the provisions
of Clause 14 (Reinstatement of Rights) of the Agreement in the event that:

 

		(a)	The Series A Investors have converted, pursuant to a requirement under Applicable Law, the Series A Preference
Shares into Ordinary Shares at any time prior to completion of QIPO or IPO; and

 

		(b)	Within the Listing Date, the QIPO or an IPO (as applicable) does not complete such that the entire issued,
paid-up and subscribed Share Capital is not admitted to trading on a Recognised Stock Exchange by the expiry of the Listing Date.

 

		4	REDEMPTION

 

		4.1	Subject to the priority in redemption of Series D Preference Shares, each Series A Preference Share shall
be redeemable in accordance with paragraph 4 upon the earlier of (the “Series A Redemption Event”):

 

		4.1.1	the expiry of the Exit Period; or

 

		4.1.2	on the occurrence of a Trigger Event; or

 

		4.1.3	the election of either or both of the Series A Investors to exercise their rights under Clause 11.4.1
of the Series A Subscription Agreement.

 

		4.2	The Series A Preference Shares shall be redeemable at the Series A Preference Amount.

 

    112

     

    

 

		4.3	Subject to paragraph 4.3 of Schedule 10, any time after the occurrence of a Series A Redemption Event
and upon issuance of the Series D Redemption Notice, each of the holders of the Series A Preference Shares may at such holders’
option issue a notice (“Series A Redemption Notice”) to the Company seeking redemption of such number of Series A Preference
Shares as mentioned in the Series A Redemption Notice along with original share certificates in respect of such Series A Preference Shares
sought to be redeemed. The Company shall within 3 (three) Business Days of receipt of the Series A Redemption Notice, notify the other
Preference Shareholders that they are in receipt of such Series A Redemption Notice, and, to the extent that the respective rights of
redemption have accrued under the terms of their respective Preference Shares, the other Preference Shareholders shall have the option
to issue redemption notices of their own in respect of their Preference Shares (“Other Shareholder Redemption Notice”)
within 10 (ten) Business Days of notification by the Company (“Other Shareholder Redemption Notice Deadline”). Within
15 (fifteen) Business Days from the Other Shareholder Redemption Notice Deadline, the Company shall take all necessary steps for redemption
of such number of Series A Preference Shares as mentioned in the Series A Redemption Notice at the Series A Preference Amount, and such
number of Preference Shares mentioned in the other Shareholder Redemption Notices at the relevant Preference Amount (where applicable).
It is clarified that the holders of Series D Preference Shares shall be entitled to redeem their Series D Preference Shares in priority
over any other Preference Shareholders (including Series A Holders, Series B Holders, Series C Holders and the Series U Preference Shares)
of the Company.

 

		4.4	Series D Preference Shares shall be redeemed in priority to the other classes of Preference Shares (including
Series A Preference Shares, Series B Preference Shares, Series C Preference Shares and Series U Preference Shares). If the funds of the
Company legally available for redemption are insufficient to redeem such shares in full, those funds that are legally available shall
be used to redeem the maximum number of Series D Preference Shares. At any time when additional funds are legally available, such funds
will be immediately used for redemption for the balance number of the Series D Preference Shares not redeemed earlier. After redemption
of the Series D Preference Shares in full, Series A Preference Shares, Series B Preference Shares, Series C Preference Shares and Series
U Preference Shares shall be eligible to be redeemed on a pro-rata basis.

 

		4.5	The Series A Preference Shares mentioned in the Series A Redemption Notice but not redeemed shall remain
outstanding and be entitled to all the rights and preferences provided herein.

 

		4.6	Upon the completion of redemption in accordance with this paragraph 4, each redeemed Series A Preference
Shares shall stand cancelled.

 

    113

     

    

 

Schedule 8

Terms of Series B Preference Shares

 

		1	VOTING

 

		1.1	From and after the First Completion Date, the voting rights of every Shareholder on every resolution placed
before the Company shall, to the extent permissible under Applicable Law, be one vote per 0.001 of a share on an As If Converted Basis.
The number of votes shall be subject to adjustment in the event that the number of Ordinary Shares to be issued upon conversion of the
Series B Preference Shares is subject to any increase or decrease pursuant to the Transaction Documents.

 

		1.2	Without prejudice to the rights of the Series B Investors under the Transaction Documents, each of the
Founders and the Company acknowledge that each Series B Investor has agreed to subscribe to Series B Preference Shares on the basis that
such Series B Investor shall be able to exercise voting rights on the Series B Preference Shares on an As If Converted Basis. In the event
(i) the Company is converted from a private company to a public company; or (ii) any Series B Investor is unable to exercise voting rights
on the Series B Preference Shares held by it due to Applicable Law or otherwise, until the conversion of such Series B Preference Shares
to Ordinary Shares, the Founders agree that they shall each vote on such number of Shares now or hereafter owned by them representing
the percentage shareholding of such Series B Investor in the Company, pursuant to the Series B Preference Shares held by such Series B
Investor, on an As If Converted Basis, whether beneficially or otherwise, or as to which they have voting power, in accordance with the
instructions of such Series B Investor at all meetings of the Shareholders of the Company or provide proxies without instructions to such
Series B Investor for the purposes of meetings of the Shareholders of the Company, such that such number of Shares (held by the Founders)
representing the shareholding of such Series B Investor in the Company, pursuant to the Series B Preference Shares held by such Series
B Investor, on an As If Converted Basis, determined in accordance with the Transaction Documents at the time of such voting, are voted
in the manner required by such Series B Investor.

 

		1.3	In pursuance of the provisions of Paragraph 1.2, the Founders jointly and severally, hereby irrevocably
appoint each Series B Investor as proxy and attorney-in-fact for the Founders and, for and on behalf of each Founder, each Series B Investor
is hereby authorised to vote or act by written consent in any manner as such Series B Investor may deem fit with respect to such Ordinary
Shares held by the Founders representing the percentage shareholding of such Series B Investor in the Company, pursuant to the Series
B Preference Shares held by such Series B Investor, on an As If Converted Basis and do and perform all such acts, deeds, matters and things
from time to time as may be necessary, desirable, or appropriate for or in connection with the powers conferred under this paragraph 1.3.
The power herein vested may be exercised if and only if the Series B Investor is not able to exercise voting rights in respect of Series
Preference Shares held by such Series B Investor on account of any provisions of Applicable Law.

 

		1.4	Notwithstanding anything herein contained, the provisions of paragraphs 1.2 and 1.3 shall only apply in
respect of Series B Preference Shares held by a Series B Investor and in respect of which voting rights cannot be exercised on account
of Applicable Law and to the extent that such voting rights are not available in respect of any resolution being considered by the Company.

 

    114

     

    

 

		2	DIVIDEND

 

		2.1	The holders of the Series B Preference Shares shall be entitled to receive, on a pari passu basis
with the Series A Holders, Series C Holders and Series U Holders, on the Series B Preference Shares, a non-cumulative and preferential
dividend at the rate of 8% (eight percent) of the subscription price of each Series B Preference Share per annum in the event that dividend
is declared by the Board in each Financial Year in which the Company has profits available for distribution in accordance with Applicable
Law, to be paid in preference and priority to the payment of dividend in respect of all other Shares of the Company, present or future,
except (i) Series A Preference Shares, Series C Preference Shares and Series U Preference Shares shall be paid pari-passu, and (ii) Series
D Preference Shares shall rank in priority, with the Series B Preference Shares for the payment of dividends with the Series B Preference
Shares. It is clarified that the Board shall determine as to whether dividend should be declared in a given year and availability of profits
shall not make it obligatory on the Company to declare any dividend.

 

		2.2	Notwithstanding the generality of the above, the Company shall not declare any dividend in respect of
Shares held by any other Shareholders (other than the Series B Investors, Series C Investors, Series D Investors and the Series U Investor),
in excess of the dividend permissible to be paid to the Series B Investors, under Applicable Law with respect to the Series B Preference
Shares held by the Series B Investors.

 

		2.3	In addition to the preferential dividend under paragraph 2.1, the holders of the Series B Preference Shares
shall be entitled to participate in any dividend declared by the Board to the holders of shares of any other class (including Ordinary
Shares and Series A Preference Shares, Series C Preference Shares, Series D Preference Shares and Series U Preference Shares), on a pari
passu basis on an As If Converted Basis.

 

		3	CONVERSION OF SERIES B PREFERENCE SHARES

 

		3.1	The Series B Preference Shares unless redeemed earlier in accordance with paragraph 4 hereof, shall be
convertible into Ordinary Shares at the option of the holders of such Series B Preference Shares in accordance with paragraph 3.2 below.
Any Series B Preference Shares that have not been converted into Ordinary Shares shall compulsorily convert into Ordinary Shares in accordance
with paragraph 3.3 on the Automatic Series B Conversion Date in accordance with the Transaction Documents.

 

		3.2	Right to Conversion

 

		3.2.1	The holders of the Series B Preference Shares shall have the right, at any time and from time to time
to require the Company, by written notice (the “Series B Conversion Notice”), to convert all or part of the Series
B Preference Shares, held by it into Ordinary Shares.

 

		3.2.2	Each 0.001 of a Series B Preference Share shall convert into 0.001 of an Ordinary Share, subject to further
adjustments in accordance with Schedule 5, without the holders of such Series B Preference Shares being required to pay any amount for
such conversion (“Series B Conversion Factor”).

 

		3.2.3	The Ordinary Shares issued under this paragraph 3.2 shall: (a) rank pari passu with other then-outstanding
Ordinary Shares; (b) be duly authorised, validly issued and fully paid up; and (c) be issued free of Encumbrances.

 

    115

     

    

 

		3.2.4	The Series B Conversion Notice shall be dated and shall comprise the following details:

 

		(a)	the number of Series B Preference Shares in respect of which
the holder of such Series B Preference Share is exercising its right under paragraph 3.2; and

 

		(b)	the number of Ordinary Shares that such Shares shall convert into pursuant to paragraph 3.2., with such
number of Ordinary Shares to be determined, for the avoidance of doubt, based upon such financial and corporate details of the Company
as are required to accurately calculate the same, which shall be provided by the Company to the relevant Series B Investors.

 

		3.2.5	Upon receiving the Series B Conversion Notice, the Company shall effect the following:

 

		(a)	Convene a meeting of the Board to be held not later than 21 (twenty one) days from the date of the Series
B Conversion Notice, in which meeting the Company shall approve:

 

		(i)	The conversion of such number of Series B Preference Shares
as are mentioned in the Series B Conversion Notice; and

 

		(ii)	The issuance and allotment of such number of Ordinary Shares as are mentioned in the Series B Conversion
Notice.

 

		(b)	Cancel the share certificates representing such number of Series B Preference Shares as are stated in
the Series B Conversion Notice. The Company and the Founders agree to do all such acts and deeds to give effect to the provisions of this
paragraph 3.2, including, if required, convening a meeting of the Board to approve the splitting of the share certificates representing
the Series B Preference Shares;

 

		(c)	Issue share certificates to the Series B Investors, to evidence such Series B Investors as the owner of
the Ordinary Shares issued upon conversion of such number of Series B Preference Shares as are mentioned in the Series B Conversion Notice;

 

		(d)	Update its register of members to reflect such Series B Investors as the owner of the Ordinary Shares
issued to it pursuant to the conversion of such number of Series B Preference Shares as are mentioned in the Series B Conversion Notice;
and

 

		(e)	Make all necessary filings, disclosures and procedures as required under Applicable Law or as required
by the Series B Investors including the return filed with the Singapore Accounting and Corporate Regulatory Authority in relation to the
allotment and issuance of Ordinary Shares and provide the Series B Investors with certified true copies of such forms duly filed with
the relevant authority along with receipts in respect of such fillings.

 

		3.3	Automatic Conversion

 

		3.3.1	The Company shall convert all the Series B Preference Shares into Ordinary Shares, based on the Series
B Conversion Factor if at any time after the First Completion Date, (a) the Company undertakes a QIPO for the issue of Shares to the public
or (b) a majority of the Series B Holders, consent in writing to convert their Series B Preference Shares into Ordinary shares. The Series
B Preference Shares shall convert into Ordinary Shares at the latest permissible time prior to the closing of the QIPO/IPO permitted under
Applicable Law for holding such Series B Preference Shares by the Series B Investors or within 21 (twenty one) days from the date on which
the Series B Investors consent in writing to convert their shares into Ordinary shares, as the case may be (the “Automatic Series
B Conversion Date”).

 

    116

     

    

 

		3.3.2	The Series B Preference Shares shall convert based on the Series B Conversion Factor determined on the
Automatic Series B Conversion Date immediately prior to such conversion.

 

		3.3.3	The Company and the Founders shall, subject to the Applicable Law, forthwith comply with the provisions
of Clause 14 (Reinstatement of Rights) of the Agreement in the event that:

 

		(a)	The Series B Investors have converted, pursuant to a requirement under Applicable Law, the Series B Preference
Shares into Ordinary Shares at any time prior to completion of QIPO or IPO; and

 

		(b)	Within the Listing Date, the QIPO or an IPO (as applicable) does not complete such that the entire issued,
paid-up and subscribed Share Capital is not admitted to trading on a Recognised Stock Exchange by the expiry of the Listing Date.

 

		4	REDEMPTION

 

		4.1	Subject to the priority in redemption of Series D Preference Shares, each Series B Preference Share shall
be redeemable in accordance with this paragraph 4 upon the earlier of (the “Series B Redemption Event”):

 

		4.1.1	the expiry of the Exit Period; or

 

		4.1.2	on the occurrence of a Trigger Event.

 

		4.2	The Series B Preference Shares shall be redeemable at the Series B Preference Amount.

 

		4.3	Subject to paragraph 4.3 of Schedule 10, any time after the occurrence of a Series B Redemption Event
and upon issuance of the Series D Redemption Notice, each of the holders of the Series B Preference Shares may at such holders’
option issue a notice (“Series B Redemption Notice”) to the Company seeking redemption of such number of Series B Preference
Shares as mentioned in the Series B Redemption Notice along with original share certificates in respect of such Series B Preference Shares
sought to be redeemed. The Company shall within 3 (three) Business Days of receipt of the Series B Redemption Notice, notify the other
Preference Shareholders that they are in receipt of such Series B Redemption Notice, and, to the extent that the respective rights of
redemption have accrued under the terms of their respective Preference Shares, the other Preference Shareholders shall have the option
to issue redemption notices of their own in respect of their Preference Shares (“Other Shareholder Redemption Notice”)
within 10 (ten) Business Days of notification by the Company (“Other Shareholder Redemption Notice Deadline”). Within
15 (fifteen) Business Days from the Other Shareholder Redemption Notice Deadline, the Company shall take all necessary steps for redemption
of such number of Series B Preference Shares as mentioned in the Series B Redemption Notice at the Series B Preference Amount, and such
number of Preference Shares mentioned in the other Shareholder Redemption Notices at the relevant Preference Amount (where applicable).
It is clarified that the holders of Series D Preference Shares shall be entitled to redeem their Series D Preference Shares in priority
over any other Preference Shareholders (including Series A Holders, Series B Holders, Series C Holders and the Series U Preference Shares)
of the Company.

  

		4.4	Series D Preference Shares shall be redeemed in priority to the other classes of Preference Shares (including
the Series A Preference Shares, Series B Preference Shares, Series C Preference Shares and Series U Preference Shares). If the funds of
the Company legally available for redemption are insufficient to redeem such shares in full, those funds that are legally available shall
be used to redeem the maximum number of Series D Preference Shares. At any time when additional funds are legally available, such funds
will be immediately used for redemption for the balance number of the Series D Preference Shares not redeemed earlier. After redemption
of the Series D Preference Shares in full, Series A Preference Shares, Series B Preference Shares, Series C Preference Shares and Series
U Preference Shares shall be eligible to be redeemed on a pro-rata basis.

 

		4.5	The Series B Preference Shares mentioned in the Series B Redemption Notice but not redeemed shall remain
outstanding and be entitled to all the rights and preferences provided herein.

 

		4.6	Upon the completion of redemption in accordance with this paragraph 4, each redeemed Series B Preference
Shares shall stand cancelled.

 

    117

     

    

 

Schedule 9

Terms of Series C Preference Shares

 

		1.	VOTING

 

		1.1	From and after the First Completion Date, the voting rights of every Shareholder on every resolution placed
before the Company shall, to the extent permissible under Applicable Law, be one vote per 0.001 of a share on an As If Converted Basis.
The number of votes shall be subject to adjustment in the event that the number of Ordinary Shares to be issued upon conversion of the
Series C Preference Shares is subject to any increase or decrease pursuant to the Transaction Documents.

 

		1.2	Without prejudice to the rights of the Series C Investors under the Transaction Documents, each of the
Founders and the Company acknowledge that each Series C Investor has agreed to subscribe to Series C Preference Shares on the basis that
such Series C Investor shall be able to exercise voting rights on the Series C Preference Shares on an As If Converted Basis. In the event
(i) the Company is converted from a private company to a public company; or (ii) any Series C Investor is unable to exercise voting rights
on the Series C Preference Shares held by it due to Applicable Law or otherwise, until the conversion of such Series C Preference Shares
to Ordinary Shares, the Founders agree that they shall each vote on such number of Shares now or hereafter owned by them representing
the percentage shareholding of such Series C Investor in the Company, pursuant to the Series C Preference Shares held by such Series C
Investor, on an As If Converted Basis, whether beneficially or otherwise, or as to which they have voting power, in accordance with the
instructions of such Series C Investor at all meetings of the Shareholders of the Company or provide proxies without instructions to such
Series C Investor for the purposes of meetings of the Shareholders of the Company, such that such number of Shares (held by the Founders)
representing the shareholding of such Series C Investor in the Company, pursuant to the Series C Preference Shares held by such Series
C Investor, on an As If Converted Basis, determined in accordance with the Transaction Documents at the time of such voting, are voted
in the manner required by such Series C Investor.

 

		1.3	In pursuance of the provisions of paragraph 1.2, the Founders jointly and severally, hereby irrevocably
appoint each Series C Investor as proxy and attorney-in-fact for the Founders and, for and on behalf of each Founder, each Series C Investor
is hereby authorised to vote or act by written consent in any manner as such Series C Investor may deem fit with respect to such Ordinary
Shares held by the Founders representing the percentage shareholding of such Series C Investor in the Company, pursuant to the Series
C Preference Shares held by such Series C Investor, on an As If Converted Basis and do and perform all such acts, deeds, matters and things
from time to time as may be necessary, desirable, or appropriate for or in connection with the powers conferred under this paragraph 1.3.
The power herein vested may be exercised if and only if the Series C Investor is not able to exercise voting rights in respect of Series
C Preference Shares held by such Series C Investor on account of any provisions of Applicable Law.

 

		1.4	Notwithstanding anything herein contained, the provisions of paragraphs 1.2 and 1.3 shall only apply in
respect of Series C Preference Shares held by a Series C Investor and in respect of which voting rights cannot be exercised on account
of Applicable Law and to the extent that such voting rights are not available in respect of any resolution being considered by the Company.

 

    118

     

    

 

		2.	DIVIDEND

 

		2.1	The holders of the Series C Preference Shares shall be entitled to receive, on a pari passu basis
with the Series A Holders, the Series B Holders and the Series U Holders, a non-cumulative and preferential dividend at the rate of 8%
(eight percent) of the subscription price of each Series C Preference Share per annum in the event that dividend is declared by the Board
in each Financial Year in which the Company has profits available for distribution in accordance with Applicable Law, to be paid in preference
and priority to the payment of dividend in respect of all other Shares of the Company, present or future, except (i) Series A Preference
Shares, Series B Preference Shares and Series U Preference Shares shall be paid pari-passu, and (ii) Series D Preference Shares shall
rank in priority, with the Series C Preference Shares for the payment of dividends with the Series C Preference Shares. It is clarified
that the Board shall determine as to whether dividend should be declared in a given year and availability of profits shall not make it
obligatory on the Company to declare any dividend.

 

		2.2	Notwithstanding the generality of the above, the Company shall not declare any dividend in respect of
Shares held by any other Shareholders (other than the preferential dividend on the Series A Preference Shares, Series B Preference Shares,
Series C Preference Shares, Series D Preference Shares and Series U Preference Shares), in excess of the dividend permissible to be paid
to the Series C Investors under Applicable Law with respect to the Series C Preference Shares held by each of the Preference Shareholders.

 

		2.3	For any other dividends or distributions (other than the preferential dividend on the Series A Preference
Shares, Series B Preference Shares, Series C Preference Shares, Series D Preference Shares, and Series U Preference Shares), the holders
of the Series C Preference Shares participates with the holders of shares of any other class (including Ordinary Shares, Series A Preference
Shares, Series B Preference Shares, Series D Preference Shares and Series U Preference Shares) on a pari passu basis, on an As
If Converted Basis.

 

		3.	CONVERSION OF SERIES C PREFERENCE SHARES

 

		3.1	The Series C Preference Shares unless redeemed earlier in accordance with paragraph 4 hereof, shall be
convertible into Ordinary Shares at the option of the holders of such Series C Preference Shares in accordance with paragraph 3.2 below.
Any Series C Preference Shares that have not been converted into Ordinary Shares shall compulsorily convert into Ordinary Shares in accordance
with paragraph 3.3 on the Automatic Series C Conversion Date in accordance with the Transaction Documents.

 

		3.2	Right to Conversion

 

		3.2.1	The holders of the Series C Preference Shares shall have the right, at any time and from time to time
to require the Company, by written notice (the “Series C Conversion Notice”), to convert all or part of the Series
C Preference Shares, held by it into Ordinary Shares.

 

		3.2.2	Each 0.001 of a Series C Preference Share shall convert into 0.001 of an Ordinary Share, subject to further
adjustments in accordance with Schedule 5, without the holders of such Series C Preference Shares being required to pay any amount for
such conversion (“Series C Conversion Factor”).

 

    119

     

    

 

		3.2.3	The Ordinary Shares issued under this paragraph 3.2 shall: (a) rank pari passu with other then-outstanding
Ordinary Shares; (b) be duly authorised, validly issued and fully paid up; and (c) be issued free of Encumbrances.

 

		3.2.4	The Series C Conversion Notice shall be dated and shall comprise the following details:

 

		(a)	the number of Series C Preference Shares in respect of which the holder of such Series C Preference Share
is exercising its right under paragraph 3.2; and

 

		(b)	the number of Ordinary Shares that such Shares shall convert into pursuant to paragraph 3.2, with such
number of Ordinary Shares to be determined, for the avoidance of doubt, based upon such financial and corporate details of the Company
as are required to accurately calculate the same, which shall be provided by the Company to the relevant Series C Investors.

 

		3.2.5	Upon receiving the Series C Conversion Notice, the Company shall effect the following:

 

		(a)	Convene a meeting of the Board to be held not later than 21 (twenty one) days from the date of the Series
C Conversion Notice, in which meeting the Company shall approve:

 

		i.	The conversion of such number of Series C Preference Shares
as are mentioned in the Series C Conversion Notice; and

 

		ii.	The issuance and allotment of such number of Ordinary Shares
as are mentioned in the Series C Conversion Notice.

 

		(b)	Cancel the share certificates representing such number of Series C Preference Shares as are stated in
the Series C Conversion Notice. The Company and the Founders agree to do all such acts and deeds to give effect to the provisions of this
paragraph 3.2, including, if required, convening a meeting of the Board to approve the splitting of the share certificates representing
the Series C Preference Shares;

 

		(c)	Issue share certificates to the Series C Investors, to evidence such Series C Investors as the owner of
the Ordinary Shares issued upon conversion of such number of Series C Preference Shares as are mentioned in the Series C Conversion Notice;

 

		(d)	Update its register of members to reflect such Series C Investors as the owner of the Ordinary Shares
issued to it pursuant to the conversion of such number of Series C Preference Shares as are mentioned in the Series C Conversion Notice;
and

 

		(e)	Make all necessary filings, disclosures and procedures as required under Applicable Law or as required
by the Series C Investors including the return filed with the Singapore Accounting and Corporate Regulatory Authority in relation to the
allotment and issuance of Ordinary Shares and provide the Series C Investors with certified true copies of such forms duly filed with
the relevant authority along with receipts in respect of such fillings.

 

    120

     

    

 

		3.3	Automatic Conversion

 

		3.3.1	The Company shall convert all the Series C Preference Shares into Ordinary Shares, based on the Series
C Conversion Factor if at any time after the First Completion Date, (a) the Company undertakes a QIPO for the issue of Shares to the public
or (b) a majority of the Series C Holders, consent in writing to convert their Series C Preference Shares into Ordinary Shares. The Series
C Preference Shares shall convert into Ordinary Shares at the latest permissible time prior to the closing of the QIPO/IPO permitted under
Applicable Law for holding such Series C Preference Shares by the Series C Investors or within 21 (twenty one) days from the date on which
the Series C Investors consent in writing to convert their shares into Ordinary shares, as the case may be (the “Automatic Series
C Conversion Date”).

 

		3.3.2	The Series C Preference Shares shall convert based on the Series C Conversion Factor determined on the
Automatic Series C Conversion Date immediately prior to such conversion.

 

		3.3.3	The Company and the Founders shall, subject to the Applicable Law, forthwith comply with the provisions
of Clause 14 (Reinstatement of Rights) of the Agreement in the event that:

 

		(a)	The Series C Investors have converted, pursuant to a requirement under Applicable Law, the Series C Preference
Shares into Ordinary Shares at any time prior to completion of QIPO or IPO; and

 

		(b)	Within the Listing Date, the QIPO or an IPO (as applicable) does not complete such that the entire issued,
paid-up and subscribed Share Capital is not admitted to trading on a Recognised Stock Exchange by the expiry of the Listing Date.

 

		4	REDEMPTION

 

		4.1	Subject to the priority in redemption of Series D Preference Shares, each Series C Preference Share shall
be redeemable in accordance with this paragraph 4 upon the earlier of (the “Series C Redemption Event”):

 

		4.1.1	the expiry of the Exit Period; or

 

		4.1.2	on the occurrence of a Trigger Event; or

 

		4.1.3	the election by any of the Series C Investor to exercise their rights under Clause 4.4(b) of the Series
C Subscription Agreement.

 

		4.2	The Series C Preference Shares shall be redeemable at the Series C Preference Amount with the declared
but unpaid dividends on the Series C Preference Shares (“Series C Redemption Price”).

 

    121

     

    

 

		4.3	Subject to paragraph 4.3 of Schedule 10, any time after the occurrence of a Series C Redemption Event
and upon issuance of the Series D Redemption Notice, each of the holders of the Series C Preference Shares may at such holders’
option issue a notice (“Series C Redemption Notice”) to the Company seeking redemption of such number of Series C Preference
Shares as mentioned in the Series C Redemption Notice along with original share certificates in respect of such Series C Preference Shares
sought to be redeemed. The Company shall within 3 (three) Business Days of receipt of the Series C Redemption Notice, notify the other
Preference Shareholders that they are in receipt of such Series C Redemption Notice, and, to the extent that the respective rights of
redemption have accrued under the terms of their respective Preference Shares, the other Preference Shareholders shall have the option
to issue redemption notices of their own in respect of their Preference Shares (“Other Shareholder Redemption Notice”)
within 10 (ten) Business Days of notification by the Company (“Other Shareholder Redemption Notice Deadline”). Within
15 (fifteen) Business Days from the Other Shareholder Redemption Notice Deadline, the Company shall take all necessary steps for redemption
of such number of Series C Preference Shares as mentioned in the Series C Redemption Notice at the Series C Preference Amount, and such
number of Preference Shares mentioned in the other Shareholder Redemption Notices at the relevant Preference Amount (where applicable).
It is clarified that the holders of Series D Preference Shares shall be entitled to redeem their Series D Preference Shares in priority
over any other Preference Shareholders (including Series A Holders, Series B Holders, Series C Holders and the Series U Preference Shares)
of the Company.

 

		4.4	The Series D Preference Shares shall be redeemed in priority to the other classes of Preference Shares
(including the Series A Preference Shares, Series B Preference Shares, Series C Preference Shares and Series U Preference Shares). If
the funds of the Company legally available for redemption are insufficient to redeem such shares in full, those funds that are legally
available shall be used to redeem the maximum number of Series D Preference Shares. At any time when additional funds are legally available,
such funds will be immediately used for redemption for the balance number of the Series D Preference Shares not redeemed earlier. After
redemption of the Series D Preference Shares in full, Series A Preference Shares, Series B Preference Shares, Series C Preference Shares
and Series U Preference shall be eligible to be redeemed on a pro-rata basis.

 

		4.5	The Series C Preference Shares mentioned in the Series C Redemption Notice but not redeemed shall remain
outstanding and be entitled to all the rights and preferences provided herein.

 

		4.6	Upon the completion of redemption in accordance with this paragraph 4, each redeemed Series C Preference
Shares shall stand cancelled.

 

    122

     

    

 

Schedule 10

Terms of Series D Preference Shares

 

		1.	VOTING

 

		1.1	From and after the First Completion Date, the voting rights of every Shareholder on every resolution placed
before the Company shall, to the extent permissible under Applicable Law, be 1 (one) vote per 0.001 of a share on an As If Converted Basis.
The number of votes shall be subject to adjustment in the event that the number of Ordinary Shares to be issued upon conversion of the
Series D Preference Shares is subject to any increase or decrease pursuant to the Transaction Documents.

 

		1.2	Without prejudice to the rights of the Series D Investors under the Transaction Documents, each of the
Founders and the Company acknowledge that each Series D Investor has agreed to subscribe to Series D Preference Shares on the basis that
such Series D Investor shall be able to exercise voting rights on the Series D Preference Shares on an As If Converted Basis. In the event
(i) the Company is converted from a private company to a public company; or (ii) any Series D Investor is unable to exercise voting rights
on the Series D Preference Shares held by it due to Applicable Law or otherwise, until the conversion of such Series D Preference Shares
to Ordinary Shares, the Founders agree that they shall each vote on such number of Shares now or hereafter owned by them representing
the percentage shareholding of such Series D Investor in the Company, pursuant to the Series D Preference Shares held by such Series D
Investor, on an As If Converted Basis, whether beneficially or otherwise, or as to which they have voting power, in accordance with the
instructions of such Series D Investor at all meetings of the Shareholders of the Company or provide proxies without instructions to such
Series D Investor for the purposes of meetings of the Shareholders of the Company, such that such number of Shares (held by the Founders)
representing the shareholding of such Series D Investor in the Company, pursuant to the Series D Preference Shares held by such Series
D Investor, on an As If Converted Basis, determined in accordance with the Transaction Documents at the time of such voting, are voted
in the manner required by such Series D Investor.

 

		1.3	In pursuance of the provisions of Paragraph 1.2, the Founders, jointly and severally, hereby irrevocably
appoint each Series D Investor as proxy and attorney-in-fact for the Founders and, for and on behalf of each Founder, each Series D Investor
is hereby authorised to vote or act by written consent in any manner as such Series D Investor may deem fit with respect to such Ordinary
Shares held by the Founders representing the percentage shareholding of such Series D Investor in the Company, pursuant to the Series
D Preference Shares held by such Series D Investor, on an As If Converted Basis and do and perform all such acts, deeds, matters and things
from time to time as may be necessary, desirable, or appropriate for or in connection with the powers conferred under this paragraph 1.3.
The power herein vested may be exercised if and only if the Series D Investor is not able to exercise voting rights in respect of Series
D Preference Shares held by such Series D Investor on account of any provisions of Applicable Law.

 

		1.4	Notwithstanding anything herein contained, the provisions of paragraphs 1.2 and 1.3 shall only apply in
respect of Series D Preference Shares held by a Series D Investor and in respect of which voting rights cannot be exercised on account
of Applicable Law and to the extent that such voting rights are not available in respect of any resolution being considered by the Company.

 

    123

     

    

 

		2.	DIVIDEND

 

		2.1	The holders of the Series D Preference Shares shall be entitled to receive, in priority to the Series
A Holders, Series B Holders, Series C Holders and Series U Holders, on the Series D Preference Shares, a non-cumulative and preferential
dividend at the rate of 8% (eight percent) of the subscription price of each Series D Preference Share per annum in the event that dividend
is declared by the Board in each Financial Year in which the Company has profits available for distribution in accordance with Applicable
Law, to be paid in preference and priority to the payment of dividend in respect of all other Shares of the Company, present or future.
It is clarified that the Board shall determine as to whether dividend should be declared in a given year and availability of profits shall
not make it obligatory on the Company to declare any dividend.

 

		2.2	Notwithstanding the generality of the above, the Company shall not declare any dividend in respect of
Shares held by any other Shareholders (including the preferential dividend on the Series A Preference Shares, Series B Preference Shares,
Series C Preference Shares and Series U Preference Shares), in excess of the dividend permissible to be paid to the Series D Investors
under Applicable Law with respect to the Series D Preference Shares held by the Series D Investors.

 

		2.3	For any other dividends or distributions (other than the preferential dividend on the Series A Preference
Shares, Series B Preference Shares, Series C Preference Shares, Series D Preference Shares and Series U Preference Shares), the holders
of the Series D Preference Shares shall participate with the holders of shares of any other class (including Ordinary Shares, Series A
Preference Shares, Series B Preference Shares, Series C Preference Shares and Series U Preference Shares) on a pari passu basis,
on an As If Converted Basis.

 

		3	CONVERSION OF SERIES D PREFERENCE SHARES

 

		3.1	The Series D Preference Shares unless redeemed earlier in accordance with paragraph 4 hereof, shall be
convertible into Ordinary Shares at the option of the holders of such Series D Preference Shares in accordance with paragraph 3.2 below.
Any Series D Preference Shares that have not been converted into Ordinary Shares shall compulsorily convert into Ordinary Shares in accordance
with paragraph 3.3 on the Automatic Series D Conversion Date in accordance with the Transaction Documents.

 

		3.2	Right to Conversion

 

		3.2.1	The holders of the Series D Preference Shares shall have the right, at any time and from time to time
to require the Company, by written notice (the “Series D Conversion Notice”), to convert all or part of the Series
D Preference Shares, held by it into Ordinary Shares.

 

		3.2.2	Each 0.001 of a Series D Preference Share shall convert into 0.001 of an Ordinary Share, subject to further
adjustments in accordance with Schedule 5, without the holders of such Series D Preference Shares being required to pay any amount for
such conversion (“Series D Conversion Factor”).

 

    124

     

    

 

		3.2.3	The Ordinary Shares issued under this paragraph 3.2 shall: (a) rank pari passu with other then-outstanding
Ordinary Shares; (b) be duly authorised, validly issued and fully paid up; and (c) be issued free of Encumbrances.

 

		3.2.4	The Series D Conversion Notice shall be dated and shall comprise the following details:

 

		(a)	the number of Series D Preference Shares in respect of which the holder of such Series D Preference Share
is exercising its right under paragraph 3.2; and

 

		(b)	the number of Ordinary Shares that such Shares shall convert into pursuant to paragraph 3.2, with such
number of Ordinary Shares to be determined, for the avoidance of doubt, based upon such financial and corporate details of the Company
as are required to accurately calculate the same, which shall be provided by the Company to the relevant Series D Investors.

 

		3.2.5	Upon receiving the Series D Conversion Notice, the Company shall effect the following:

 

		(a)	Convene a meeting of the Board to be held not later than 21 (twenty one) days from the date of the Series
D Conversion Notice, in which meeting the Company shall approve:

 

		i.	The conversion of such number of Series D Preference Shares
as are mentioned in the Series D Conversion Notice; and

 

		ii.	The issuance and allotment of such number of Ordinary Shares
as are mentioned in the Series D Conversion Notice.

 

		(b)	Cancel the share certificates representing such number of Series D Preference Shares as are stated in
the Series D Conversion Notice. The Company and the Founders agree to do all such acts and deeds to give effect to the provisions of this
paragraph 3.2, including, if required, convening a meeting of the Board to approve the splitting of the share certificates representing
the Series D Preference Shares;

 

		(c)	Issue share certificates to the Series D Investors, to evidence such Series D Investors as the owner of
the Ordinary Shares issued upon conversion of such number of Series D Preference Shares as are mentioned in the Series D Conversion Notice;

 

		(d)	Update its register of members to reflect such Series D Investors as the owner of the Ordinary Shares
issued to it pursuant to the conversion of such number of Series D Preference Shares as are mentioned in the Series D Conversion Notice;
and

 

		(e)	Make all necessary filings, disclosures and procedures as required under Applicable Law or as required
by the Series D Investors including the return filed with the Singapore Accounting and Corporate Regulatory Authority in relation to the
allotment and issuance of Ordinary Shares and provide the Series D Investors with certified true copies of such forms duly filed with
the relevant authority along with receipts in respect of such fillings.

 

    125

     

    

 

		3.3	Automatic Conversion

 

		3.3.1	The Company shall convert all the Series D Preference Shares into Ordinary Shares, based on the Series
D Conversion Factor if at any time after the First Completion Date, (a) the Company undertakes a QIPO for the issue of Shares to the public
or (b) a majority of the Series D Holders consent in writing to convert their Series D Preference Shares into Ordinary Shares. The Series
D Preference Shares shall convert into Ordinary Shares at the latest permissible time prior to the closing of the QIPO/IPO permitted under
Applicable Law for holding such Series D Preference Shares by the Series D Investors or within 21 (twenty one) days from the date on which
the Series D Investors consent in writing to convert their shares into Ordinary shares, as the case may be (the “Automatic Series
D Conversion Date”).

 

		3.3.2	The Series D Preference Shares shall convert based on the Series D Conversion Factor determined on the
Automatic Series D Conversion Date immediately prior to such conversion.

 

		3.3.3	The Company and the Founders shall, subject to the Applicable Law, forthwith comply with the provisions
of Clause 14 (Reinstatement of Rights) of the Agreement in the event that:

 

		(a)	The Series D Investors have converted, pursuant to a requirement under Applicable Law, the Series D Preference
Shares into Ordinary Shares at any time prior to completion of QIPO or IPO; and

 

		(b)	Within the Listing Date, the QIPO or an IPO (as applicable) does not complete such that the entire issued,
paid-up and subscribed Share Capital is not admitted to trading on a Recognised Stock Exchange by the expiry of the Listing Date.

 

		4	REDEMPTION

 

		4.1	Each Series D Preference Share shall be redeemable in priority to any other class of Shares, accordance
with this Paragraph 4 upon the earlier of (the “Series D Redemption Event”):

 

		4.1.1	the expiry of Exit Period;

 

		4.1.2	on the occurrence of a Trigger Event; or

 

		4.1.3	the election by any of the Series D Investor to exercise their rights under Clause 4.5 of the Series D
Subscription Agreement.

 

		4.2	The Series D Preference Shares shall be redeemable at the Series D Preference Amount with the declared
but unpaid dividends on the Series D Preference Shares (“Series D Redemption Price”).

 

    126

     

    

 

		4.3	Any time after the occurrence of a Series D Redemption Event, each of the holders of the Series D Preference
Shares may at such holders’ option issue a notice (“Series D Redemption Notice”) to the Company seeking redemption
of such number of Series D Preference Shares as mentioned in the Series D Redemption Notice along with original share certificates in
respect of such Series D Preference Shares sought to be redeemed. The Company shall within 3 (three) Business Days of receipt of the Series
D Redemption Notice, notify the other Preference Shareholders that they are in receipt of such Series D Redemption Notice, and, to the
extent that the respective rights of redemption have accrued under the terms of their respective Preference Shares, the other Preference
Shareholders shall have the option to issue redemption notices of their own in respect of their Preference Shares on a pro-rata basis
(“Other Shareholder Redemption Notice”) within 10 (ten) Business Days of notification by the Company (“Other
Shareholder Redemption Notice Deadline”). Within 15 (fifteen) Business Days from the Other Shareholder Redemption Notice Deadline,
the Company shall take all necessary steps for redemption of such number of Series D Preference Shares as mentioned in the Series D Redemption
Notice at the Series D Preference Amount, and such number of Preference Shares mentioned in the other Shareholder Redemption Notices at
the relevant Preference Amount (where applicable). It is clarified that the holders of the Series D Preference Shares shall be entitled
to redeem their Series D Preference Shares in priority over any other Preference Shareholders (including Series A Holders, Series B Holders,
Series C Holders and the Series U Preference Shares) of the Company.

 

		4.4	The Series D Preference Shares shall be redeemed in priority to the other classes of Preference Shares
(including Series A Preference Shares, Series B Preference Shares, Series C Preference Shares and Series U Preference Shares). If the
funds of the Company legally available for redemption are insufficient to redeem such shares in full, those funds that are legally available
shall be used to redeem the maximum number of Series D Preference Shares. At any time when additional funds are legally available, such
funds will be immediately used for the redemption for the balance number of Series D Preference Shares not redeemed earlier. After redemption
of the Series D Preference Shares in full, Series A Preference Shares, Series B Preference Shares, Series C Preference Shares and Series
U Preference Shares shall be eligible to be redeemed on a pro-rata basis.

 

		4.5	The Series D Preference Shares mentioned in the Series D Redemption Notice but not redeemed shall remain
outstanding and be entitled to all the rights and preferences provided herein.

 

		4.6	Upon the completion of redemption in accordance with this paragraph 4, each redeemed Series D Preference
Shares shall stand cancelled.

 

    127

     

    

 

Schedule 11

Terms of Series U Preference Shares

 

		1.	VOTING

 

		1.1	From and after the Closing Date, the voting rights of every Shareholder on every resolution placed before
the Company shall, to the extent permissible under Applicable Law, be one vote per 0.001 share on an As If Converted Basis. The number
of votes shall be subject to adjustment in the event that the number of Ordinary Shares to be issued upon conversion of the Series U Preference
Shares is subject to any increase or decrease pursuant to the Transaction Documents.

 

		1.2	Without prejudice to the rights of the Series U Investor under the Transaction Documents, each of the
Founders and the Company acknowledge that the Series U Investor has agreed to subscribe to Series U Preference Shares on the basis that
the Series U Investor shall be able to exercise voting rights on the Series U Preference Shares on an As If Converted Basis. In the event
(i) the Company is converted from a private company to a public company; or (ii) the Series U Investor is unable to exercise voting rights
on the Series U Preference Shares held by it due to Applicable Law or otherwise, until the conversion of such Series U Preference Shares
to Ordinary Shares, the Founders agree that they shall each vote on such number of Shares now or hereafter owned by them representing
the percentage shareholding of the Series U Investor in the Company, pursuant to the Series U Preference Shares held by the Series U Investor,
on an As If Converted Basis, whether beneficially or otherwise, or as to which they have voting power, in accordance with the instructions
of the Series U Investor at all meetings of the Shareholders of the Company or provide proxies without instructions to the Series U Investor
for the purposes of meetings of the Shareholders of the Company, such that such number of Shares (held by the Founders) representing the
shareholding of the Series U Investor in the Company, pursuant to the Series U Preference Shares held by the Series U Investor, on an
As If Converted Basis, determined in accordance with the Transaction Documents at the time of such voting, are voted in the manner required
by the Series U Investor.

 

		1.3	In pursuance of the provisions of paragraph 1.2, the Founders jointly and severally, hereby irrevocably
appoint the Series U Investor as proxy and attorney-in-fact for the Founders and, for and on behalf of each Founder, the Series U Investor
is hereby authorised to vote or act by written consent in any manner as the Series U Investor may deem fit with respect to such Ordinary
Shares held by the Founders representing the percentage shareholding of the Series U Investor in the Company, pursuant to the Series U
Preference Shares held by the Series U Investor, on an As If Converted Basis and do and perform all such acts, deeds, matters and things
from time to time as may be necessary, desirable, or appropriate for or in connection with the powers conferred under this paragraph 1.3.
The power herein vested may be exercised if and only if the Series U Investor is not able to exercise voting rights in respect of Series
U Preference Shares held by the Series U Investor on account of any provisions of Applicable Law.

 

		1.4	Notwithstanding anything herein contained, the provisions of paragraphs 1.2 and 1.3 shall only apply in
respect of Series U Preference Shares held by the Series U Investor and in respect of which voting rights cannot be exercised on account
of Applicable Law and to the extent that such voting rights are not available in respect of any resolution being considered by the Company.

 

    128

     

    

 

		2.	DIVIDEND

 

		2.1	The holders of the Series U Preference Shares shall be entitled to receive, on a pari passu basis
with the Series A Holders, the Series B Holders and the Series C Holders a non-cumulative and preferential dividend at the rate of 8%
(eight percent) of the subscription price of each Series U Preference Share per annum in the event that dividend is declared by the Board
in each Financial Year in which the Company has profits available for distribution in accordance with Applicable Law, to be paid in preference
and priority to the payment of dividend in respect of all other Shares of the Company, present or future, except (i) Series A Preference
Shares, Series B Preference Shares and Series C Preference Shares shall be paid pari-passu, and (ii) Series D Preference Shares shall
rank in priority, with the Series U Preference Shares for the payment of dividends with the Series U Preference Shares. It is clarified
that the Board shall determine as to whether dividend should be declared in a given year and availability of profits shall not make it
obligatory on the Company to declare any dividend.

 

		2.2	Notwithstanding the generality of the above, the Company shall not declare any dividend in respect of
Shares held by any other Shareholders (other than the preferential dividend on the Series A Preference Shares, Series B Preference Shares,
Series C Preference Shares, Series D Preference Shares and Series U Preference Shares), in excess of the dividend permissible to be paid
to the Series U Investor under Applicable Law with respect to the Series U Preference Shares held by the Series U Investor.

 

		2.3	For any other dividends or distributions (other than the preferential dividend on the Series A Preference
Shares, Series B Preference Shares, Series C Preference Shares, Series D Preference Shares and Series U Preference Shares), the holders
of the Series U Preference Shares participate with the holders of shares of any other class (including Ordinary Shares, Series A Preference
Shares, Series B Preference Shares, Series C Preference Shares, and Series D Preference Shares) on a pari passu basis, on an As
If Converted Basis.

 

		3.	CONVERSION OF SERIES U PREFERENCE SHARES

 

		3.1	The Series U Preference Shares, unless redeemed earlier in accordance with paragraph 4 hereof, shall be
convertible into Ordinary Shares at the option of the holders of such Series U Preference Shares in accordance with paragraph 3.2 below.
Any Series U Preference Shares that have not been converted into Ordinary Shares shall compulsorily convert into Ordinary Shares in accordance
with paragraph 3.3 on the Automatic Series U Conversion Date in accordance with the Transaction Documents.

 

		3.2	Right to Conversion

 

		3.2.1	The holders of the Series U Preference Shares shall have the right, at any time and from time to time
to require the Company, by written notice (the “Series U Conversion Notice”), to convert all or part of the Series
U Preference Shares, held by it into Ordinary Shares.

 

		3.2.2	Each 0.001 of a Series U Preference Share shall convert into 0.001 of an Ordinary Share, subject to further
adjustments in accordance with Schedule 5, without the holders of such Series U Preference Shares being required to pay any amount for
such conversion (“Series U Conversion Factor”).

 

    129

     

    

 

		3.2.3	The Ordinary Shares issued under this paragraph 3.2 shall: (a) rank pari passu with other then-outstanding
Ordinary Shares; (b) be duly authorised, validly issued and fully paid up; and (c) be issued free of Encumbrances.

 

		3.2.4	The Series U Conversion Notice shall be dated and shall comprise the following details:

 

		(a)	the number of Series U Preference Shares in respect of which the holder of such Series U Preference Shares
is exercising its right under paragraph 3.2; and

 

		(b)	the number of Ordinary Shares that such Shares shall convert into pursuant to paragraph 3.2, with such
number of Ordinary Shares to be determined, for the avoidance of doubt, based upon such financial and corporate details of the Company
as are required to accurately calculate the same, which shall be provided by the Company to the Series U Investor.

 

		3.2.5	Upon receiving the Series U Conversion Notice, the Company shall effect the following:

 

		(a)	Convene a meeting of the Board to be held not later than 21 (twenty one) days from the date of the Series
U Conversion Notice, in which meeting the Company shall approve:

 

		i.	The conversion of such number of Series U Preference Shares
as are mentioned in the Series U Conversion Notice; and

 

		ii.	The issuance and allotment of such number of Ordinary Shares
as are mentioned in the Series U Conversion Notice.

 

		(b)	Cancel the share certificates representing such number of Series U Preference Shares as are stated in
the Series U Conversion Notice. The Company and the Founders agree to do all such acts and deeds to give effect to the provisions of this
paragraph 3.2, including, if required, convening a meeting of the Board to approve the splitting of the share certificates representing
the Series U Preference Shares;

 

		(c)	Issue share certificates to the Series U Investor, to evidence the Series U Investor as the owner of the
Ordinary Shares issued upon conversion of such number of Series U Preference Shares as are mentioned in the Series U Conversion Notice;

 

		(d)	Update its register of members to reflect the Series U Investor as the owner of the Ordinary Shares issued
to it pursuant to the conversion of such number of Series U Preference Shares as are mentioned in the Series U Conversion Notice; and

 

		(e)	Make all necessary filings, disclosures and procedures as required under Applicable Law or as required
by the Series U Investor including the return filed with the Singapore Accounting and Corporate Regulatory Authority in relation to the
allotment and issuance of Ordinary Shares and provide the Series U Investor with certified true copies of such forms duly filed with the
relevant authority along with receipts in respect of such fillings.

 

    130

     

    

 

		3.3	Automatic Conversion

 

		3.3.1	The Company shall convert all the Series U Preference Shares into Ordinary Shares, based on the Series
U Conversion Factor if at any time after the Closing Date, (a) the Company undertakes a QIPO for the issue of Shares to the public or
(b) a majority of the Series U Holders, consent in writing to convert their Series U Preference Shares into Ordinary Shares. The Series
U Preference Shares shall convert into Ordinary Shares at the latest permissible time prior to the closing of the QIPO/IPO permitted under
Applicable Law for holding such Series U Preference Shares by the Series U Investor or within 21 (twenty one) days from the date on which
the Series U Investor consents in writing to convert their shares into Ordinary Shares, as the case may be (the “Automatic Series
U Conversion Date”).

 

		3.3.2	The Series U Preference Shares shall convert based on the Series U Conversion Factor determined on the
Automatic Series U Conversion Date immediately prior to such conversion.

 

		3.3.3	The Company and the Founders shall, subject to the Applicable Law, forthwith comply with the provisions
of Clause 14 (Reinstatement of Rights) of the Agreement in the event that:

 

		(a)	The Series U Investor has converted, pursuant to a requirement
under Applicable Law, the Series U Preference Shares into Ordinary Shares at any time prior to completion of QIPO or IPO; and

 

		(b)	Within the Listing Date, the QIPO or an IPO (as applicable) does not complete such that the entire issued,
paid-up and subscribed Share Capital is not admitted to trading on a Recognised Stock Exchange by the expiry of the Listing Date.

 

		3.4	Company’s right to repurchase Ordinary Shares issued upon conversion of Series U Preference Shares

 

		3.4.1	Subject to Applicable Law, each holder of Series U Preference Shares and each holder of Ordinary Shares
issued upon conversion of any Series U Preference Shares (including the Series U Investor and its successors and permitted assigns and
all subsequent holders of Series U Preference Shares issued or Ordinary Shares issued upon the conversion of any Series U Preference Shares
after the consummation of the Merger) irrevocably agree that upon the occurrence of each Holdback Event the Company shall have the right
to repurchase such number of Ordinary Shares converted from the Series U Preference Shares, necessary to satisfy such Holdback Event,
in accordance with the terms set out in the Merger Agreement, and such repurchased shares shall constitute Holdback Shares hereunder.
Each holder of Series U Preference Shares and each holder of Ordinary Shares issued upon conversion of any Series U Preference Shares
hereby acknowledges that the Company’s repurchase rights set forth in this paragraph 3.4 may be exercised by the Company upon the
occurrence of a Holdback Event whether or not such holder benefited from the Merger or holds or has ever held any equity securities of
the initial Series U Investor.

 

		3.4.2	The Company shall repurchase the Holdback Shares at the Series U Redemption Price.

 

		3.4.3	The Company’s right to repurchase the Ordinary Shares issued upon conversion of the Series U Preference
Shares shall continue until the expiry of all of the indemnification obligations of the Preferred Stockholders (as defined in the Merger
Agreement) under the Merger Agreement, notwithstanding any earlier redemption or repurchase of Holdback Shares, conversion of the Series
U Preference Shares, or any transfer of any Ordinary Shares issued upon conversion of the Series U Preference Shares to any person pursuant
to this Agreement.

 

		3.4.4	The Series U Investor and/or any subsequent holder of the Series U Preference Shares and each holder of
Ordinary Shares issued upon conversion of any Series U Preference Shares hereby irrevocably instructs the Company, upon exercise of the
repurchase right provided for in this paragraph 3.4, to retain and utilise the Series U Redemption Price in full discharge of its obligations
and liabilities arising from such Holdback Event, and waives any rights it may have in relation to the Series U Redemption Price.

 

    131

     

    

 

		3.4.5	The Company and all Shareholders undertake to do all reasonable acts and deeds as may be necessary to
give effect to the repurchase of the Holdback Shares by the Company in connection with the occurrence of each Holdback Event.

 

		3.4.6	Upon the completion of repurchase in accordance with this paragraph 3.4, each repurchased Ordinary Share
shall stand cancelled.

 

		4.	REDEMPTION

 

		4.1	The Series U Preference Shares shall not be redeemable by any Series U Holder but each Series U Holder
shall have the right to participate as set forth below.

 

		4.2	Subject to Applicable Law, each holder of Series U Preference Shares (including the Series U Investor
and its successors and permitted assigns and all holders of Series U Preference Shares issued after the consummation of the Merger) irrevocably
agrees that upon the occurrence of each Holdback Event the Company shall have the right to redeem such number of Series U Preference Shares,
necessary to satisfy such Holdback Event, in accordance with the terms set out in the Merger Agreement, and such redeemed shares shall
constitute Holdback Shares hereunder. Each holder of Series U Preference Shares hereby acknowledges that the Company’s redemption
rights set forth in this paragraph 4 may be exercised by the Company upon the occurrence of a Holdback Event whether or not such holder
benefited from the Merger or holds or has ever held any equity securities of the initial Series U Investor.

 

		4.3	In addition, each Series U Preference Share shall subject to the priority in redemption or repurchase
of Series D Preference Shares and the provisions of Clause 12, (a) be redeemable by the Company in accordance with this paragraph 4 (solely
upon provision by the respective Series U Holder of a Series U Redemption Notice) upon the earlier of (i) the expiry of the Exit Period
or (ii) the occurrence of a Trigger Event or (iii) the Company’s receipt of a Series D Redemption Notice (each a “Series
U Redemption Event”) or (b) be purchased upon the valid exercise of Exit Default Rights and Trade Sale Rights, to give effect
to any participating Series U Holder’s rights pursuant to Clause 12.4.8.

 

		4.4	The applicable Series U Preference Shares shall be redeemable at the following applicable price (“Series
U Redemption Price”):

 

		4.4.1	The Holdback Shares shall be redeemable at the Series U Subscription Price; and

 

		4.4.2	The Series U Preference Shares redeemable pursuant to paragraph 4.3 above shall be redeemable at the Series
U Preference Amount.

 

		4.5	In relation to the Holdback Shares:

 

		4.5.1	The Company’s right to redeem the Series U Preference Shares shall continue until the expiry of
all of the indemnification obligations of the Preferred Stockholders (as defined in the Merger Agreement) under the Merger Agreement,
notwithstanding any earlier redemption or repurchase, conversion of the Series U Preference Shares, or any transfer of the Series U Preference
Shares or the Ordinary Shares issued upon conversion of the Series U Preference Shares to any person pursuant to this Agreement.

 

    132

     

    

 

		4.5.2	The Series U Investor and/or any subsequent holder of the Series U Preference Shares hereby irrevocably
instructs the Company, upon the exercise of the redemption right provided for in paragraph 4.2, to retain and utilise the Series U Redemption
Price in full discharge of its obligations and liabilities arising from such Holdback Event, and waives any rights it may have in relation
to the Series U Redemption Price.

 

		4.5.3	The Company and all Shareholders undertake to do all reasonable acts and deeds as may be necessary to
give effect to the redemption of the Holdback Shares by the Company in connection with the occurrence of each Holdback Event.

 

		4.6	In relation to Series U Preference Shares that are redeemed by the Company pursuant to paragraph 4.3 above:

 

		4.6.1	Subject to paragraph 4.3 of Schedule 10, any time after the occurrence of a Series U Redemption Event,
each of the holders of the Series U Preference Shares may at each such holder’s option issue a notice (“Series U Redemption
Notice”) to the Company confirming such Series U Holder’s participation, with respect to such number of Series U Preference
Shares mentioned in the Series U Redemption Notice along with original share certificates in respect of such Series U Preference Shares
sought to be redeemed, in the Company’s redemption of Series U Preference Shares following a Series U Redemption Event. The Company
shall within 3 (three) Business Days of receipt of the Series U Redemption Notice, notify the other Preference Shareholders that they
are in receipt of such Series U Redemption Notice, and, to the extent that the respective rights of redemption have accrued under the
terms of their respective Preference Shares, the other Preference Shareholders shall have the option to issue redemption notices of their
own in respect of their Preference Shares (“Other Shareholder Redemption Notice”) within 10 (ten) Business Days of notification
by the Company (“Other Shareholder Redemption Notice Deadline”).

 

		4.6.2	The Series D Preference Shares shall be redeemed in priority to the other classes of Preference Shares
(including the Series A Preference Shares, Series B Preference Shares, Series C Preference Shares and Series U Preference Shares). If
the funds of the Company legally available for redemption are insufficient to redeem such shares in full, those funds that are legally
available shall be used to redeem the maximum number of Series D Preference Shares. At any time when additional funds are legally available,
such funds will be immediately used for redemption for the balance number of the Series D Preference Shares not redeemed earlier.

 

		4.6.3	After redemption of the Series D Preference Shares in full, Series A Preference Shares, Series B Preference
Shares, Series C Preference Shares and Series U Preference Shares shall be eligible to be redeemed on a pro-rata basis, and within 15
(fifteen) Business Days from the Other Shareholder Redemption Notice Deadline, the Company shall take all necessary steps to ensure the
Series U Redemption Price shall be paid by the Company to the relevant participating Series U Holders.

 

		4.6.4	The Series U Preference Shares not redeemed shall remain outstanding and be entitled to all the rights
and preferences provided herein.

 

		4.7	Upon the completion of redemption in accordance with this paragraph 4, each redeemed Series U Preference
Share shall stand cancelled.

 

    133

     

    

 

Annexure A –
[deleted]

 

    134

     

    

 

Annexure B –
[deleted]

 

    135

     

    

 

Annexure C –
Form of Financial Statements

 

    136

     

    

 

Schedule 12

 

Second Amended And Restated Certificate Of Incorporation

 

 

137

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]